0001654954-21-000482.txt : 20210114 0001654954-21-000482.hdr.sgml : 20210114 20210114172224 ACCESSION NUMBER: 0001654954-21-000482 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 74 CONFORMED PERIOD OF REPORT: 20201130 FILED AS OF DATE: 20210114 DATE AS OF CHANGE: 20210114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Loop Industries, Inc. CENTRAL INDEX KEY: 0001504678 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 272094706 STATE OF INCORPORATION: NV FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38301 FILM NUMBER: 21529669 BUSINESS ADDRESS: STREET 1: 480 FERNAND POITRAS CITY: TERREBONNE STATE: A8 ZIP: J6Y 1Y4 BUSINESS PHONE: 781-821-6600 MAIL ADDRESS: STREET 1: 480 FERNAND POITRAS CITY: TERREBONNE STATE: A8 ZIP: J6Y 1Y4 FORMER COMPANY: FORMER CONFORMED NAME: FIRST AMERICAN GROUP INC. DATE OF NAME CHANGE: 20101101 10-Q 1 lpi_10q.htm QUARTERLY REPORT lpi_10q
 

United States
Securities and Exchange Commission
Washington, D.C. 20549
 
FORM 10-Q
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
 
 
 
For the quarterly period ended November 30, 2020
 
or
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from ___________ to __________
 
Commission File No. 000-54768
 
 
Loop Industries, Inc.
(Exact name of Registrant as specified in its charter)
 
Nevada
 
27-2094706
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
 
480 Fernand-Poitras Terrebonne, Québec, Canada J6Y 1Y4
(Address of principal executive offices zip code)
 
Registrant’s telephone number, including area code (450) 951-8555
 
Securities registered pursuant to Section 12(b) of the Act: None
 
Securities registered pursuant to Section 12(g) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock
LOOP
Nasdaq Global Market
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files) Yes ☒  No ☐
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
 
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
 
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ☐  No ☒
 
As at January 14, 2021, there were 42,413,691 shares of the Registrant’s common stock, par value $0.0001 per share, outstanding.
 

 
 
 
LOOP INDUSTRIES, INC.
 
TABLE OF CONTENTS
 
 
 
  3
 
 
PART I. FINANCIAL INFORMATION
 
ITEM 1. FINANCIAL STATEMENTS
 
Loop Industries, Inc.
Three and Nine months ended November 30, 2020
Index to the Unaudited Interim Condensed Consolidated Financial Statements
 
 
 
 
 
 
 
 
 
 
  4
 
 
Loop Industries, Inc.
Condensed Consolidated Balance Sheets
(Unaudited)
 
 
 
November 30, 2020
 
 
February 29, 2020
 
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
Current assets
 
 
 
 
 
 
Cash and cash equivalents
 $43,613,815 
 $33,717,671 
Sales tax, tax credits and other receivables (Note 3)
  1,182,107 
  664,544 
Prepaid expenses and deposits (Note 4)
  1,230,442 
  141,226 
Total current assets
  46,026,364 
  34,523,441 
Investment in joint venture (Note 9)
  1,500,000 
  850,000 
Property, plant and equipment, net (Note 5)
  3,355,410 
  7,260,254 
Intangible assets, net (Note 6)
  631,590 
  202,863 
Total assets
 $51,513,364 
 $42,836,558 
 
    
    
Liabilities and Stockholders' Equity
    
    
Current liabilities
    
    
Accounts payable and accrued liabilities (Note 8)
 $4,088,147 
 $2,082,698 
Current portion of long-term debt (Note 10)
  53,992 
  52,126 
Total current liabilities
  4,142,139 
  2,134,824 
Long-term debt (Note 10)
  2,336,374 
  2,238,026 
Total liabilities
  6,478,513 
  4,372,850 
 
    
    
Commitments and Continencies (Note 17)
    
    
 
    
    
Stockholders' Equity
    
    
Series A Preferred stock par value $0.0001; 25,000,000 shares authorized; one share issued and outstanding (Note 12)
  - 
  - 
Common stock par value $0.0001: 250,000,000 shares authorized; 42,412,739 shares issued and outstanding (February 29, 2020 – 39,910,774) (Note 12)
  4,242 
  3,992 
Additional paid-in capital
  112,112,970 
  82,379,413 
Additional paid-in capital – Warrants
  9,475,996 
  9,785,799 
Accumulated deficit
  (76,468,478)
  (53,317,047)
Accumulated other comprehensive loss
  (89,879)
  (388,449)
Total stockholders' equity
  45,034,851 
  38,463,708 
Total liabilities and stockholders' equity
 $51,513,364 
 $42,836,558 
 
See accompanying notes to the condensed consolidated financial statements.
 
 
F-1
 
 
Loop Industries, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Loss
(Unaudited)
 
 
 
 Three Months Ended November 30
 
 
 Nine Months Ended November 30
 
 
 
 2020
 
 
 2019
 
 
 2020
 
 
 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 $- 
 $- 
 $- 
 $- 
 
    
    
    
    
Expenses
    
    
    
    
Research and development (Notes 13 and 14)
  6,274,283 
  1,278,172 
  10,504,093 
  3,246,246 
General and administrative (Note 14)
  2,724,016 
  1,825,813 
  6,726,339 
  5,447,056 
Write-down and impairment of property, plant and equipment (Note 5)
  5,034,606 
  - 
  5,043,120 
  - 
Depreciation and amortization (Notes 5 and 6)
  104,307 
  219,628 
  654,354 
  562,382 
Interest and other financial (income) expenses (Note 17)
  (41,855)
  693,027 
  26,016 
  1,817,091 
Interest income
  (20,008)
  (171,274)
  (78,394)
  (363,565)
Foreign exchange loss
  95,644 
  5,533 
  275,903 
  15,297 
Total expenses
  14,170,993 
  3,850,899 
  23,151,431 
  10,747,492 
 
    
    
    
    
Net Loss
  (14,170,993)
  (3,850,899)
  (23,151,431)
  (10,747,492)
 
    
    
    
    
Other comprehensive income (loss)
    
    
    
    
Foreign currency translation adjustment
  66,170 
  7,552 
  298,570 
  (30,133)
Comprehensive income (loss)
 $(14,104,823)
 $(3,843,347)
 $(22,852,861)
 $(10,777,625)
 
    
    
    
    
Loss per share
    
    
    
    
Basic and Diluted
 $(0.34)
 $(0.10)
 $(0.57)
 $(0.29)
 
    
    
    
    
Weighted average common shares outstanding
    
    
    
    
Basic and Diluted
  41,715,806 
  39,133,627 
  40,515,885 
  37,404,165 
 
See accompanying notes to the condensed consolidated financial statements.
 
 
F-2
 
 
Loop Industries, Inc.
Condensed Consolidated Statements of Changes in Stockholders’ Equity
(Unaudited)
 
 
 
Three Months Ended November 30, 2020
 
 
 
Common stock par value $0.0001
 
 
Preferred stock par value $0.0001
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of Shares
 
 
Amount
 
 
Number of Shares
 
 
Amount
 
 
Additional Paid-in Capital
 
 
 
 
Additional Paid-in Capital - Warrants
 
 
Additional
Paid-in Capital – Beneficial Conversion Feature
 
 
Common Stock Issuable
 
 
Accumulated Deficit
 
 
Accumulated Other Comprehensive (Loss)
 
 
Total Stockholders' Equity
 
Balance, August 31, 2020
  39,935,210 
 $3,994 
  1 
 $- 
 $84,172,723 
 $9,870,241 
 $- 
 $- 
 $(62,297,485)
 $(156,049)
 $31,593,424 
Issuance of common shares for cash, net of share issuance costs (Note 12)
  2,087,000 
  209 
  - 
  - 
  24,996,419 
  - 
  - 
  - 
  - 
  - 
  24,996,628 
Issuance of shares upon exercise of warrants (Note 16)
  190,529 
  19 
  - 
  - 
  2,046,854 
  (394,245)
  - 
  - 
  - 
  - 
  1,652,628 
Issuance of shares upon the vesting of restricted stock units (Notes 12 and 14)
  200,000 
  20 
  - 
  - 
  (20)
  - 
  - 
  - 
  - 
  - 
  - 
Stock options granted for services (Note 14)
  - 
  - 
  - 
  - 
  551,720 
  - 
  - 
  - 
  - 
  - 
  551,720 
Restricted stock units granted for services (Note 14)
  - 
  - 
  - 
  - 
  345,274 
  - 
  - 
  - 
  - 
  - 
  345,274 
Foreign currency translation
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  66,170 
  66,170 
Net loss
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  (14,170,993)
  - 
  (14,170,993)
Balance, November 30, 2020
  42,412,739 
 $4,242 
  1 
 $- 
 $112,112,970 
 $9,475,996 
 $- 
 $- 
 $(76,468,478)
 $(89,879)
 $45,034,851 
 
 
F-3
 
 
 
        Three Months Ended November 30, 2019 
 
 
Common stock par value $0.0001
 
 
Preferred stock par value $0.0001
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of Shares
 
 
Amount
 
 
Number of Shares
 
 
Amount
 
 
Additional Paid-in Capital
 
 
 
 
Additional Paid-in Capital - Warrants
 
 
Additional Paid-in Capital – Beneficial Conversion Feature
 
 
Common Stock Issuable
 
 
Accumulated Deficit
 
 
Accumulated Other Comprehensive Loss
 
 
Total Stockholders' Equity
 
Balance, August 31, 2019
  39,032,528 
 $3,903 
  1 
 $- 
 $74,414,197 
 $9,700,102 
 $1,200,915 
  - 
 $(45,708,185)
 $(327,909)
 $39,283,023 
Issuance of common shares for cash, net of share issuance costs (Note 12)
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  - 
Issuance of shares upon the vesting of restricted stock units (Notes 12 and 14)
  200,000 
  20 
    
    
  (20)
    
    
  - 
    
    
  - 
Stock options granted for services (Note 14)
  - 
  - 
  - 
  - 
  549,810 
  - 
  - 
  - 
  - 
  - 
  549,810 
Restricted stock units granted for services (Note 14)
  - 
  - 
  - 
  - 
  326,983 
  - 
  - 
  - 
  - 
  - 
  326,983 
Foreign currency translation
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  7,552 
  7,552 
Net loss
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  (3,850,899)
  - 
  (3,850,899)
Balance, November 30, 2019
  39,232,528 
 $3,923 
  1 
 $- 
 $75,290,970 
 $9,700,102 
 $1,200,915 
  - 
 $(49,559,084)
 $(320,357)
 $36,316,469 
 
 
F-4
 
 
 
 
Nine Months Ended November 30, 2020
 
 
 
Common stock par value $0.0001
 
 
Preferred stock par value $0.0001
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of Shares
 
 
Amount
 
 
Number of Shares
 
 
Amount
 
 
Additional
Paid-in Capital
 
 
 
 
Additional
Paid-in Capital - Warrants
 
 
Additional
Paid-in Capital – Beneficial Conversion Feature
 
 
Common Stock Issuable
 
 
Accumulated Deficit
 
 
Accumulated Other Comprehensive (Loss)
 
 
Total Stockholders' Equity
 
Balance, February 29, 2020
  39,910,774 
 $3,992 
  1 
 $- 
 $82,379,413 
 $9,785,799 
 $- 
 $- 
 $(53,317,047)
 $(388,449)
 $38,463,708 
Issuance of common shares for cash, net of share issuance costs (Note 12)
  2,087,000 
  209 
  - 
  - 
  24,996,419 
  - 
  - 
  - 
  - 
  - 
  24,996,628 
Issuance of shares upon exercise of warrants (Note 16)
  190,529 
  19 
  - 
  - 
  2,046,853 
  (394,245)
  - 
  - 
  - 
  - 
  1,652,627 
Warrant issued for services (Note 16)
  - 
  - 
  - 
  - 
  - 
  84,442 
  - 
  - 
  - 
  - 
  84,442 
Issuance of shares upon the vesting of restricted stock units (Notes 12 and 14)
  224,436 
  22 
  - 
  - 
  (22)
  - 
  - 
  - 
  - 
  - 
  - 
Stock options granted for services (Note 14)
  - 
  - 
  - 
  - 
  1,662,155 
  - 
  - 
  - 
  - 
  - 
  1,662,155 
Restricted stock units granted for services (Note 14)
  - 
  - 
  - 
  - 
  1,028,152 
  - 
  - 
  - 
  - 
  - 
  1,028,152 
Foreign currency translation
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  298,570 
  298,570 
Net loss
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  (23,151,431)
  - 
  (23,151,431)
Balance, November 30, 2020
  42,412,739 
 $4,242 
  1 
 $- 
 $112,112,970 
 $9,475,996 
 $- 
 $- 
 $(76,468,478)
 $(89,879)
 $45,034,851 
 
 
F-5
 
 
 
        Nine Months Ended November 30, 2019 
 
 
Common stock par value $0.0001
 
 
Preferred stock par value $0.0001
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of Shares
 
 
Amount
 
 
Number of Shares
 
 
Amount
 
 
Additional
Paid-in Capital
 
 
 
 
Additional
Paid-in Capital - Warrants
 
 
Additional
Paid-in Capital – Beneficial Conversion Feature
 
 
Common Stock Issuable
 
 
Accumulated Deficit
 
 
Accumulated Other Comprehensive Loss
 
 
Total Stockholders' Equity
 
Balance, February 28, 2019
  33,805,706 
 $3,381 
  1 
 $- 
 $38,966,208 
 $757,704 
 $1,200,915 
 $800,000 
 $(38,811,592)
 $(290,224)
 $2,626,392 
Issuance of common shares for cash, net of share issuance costs (Note 12)
  4,693,567 
  469 
  - 
  - 
  30,359,394 
  8,663,769 
  - 
  - 
  - 
  - 
  39,023,632 
Issuance of shares for legal settlement
  150,000 
  15 
  - 
  - 
  (15)
  - 
  - 
  - 
  - 
  - 
  - 
Issuance of shares upon conversion of Convertible notes
  319,326 
  32 
  - 
  - 
  2,372,549 
  316,929 
  - 
  - 
  - 
  - 
  2,689,510 
Issuance of shares upon the vesting of restricted stock units (Notes 12 and 14)
  243,932 
  24 
    
  - 
  799,976 
    
    
  (800,000)
    
    
  - 
Issuance of shares upon the cashless exercise of stock options (Note 14)
  4,565 
  1 
    
    
  (1)
    
    
    
    
    
  - 
Issuance of shares upon exercise of warrants
  15,432 
  1 
    
    
  182,048 
  (38,300)
    
    
    
    
  143,749 
Stock options granted for services (Note 14)
  - 
  - 
  - 
  - 
  1,628,897 
  - 
  - 
  - 
  - 
  - 
  1,628,897 
Restricted stock units granted for services (Note 14)
  - 
  - 
  - 
  - 
  981,914 
  - 
  - 
  - 
  - 
  - 
  981,914 
Foreign currency translation
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  (30,133)
  (30,133)
Net loss
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  - 
  (10,747,492)
  - 
  (10,747,492)
Balance, November 30, 2019
  39,232,528 
 $3,923 
  1 
 $- 
 $75,290,970 
 $9,700,102 
 $1,200,915 
  - 
 $(49,559,084)
 $(320,357)
 $36,316,469 
 
See accompanying notes to the condensed consolidated financial statements.
 
 
F-6
 
 
Loop Industries, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
 
 
 
Nine Months Ended November 30
 
 
 
2020
 
 
2019
 
Cash Flows from Operating Activities
 
 
 
 
 
 
Net loss
 $(23,151,431)
 $(10,747,492)
Adjustments to reconcile net loss to net cash used in operating activities:
    
    
Depreciation and amortization (Notes 5 and 6)
  654,354 
  562,382 
Stock-based compensation expense (Note 14)
  2,774,749 
  2,610,811 
Write-down and impairment of property, plant and equipment (Note 5)
  5,043,120 
  22,985 
Accretion and accrued interest (Note 10)
  56,259 
  1,898,409 
Loss on revaluation of warrants
  - 
  8,483 
Deferred financing costs
  - 
  86,212 
Gain on conversion of convertible notes
  - 
  (232,565)
Loss (gain) on revaluation of foreign exchange contracts
  (58,945)
  10,881 
Changes in operating assets and liabilities:
    
    
Sales tax, tax credits and other receivables (Note 3)
  (477,855)
  (37,536)
Prepaid expenses (Note 4)
  (1,075,291)
  52,649 
Accounts payable and accrued liabilities (Note 8)
  1,690,789 
  (1,054,967)
Net cash used in operating activities
  (14,544,251)
  (6,819,748)
 
    
    
Cash Flows from Investing Activities
    
    
Investment in joint venture (Note 9)
  (650,000)
  (850,000)
Additions to property, plant and equipment (Note 5)
  (1,580,795)
  (1,647,433)
Additions to intangible assets (Note 6)
  (155,798)
  (95,488)
Net cash used in investing activities
  (2,386,593)
  (2,592,921)
 
    
    
Cash Flows from Financing Activities
    
    
Proceeds from sale of common shares and exercise of warrants, net of share issuance costs (Note 12)
  26,649,253 
  39,167,381 
Repayment of long-term debt (Note 10)
  (32,781)
  (39,506)
Net cash provided from financing activities
  26,616,472 
  39,127,875 
 
    
    
Effect of exchange rate changes
  210,516 
  (57,105)
Net change in cash and cash equivalents
  9,896,144 
  29,658,101 
Cash and cash equivalents, beginning of period
  33,717,671 
  5,833,390 
Cash and cash equivalents, end of period
 $43,613,815 
 $35,491,491 
 
    
    
Supplemental Disclosure of Cash Flow Information:
    
    
Income tax paid
 $- 
 $- 
Interest paid
 $28,613 
 $45,668 
Interest received
 $78,394 
 $363,565 
 
See accompanying notes to the condensed consolidated financial statements.
 
 
F-7
 
 
Loop Industries, Inc.
Three and Nine Months Ended November 30, 2020 and 2019
Notes to the Condensed Consolidated Financial Statements
(Unaudited)
 
1. The Company and Basis of Presentation
 
The Company
 
Loop Industries, Inc. (the “Company,” “Loop Industries,” “we,” or “our”) is a technology company that owns patented and proprietary technology that depolymerizes no and low-value waste PET plastic and polyester fiber to its base building blocks (monomers).  The monomers are filtered, purified and polymerized to create virgin-quality Loop™ branded PET resin suitable for use in food-grade packaging and polyester fiber.
 
On November 20, 2017, Loop Industries commenced trading on the NASDAQ Global Market under its new trading symbol, “LOOP.” From April 10, 2017 to November 19, 2017, our common stock was quoted on the OTCQX tier of the OTC Markets Group Inc. under the symbol “LLPP.”
 
Basis of presentation
 
The accompanying unaudited interim condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“US GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures included in these unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended February 29, 2020, filed with the SEC on May 5, 2020. The unaudited interim condensed consolidated financial statements comprise the consolidated financial position and results of operations of Loop Industries, Inc. and its subsidiaries, Loop Innovations, LLC and Loop Canada Inc. All subsidiaries are, either directly or indirectly, wholly owned subsidiaries of Loop Industries, Inc. (collectively, the “Company”). The Company also owns, through Loop Innovations, LLC, a 50% interest in a joint venture, Indorama Loop Technologies, LLC, which is accounted for under the equity method.
 
Intercompany balances and transactions are eliminated on consolidation. The condensed consolidated balance sheet as of February 29, 2020, included herein, was derived from the audited financial statements as of that date, but does not include all disclosures including certain notes required by GAAP on an annual reporting basis. In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements present fairly the financial position, results of operations, comprehensive loss and cash flows for the interim periods. The results for the three- and nine-month periods ended November 30, 2020 are not necessarily indicative of the results to be expected for any subsequent quarter, the fiscal year ending February 28, 2021, or any other period.
 
2. Summary of Significant Accounting Policies
 
Use of estimates
 
The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for depreciable lives of property, plant and equipment, intangible assets, analysis of impairments of long-lived assets and intangible assets, accruals for potential liabilities and assumptions made in calculating the fair value of stock-based compensation and other equity instruments.
 
The COVID-19 pandemic has disrupted business operations for us and our customers, suppliers, vendors and other parties with whom we do business, and such disruptions are expected to continue for an indefinite period of time. The uncertain duration of these measures has had and may continue to have an effect on our development and commercialization efforts. In particular, as previously disclosed, the situation in the United States and the continued travel restrictions and quarantine requirements between Canada and the United States have caused disruptions in our timetable of our joint venture with Indorama in the development of our Spartanburg facility and commercialization of our technology.
 
Although the Company continues to monitor the situation and may adjust the Company’s current policies as more information and public health guidance become available, the COVID-19 pandemic is ongoing, and its dynamic nature, including uncertainties relating to the ultimate spread of the virus, the severity of the disease, the duration of the outbreak and actions that may be taken by governmental authorities to contain the outbreak or to treat its impact, makes it difficult to assess whether there will be further impact on the development and commercialization of the Company’s technology which could have a material adverse effect on the Company’s results of operations and cash flows.
 
 
F-8
 
 
Foreign currency translations and transactions
 
The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars, the reporting currency of the Company. Assets and liabilities of subsidiaries that have a functional currency other than that of the Company are translated to U.S. dollars at the exchange rate as at the balance sheet date. Income and expenses are translated at the average exchange rate of the period. The resulting translation adjustments are included in other comprehensive income (loss) (“OCI”). As a result, foreign currency exchange fluctuations may impact operating expenses. The Company currently has not engaged in any currency hedging activities.
 
For transactions and balances, monetary assets and liabilities denominated in foreign currencies are translated into the functional currency of the entity at the prevailing exchange rate at the reporting date. Non-monetary assets and liabilities, and revenue and expense items denominated in foreign currencies are translated into the functional currency using the exchange rate prevailing at the dates of the respective transactions. Foreign exchange gains and losses resulting from the settlement of such transactions are recognized in the consolidated statements of operations and comprehensive loss, except for gains or losses arising from the translation of intercompany balances denominated in foreign currencies that forms part in the net investment in the subsidiary which are included in OCI.
 
Stock-based compensation
 
The Company periodically issues stock options, warrants and restricted stock units to employees and non-employees in non-capital raising transactions for services and financing expenses. The Company accounts for stock options granted to employees based on the authoritative guidance provided by the FASB wherein the fair value of the award is measured on the grant date and where there are no performance conditions, recognized as compensation expense on the straight-line basis over the vesting period and where performance conditions exist, recognize compensation expense when it becomes probable that the performance condition will be met. Forfeitures on share-based payments are accounted for by recognizing forfeitures as they occur.
 
The Company accounts for stock options and warrants granted to non-employees in accordance with the authoritative guidance of the FASB wherein the fair value of the stock compensation is based upon the measurement date determined as the earlier of the date at which either a) a commitment is reached with the counterparty for performance or b) the counterparty completes its performance.
 
The Company estimates the fair value of restricted stock unit awards to employees and directors based on the closing market price of its common stock on the date of grant.
 
The fair value of the stock options granted are estimated using the Black-Scholes-Merton Option Pricing (“Black-Scholes”) model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options, and future dividends. Stock-based compensation expense is recorded based on the value derived from the Black-Scholes model and on actual experience. The assumptions used in the Black-Scholes model could materially affect stock-based compensation expense recorded in the current and future periods.
 
Income taxes
 
The Company calculates its provision for income tax on the basis of the tax laws enacted at the balance sheet date in the countries where the Company and its subsidiaries operate and generate taxable income, in accordance with FASB ASC 740, Income Taxes. The Company uses an asset and liability approach for financial accounting and reporting for income taxes that allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The Company’s policy is to recognize interest and/or penalties related to income tax matters in income tax expense.
 
Research and development expenses
 
Research and development expenses relate primarily to the development, design, testing of preproduction samples, prototypes and models, compensation, and consulting fees, and are expensed as incurred. Starting in the current quarter, machinery and equipment purchases related to the pilot plant which is now dedicated solely to research and development activities with no alternative use are also expensed as incurred. Total research and development costs recorded during the three- and nine-month periods ended November 30, 2020 amounted to $6,724,283 and $10,504,093 (2019 – $1,278,172 and $3,246,246), respectively, and are net of government research and development tax credits and government grants from the federal and provincial taxation authorities accrued and recorded based on qualifying expenditures incurred during the fiscal periods.
 
Net earnings (loss) per share
 
The Company computes net loss per share in accordance with FASB ASC 260, Earnings Per Share. Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year. The Company includes common stock issuable in its calculation. Diluted earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation if their effect is antidilutive.
 
 
F-9
 
  
For the three- and nine-month periods ended November 30, 2020 and 2019, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have an antidilutive effect. As at November 30, 2020, the potentially dilutive securities consisted of 1,590,470 outstanding stock options (November 30, 2019 – 1,657,081), 4,171,609 outstanding restricted stock units (November 30, 2019 – 4,219,753) and 4,693,802 outstanding warrants (November 30, 2019 – 5,040,267).
 
Recently adopted accounting pronouncements
 
In August 2018, the FASB issued ASU 2018-15, “Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that Is a Service Contract,” which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). This update is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The adoption of the standard had no impact on the consolidated financial statements of the Company.
 
In February 2018, the FASB issued ASU 2018-02, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which permits entities to reclassify the disproportionate income tax effects of the Tax Reform Act on items within accumulated other comprehensive income (loss) (“AOCI”) to retained earnings. These disproportionate income tax effect items are referred to as "stranded tax effects." Amendments in this update only relate to the reclassification of the income tax effects of the Tax Reform Act. Other accounting guidance that requires the effect of changes in tax laws or rates to be included in net income from continuing operations is not affected by this update. ASU 2018-02 should be applied either in the period of adoption or retrospectively to each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Reform Act is recognized. ASU 2018-02 is applicable beginning March 1, 2020. The adoption of the standard had no impact on the consolidated financial statements of the Company.
 
In February 2016, the FASB issued ASU 2016-02, “Leases,” amended in July by ASU 2018-10, “Codification Improvements to Topic 842, Leases,” ASU 2018-11, “Targeted Improvements,” and ASU 2018-20, “Narrow-Scope Improvements for Lessors,” which requires lessees to recognize leases on the balance sheet while continuing to recognize expenses in the income statement in a manner similar to current accounting standards. For lessors, the new standard modifies the classification criteria and the accounting for sales-type and direct financing leases. Enhanced disclosures will also be required to give financial statement users the ability to assess the amount, timing, and uncertainty of cash flows arising from leases. This ASU may either be adopted on a modified retrospective approach at the beginning of the earliest comparative period, or through a cumulative-effect adjustment at the adoption date. This update is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company adopted these standards effective March 1, 2020. The adoption of the standard had no impact on the consolidated financial statements of the Company. The Company elected to apply the package of practical expedients that allows us not to reassess whether expired or existing contracts contain leases, the classification of these leases and whether previously capitalized initial direct costs would qualify for capitalization under Accounting Standards Codification (or “ASC”) 842. Furthermore, we elected to use hindsight in determining the lease term and assessing impairment of the right-of-use assets.
 
Recently issued accounting pronouncements not yet adopted
 
In December 2019, the FASB issued ASU 2019-12, “Simplifying the Accounting for Income Taxes,” which removes specific exceptions to the general principles in ASC 740, “Income Taxes,” and clarifies certain aspects of the existing guidance. This update is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years, with early adoption being permitted as of the beginning of an interim or annual reporting period. All amendments to this ASU must be adopted in the same period on a prospective basis, with certain exceptions. We are still evaluating the impact of this accounting guidance on our results of operations and financial position.
 
In June 2016, the FASB issued ASU 2016-13, “Financial Instruments—Credit Losses”. This ASU added a new impairment model (known as the current expected credit loss (“CECL”) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes an allowance for its estimate of expected credit losses and applies to most debt instruments, trade receivables, lease receivables, financial guarantee contracts, and other loan commitments. The CECL model does not have a minimum threshold for recognition of impairment losses and entities will need to measure expected credit losses on assets that have a low risk of loss. This update is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years for smaller reporting companies. We are still evaluating the impact of this accounting guidance on our results of operations and financial position.
 
3. Sales Tax, Tax Credits and Other Receivables
 
Sales tax, research and development tax credits and other receivables as at November 30, 2020 and February 29, 2020 were as follows:
 
 
 
November 30, 2020
 
 
February 29, 2020
 
Sales tax
 $669,966 
 $180 971 
Research and development tax credits
  390,885 
  447,843 
Other receivables
  121,256 
  35,730 
 
 $1,182,107 
 $664,544 
 
 
F-10
 
 
4. Prepaid Expenses and Deposits
 
Prepaid expenses and deposits as at November 30, 2020 and February 29, 2020 were as follows:
 
 
 
November 30, 2020
 
 
February 29, 2020
 
Deposits on machinery and equipment
 $747,250 
 $- 
Insurance
  427,013 
  61,891 
Other prepaid expenses
  56,179 
  79,335 
 
 $1,230,442 
 $141,226 
 
Non-refundable cash deposits on machinery and equipment that will be used in research and development activities will be expensed, and classified as research and development expenses, in the period the equipment is received and placed into use.
 
5. Property, Plant and Equipment
 
 
 
As at November 30, 2020
 
 
 
Cost
 
 
Accumulated depreciation, write-down and impairment
 
 
Net book value
 
Building
 $1,912,138 
 $(181,308)
 $1,730,830 
Land
  236,360 
  - 
  236,360 
Building and land improvements
  1,602,766 
  (379,164)
  1,223,602 
Machinery and equipment
  6,514,252 
  (6,514,252)
  - 
Office equipment and furniture
  260,220 
  (95,602)
  164,618 
Balances, end of period
 $10,525,736 
 $(7,170,326)
 $3,355,410 
 
 
 
As at February 29, 2020
 
 
 
Cost
 
 
Accumulated depreciation, write-down and impairment
 
 
Net book value
 
Building
 $1,846,070 
 $(128,911)
 $1,717,159 
Land
  264,868 
  - 
  264,868 
Building and land improvements
  733,884 
  (214,068)
  519,816 
Machinery and equipment
  6,085,195 
  (1,426,465)
  4,658,730 
Office equipment and furniture
  162,466 
  (62,785)
  99,681 
Balances, end of period
 $9,092,483 
 $(1,832,229)
 $7,260,254 
 
Depreciation expense for the three- and nine-month periods ended November 30, 2020 amounted to $93,006 and $624,189, respectively (2019 – $212,968 and $570,165, respectively), and is recorded as an expense in the consolidated statements of operations and comprehensive loss.
 
During the three- and nine-month periods ended November 30, 2020, the Company recorded write-down and impairment expenses of $5,034,606 and 5,043,120, respectively (2019 – nil and $22,985). In the quarter ended November 30, 2020, the Company’s management made the decision to convert its pilot plant to exclusively a demonstration and training facility for our future Infinite Loop™ manufacturing facilities, therefore foregoing any alternative future use of its machinery and equipment assets contained within the pilot plant. As such, the carrying value of the machinery and equipment was written off resulting in an expense of $5,034,606 being recognized in the three-month period ended November 30, 2020. With the decision to dedicate the demonstration and training facility to research and development, the accounting for future costs associated with these activities are considered in scope of ASC 730, Research and Development Costs, and will be recognized as a research and development expense in the consolidated statements of operations and comprehensive loss in the period they are incurred. During the three-month period ended November 30, 2020, the Company purchased $2,325,540 of machinery and equipment associated with its ongoing research and development activities, which have no future alternative use and as such, were recognized as research and development expenses in the consolidated statements of operations and comprehensive loss. See Note 13 for components of research and development expenses.
 
 
F-11
 
 
6. Intangible Assets
 

 
November 30, 2020
 
 
February 29, 2020
 
 
 
 
 
 
 
 
Intangible assets, at cost - beginning of period
 $225,174 
 $127,672 
Intangible assets, accumulated depreciation – beginning of period
  (22,311)
  - 
 
  202,863 
  127,672 
 
    
    
Additions in the period
  452,758 
  99,972 
Amortization of intangibles
  (30,165)
  (22,631)
Foreign exchange effect – increase (decrease)
  6,133 
  (2,150)
 
 $631,589 
 $202,863 
 
Amortization expense for the three- and nine-month periods ended November 30, 2020 amounted to $11,301 and $30,165, respectively (2019 - $6,660 and $15,202, respectively), and is recorded as an expense in the unaudited condensed consolidated statements of operations and comprehensive loss.
 
7. Fair value of financial instruments
 
The following tables present the fair value of the Company’s financial (assets) liabilities as at November 30, 2020 and February 29, 2020:
 
 
 
Fair Value Measurements as at November 30, 2020
 
 
 
Carrying Amount
 
 
Fair Value
 
 
Level in the hierarchy
 
Instruments measured at fair value on a recurring basis:
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 $(25,797)
 $(25,797)
  Level 2 
 
    
    
    
Instruments measured at amortized cost:
    
    
    
Long-term debt
 $2,390,366 
 $2,400,897 
  Level 2 
 
 
 
Fair Value Measurements at February 29, 2020
 
 
 
Carrying Amount
 
 
Fair Value
 
 
Level in the hierarchy
 
Instruments measured at fair value on a recurring basis:
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 $26,840 
 $26,840 
  Level 2 
 
    
    
    
Instruments measured at amortized cost:
    
    
    
Long-term debt
 $2,290,152 
 $2,291,109 
  Level 2 
 
8. Accounts Payable and Accrued Liabilities
 
Accounts payable and accrued liabilities as at November 30, 2020 and February 29, 2020 were as follows:
 
 
 
November 30, 2020
 
 
February 29, 2020
 
Trade accounts payable
 $1,514,881 
 $814,081 
Accrued engineering fees
  686,061 
  - 
Accrued employee compensation and payroll taxes
  678,925 
  873,242 
Accrued professional fees
  676,153 
  133,038 
Accrued cost of machinery and equipment
  415,522 
  92,126 
Other accrued liabilities
  116,605 
  170,211 
 
 $4,088,147 
 $2,082,698 
 
9. Joint Venture
 
On September 15, 2018, the Company, through its wholly-owned subsidiary Loop Innovations, LLC, a Delaware limited liability company, entered into a Joint Venture Agreement (the “Joint Venture Agreement”) with Indorama Ventures Holdings LP, USA, an indirect subsidiary of Indorama Ventures Public Company Limited, to manufacture and commercialize sustainable polyester resin. Each company has a 50/50 equity interest in Indorama Loop Technologies, LLC (“ILT”), which was specifically formed to operate and execute the joint venture.
 
 
F-12
 
  
Under the Joint Venture Agreement, Indorama Ventures is contributing manufacturing knowledge and Loop Industries is required to contribute its proprietary science and technology. Specifically, the Company is contributing an exclusive world-wide royalty-free license to ILT to use its proprietary technology to produce 100% sustainably produced PET resin and polyester fiber.
 
ILT meets the accounting definition of a joint venture where neither party has control of the joint venture entity and both parties have joint control over the decision-making process in ILT. As such, the Company uses the equity method of accounting to account for its share of the investment in ILT. There were no operations in ILT from the date of inception of September 24, 2018 to November 30, 2020 and, as at November 30, 2020, the carrying value of the equity investment was $1,500,000, which is the total of the cash contributions we have made to ILT. During the three- and nine-month periods ended November 30, 2020, we made contributions to ILT of nil and $650,000 respectively (2019 – $350,000 and $850,000). These contributions to ILT, which have been matched by Indorama Ventures, were used to fund engineering design costs which have been capitalized in ILT.
 
The joint venture made a decision in July that due to the COVID-19 situation it would delay work on the project. Since then, no expenditures have been incurred by the joint venture.
 
10. Long-Term Debt
 
 
 
November 30, 2020
 
 
February 29, 2020
 
Investissement Québec financing facility:
 
 
 
 
 
 
Principal amount
 $1,703,998 
 $1,645,122 
Unamortized discount
  (272,036)
  (289,852)
Accrued interest
  31,549 
  958 
Total Investissement Québec financing facility
  1,463,511 
  1,356,228 
Term loan
    
    
Principal amount
  926,855 
  933,924 
Less: current portion
  (53,992)
  (52,126)
Total term loan, net of current portion
  872,863 
  881,798 
Long-term debt, net of current portion
 $2,336,374 
 $2,238,026 
 
Investissement Québec financing facility
 
On February 21, 2020, the Company received $1,703,998 (CDN$2,209,234) from Investissement Québec as the first disbursement of our financing facility, out of a maximum of $3,548,014 (CDN$4,600,000) (the “Financing Facility”). The loan bears interest at 2.36% and there is a 36-month moratorium on both capital and interest repayments starting on the date of the first disbursement, after which capital and interest is repayable in 84 monthly installments. The Company established the fair value of the loan for the first disbursement at $1,354,408 based on a discount rate of 5.45%, which reflected a debt discount of $290,714. The discount rate used was based on the external financing from a Canadian bank. The Company, under the loan agreement, was required to pay fees representing 1% of the loan amount, $35,480 (CDN$46,000) to Investissment Québec which we deferred and recorded as a reduction of the Financing Facility. Debt discount and deferred financing expenses are amortized to “Interest and other financial expenses” in our Consolidated Statements of Operations and Comprehensive Loss. The Company recorded interest expense on the Investissement Québec loan for the three- and nine-month periods ended November 30, 2020 in the amount of $10,003 and $28,816 respectively (2019 – nil and nil) and an accretion expense of $9,387 and $27,045 respectively (2019 – nil and nil).
 
The Company has also agreed to issue to Investissement Québec warrants to purchase shares of common stock of the Company in an amount equal to 10% of each disbursement up to a maximum aggregate amount of $354,801 (CDN$460,000). The exercise price of the warrants is equal to the higher of (i) $11.00 per share and (ii) the ten-day weighted average closing price of Loop Industries shares of common stock on the Nasdaq stock market for the 10 days prior to the issue of the warrants. The warrants can be exercised immediately upon grant and will have a term of three years from the date of issuance. The loan can be repaid at any time by the Company without penalty. In connection the first disbursement of the Financing Facility, the Company issued a warrant (“First Disbursement Warrant”) to acquire 15,153 shares of common stock at a strike price of $11.00 per share to Investissement Québec. The Company determined the fair value of the warrants using the Black-Scholes pricing formula. The fair value of the First Disbursement Warrant was determined to be $77,954 and is included in “Additional paid-in capital – Warrants” in our Condensed Consolidated Balance Sheets. The First Disbursement Warrant remains outstanding as at November 30, 2020.
 
The remaining amount available under the financing facility is $1,844,015 (CDN$2,390,766) to be received in a maximum of two additional disbursements.
 
Term loan
 
On January 24, 2018, the Company obtained a $1,079,830 (CDN$1,400,000) 20-year term instalment loan (the “Loan”), from a Canadian bank. The Loan bears interest at the bank’s Canadian prime rate plus 1.5%. By agreement, the Loan is repayable in monthly payments of $4,499 (CDN$5,833) plus interest, until January 2021, at which time the monthly repayment amount and interest rate will be subject to renewal. It includes an option allowing for the prepayment of the Loan without penalty. In January 2021, the Company and the Canadian bank agreed to maintain the same repayment amount and interest rate until January 2022. During the three- and nine-month periods ended November 30, 2020, we repaid $13,497 and $32,781 respectively (2019 – $13,168 and $39,506) on the principal balance of the Loan and interest paid amounted to $9,172 and $29,102 and (2019 - $14,778 and $41,840). The terms of the credit facility require the Company to comply with certain financial covenants. As at November 30, 2020 and 2019, the Company was in compliance with its financial covenants.
 
 
F-13
 
 
Principal repayments due on the Company’s long-term debt over the next five years are as follows:
 
Years ending
 
Amount
 
February 28, 2021
 $13,498 
February 28, 2022
  53,992 
February 28, 2023
  53,992 
February 29, 2024
  297,416 
February 28, 2025
  297,416 
Thereafter
  1,901,043 
Total
 $2,617,355 
 
11.
Related Party Transactions
 
Employment Agreement
 
On June 29, 2015, the Company entered into an employment agreement with Mr. Daniel Solomita, the Company’s President and Chief Executive Officer (“CEO”). The employment agreement is for an indefinite term.
 
On July 13, 2018, the Company and Mr. Solomita entered into an amendment and restatement of the employment agreement which provided for a long-term incentive grant of 4,000,000 shares of the Company’s common stock, in tranches of one million shares each, upon the achievement of four performance milestones. This was modified to provide a grant of 4,000,000 restricted stock units (“RSUs”) covering 4,000,000 shares of the Company’s common stock while the performance milestones remained the same. The grant of the restricted stock units became effective upon approval by the Company’s shareholders at the Company’s 2019 annual meeting, of an increase in the number of shares available for grant under the Plan.  Such approval was granted by the Company’s shareholders at the Company’s 2019 annual meeting.
 
On April 30, 2020, the Company and Mr. Solomita entered into an amendment of Mr. Solomita’s employment agreement.  The amendment clarified the milestones consistent with the shift in the Company’s business from the production of terephthalate to the production of dimethyl terephthalate, another proven monomer of PET plastic.
 
As at November 30, 2020, 3,600,000 (2019 – 3,800,000) of Mr. Solomita’s RSUs were outstanding of which 600,000 were vested (2019 – 800,000). The vested units are settled annually in tranches of 200,000 units. During the three- and nine-month periods ended November 30, 2020 and November 30, 2019, no outstanding milestones were probable of being met based on the authoritative guidance provided by the FASB and, accordingly, the Company did not record any additional compensation expense. When a milestone becomes probable, the corresponding expense will be valued based on the grant date fair value on April 30, 2020, the date of the last modification of Mr. Solomita’s employment agreement. The closing price of the Company’s common stock on the Nasdaq on April 30, 2020 was $7.74 per share.
 
12. Stockholders’ Equity
 
Common Stock
 
For the period ended November 30, 2020
 
Number of shares
 
 
Amount
 
Balance, February 29, 2020
  39,910,774 
 $3,992 
Issuance of shares for cash
  2,087,000 
  209 
Issuance of shares upon the exercise of warrants
  190,529 
  19 
Issuance of shares upon settlement of restricted stock units
  224,436 
  22 
Balance, November 30, 2020
  42,412,739 
 $4,242 
 
For the period ended November 30, 2019
 
Number of shares
 
 
Amount
 
Balance, February 28, 2019
  33,805,706 
 $3,381 
Issuance of shares for cash
  4,693,567 
  469 
Issuance of shares upon vesting of restricted stock units
  243,932 
  24 
Issuance of shares upon the cashless exercise of stock options
  4,565 
  1 
Issuance of shares upon the exercise of warrants
  15,432 
  1 
Issuance of shares upon settlement of legal matter
  150,000 
  15 
Issuance of shares upon conversion of Convertible notes
  319,326 
  32 
Balance, November 30, 2019
  39,232,528 
 $3,923 
 
 
F-14
 
 
During the nine months ended November 30, 2020, the Company recorded the following common stock transaction:
 
(i)
On September 23, 2020 and October 1, 2020, the Company sold 1,880,000 and 207,000 shares, respectively of its common stock at an offering price of $12.75 per share in a registered direct offering, for total gross proceeds of $26,609,250.
(ii)
The company issued 192,529 shares of its common stock upon the exercise of warrants.
(iii)
On October 15, 2020, the Company issued 200,000 shares of common stock to settle restricted stock units related to the President and Chief Executive Officer.
(iv)
The Company issued 24,436 shares of its common stock to settle restricted stock units that vested in the period.
 
During the nine months ended November 30, 2019, the Company recorded the following common stock transactions:
 
(i)
On March 1, 2019, the Company sold 600,000 shares of its common stock at an offering price of $8.55 per share in a registered direct offering, for gross proceeds of $5,130,000.
(ii)
On March 8, 2019 and March 11, 2019, the Company issued 150,000 shares of its common stock in settlement of a legal matter.
(iii)
On April 9, 2019, the Company converted Convertible notes with a face value of $2,650,000 plus accrued interest of $80,241 at a conversion price of $8.55, into 319,326 common shares.
(iv)
On June 14, 2019, the Company sold 4,093,567 shares of its common stock at an offering price of $8.55 per share in a registered direct offering, for gross proceeds of $35,000,000.
(v)
On June 21, 2019, the Company issued 7,043 shares of common stock upon the vesting of restricted stock units related to an employee.
(vi)
On July 2, 2019 and July 3, 2019, the Company issued 23,547 shares of common stock upon the vesting of restricted stock units related to current and former Directors.
(vii)
On July 12, 2019, the Company issued 4,565 shares of common stock upon the cashless exercise of stock options related to an employee.
(viii)
On July 15, 2019, the Company issued 13,342 shares of common stock upon the vesting of restricted stock units related to a former Director.
(ix)
On July 17, 2019, the Company issued 15,432 shares of common stock upon the exercise of warrants.
(x)
On October 15, 2019, the Company issued 200,000 shares of common stock to settle restricted stock units related to the President and Chief Executive Officer.
 
13. Research and development expenses
 
Research and development expenses for the three months ended November 30, 2020 and 2019 were as follows:
 

 
November 30, 2020
 
 
November 30, 2019
 
External engineering
 $2,224,910 
 $33,131 
Machinery and equipment expenditures
  2,325,540 
  - 
Employee compensation
  1,214,434 
  973,679 
Pilot plant operating expenses
  399,031 
  166,753 
Other
  110,368 
  104,610 
 
 $6,274,283 
 $1,278,173 
 
Research and development expenses for the nine months ended November 30, 2020 and 2019 were as follows:
 
 
 
November 30, 2020
 
 
 November 30, 2019
 
External engineering
 $3,241,959 
 $83,462 
Employee compensation
  3,094,151 
  2,453,743 
Machinery and equipment expenditures
  2,325,540 
  - 
Pilot plant operating expenses
  1,537,271 
  456,942 
Other
  305,172 
  252,099 
 
 $10,504,093 
 $3,246,246 
 
14. Share-based Payments
 
Stock Options
 
During the three- and nine-month period ended November 30, 2020, the Company granted 3,389 stock options (2019 – nil) with a weighted average exercise price of $8.78 (2019 – nil), no stock options were forfeited (2019 – 39,902; weighted average exercise price: $9.67) or exercised (2019 – 5,000; weighted average exercise price: $0.80) and no stock options expired (2019 – 260,417; weighted average exercise price: $13.59).
 
 
F-15
 
 
The Company applies the fair value method of accounting for stock-based compensation awards granted. Fair value is calculated based on a Black-Scholes option pricing model. The principal components of the pricing model were as follows:
 
 
 
2020
 
 
2019
 
Exercise price
 $8.78 
 $- 
Risk-free interest rate
  1.05%
  - 
Expected dividend yield
  0.00%
  - 
Expected volatility
  75.95%
  - 
Expected life
 
7.5 years
 
  - 
 
The total number of stock options outstanding as at November 30, 2020 was 1,587,081 (2019 – 1,657,081) with a weighted average exercise price of $6.81 (2019 - $6.55), of which 1,132,498 were exercisable (2019 – 1,007,498) with a weighted average exercise price of $7.12 (2019 – $6.38).
 
During the three- and nine-month periods ended November 30, 2020, stock-based compensation expense attributable to stock options amounted to $551,720 and $1,662,155 respectively (2019 - to $549,810 and $1,628,897) and is included in expenses.
 
Restricted Stock Units
 
The Company applies the fair value method of accounting for awards granted through the issuance of restricted stock units. Fair value is calculated based on the closing share price at grant date multiplied by the number of restricted stock unit awards granted.
 
During the three-month period ended November 30, 2020, the Company granted 57,859 restricted stock units (“RSUs”) (2019 – nil) with a weighted average fair value of $12.96 (2019 – nil), settled 200,000 RSUs (2019 – 200,000) with a weighted average fair value of $0.80 (2019 – $0.80) and no RSUs were forfeited (2019 – nil).
 
During the nine-month period ended November 30, 2020, the Company granted 180,232 RSUs (2019 – 4,114,567) with a weighted average fair value of $10.18 (2019 – $1.06), settled 224,436 RSUs (2019 – 243,932) with a weighted average fair value of $1.78 (2019 – 2.52) and 2,989 RSUs were forfeited (2019 – 53,750) with a weighted average fair value of $8.78 (2019 – $9.82).
 
The total number of RSUs outstanding as at November 30, 2020 was 4,171,609 (2019 – 4,219,753), of which 691,327 were vested (2019 – 831,684).
 
During the three- and nine-month periods ended November 30, 2020, stock-based compensation expense attributable to RSUs amounted to $345,274 and $1,028,152 respectively (2019 - $326,983 and $981,914) and is included in expenses.
 
During the three- and nine-month periods ended November 30, 2020 and November 30, 2019, stock-based compensation included in research and development expenses amounted to $350,393 and $1,054,682 respectively (2019 – $311,353 and $941,142), and in general and administrative expenses amounted to $546,601 and $1,720,067 respectively (2019 - $565,440 and $1,669,669).
 
15. Equity Incentive Plan
 
On July 6, 2017, the Company adopted the 2017 Equity Incentive Plan (the “Plan”). The Plan permits the granting of warrants, stock options, stock appreciation rights and restricted stock units to employees, directors and consultants of the Company. A total of 3,000,000 shares of common stock were initially reserved for issuance under the Plan at July 6, 2017, with annual automatic share reserve increases, as defined in the Plan, amounting to the lessor of (i) 1,500,000 shares, (ii) 5% of the outstanding shares on the last day of the immediately preceding fiscal year, or (iii) or such number of shares determined by the Administrator of the Plan, effective March 1, 2018. In March 2020, the Board of Directors elected to waive the annual share reserve increase for the fiscal year ending February 28, 2021. The Plan is administered by the Board of Directors who designates eligible participants to be included under the Plan, the number of awards granted, the share price pursuant to the awards and the vesting conditions and period. The awards, when granted, will have an exercise price of no less than the estimated fair value of shares at the date of grant and a life not exceeding 10 years from the grant date. However, where a participant, at the time of the grant, owns stock representing more than 10% of the voting power of the Company, the life of the options shall not exceed 5 years.
 
 
F-16
 
 
The following table summarizes the continuity of the Company’s Equity Incentive Plan units during the nine-month periods ended November 30, 2020 and 2019:
 
 
 
2020
 
 
2019
 
 
 
Number of units
 
 
Number of units
 
Outstanding, beginning of period
  1,300,518 
  3,223,516 
Share reserve increase
  - 
  2,000,000 
Units granted
  (183,621)
  (4,114,567)
Units forfeited
  2,989 
  93,652 
Units expired
  - 
  260,417 
Outstanding, end of period
  1,119,886 
  1,463,018 
 
16. Warrants
 
During the three-month period ended November 30, 2020 159,664 warrants were exercised at the price of $8.55 per share and 30,864 warrants were exercised at the price of $9.32 per share. No warrants were granted, were forfeited nor expired in the three-month period ended November 30, 2020.
 
During the three-month period ended November 30, 2019, no warrants were granted, were forfeited, were exercised nor expired.
 
During the nine-month period ended November 30, 2020, the Company issued, in exchange for consulting services, a warrant to purchase 25,000 shares of our common stock at the price of $9.43 per share expiring May 12, 2022 and warrants to issue 200,000 shares of our common stock with an exercise price of $11.00 expired. During the nine-month periods ended November 30, 2020, 159,664 warrants were exercised at the price of $8.55 per share and 30,864 warrants were exercised at the price of $9.32 per share. No warrants were forfeited in the nine-month period ended November 30, 2020.
 
During the nine-month period ended November 30, 2019, the Company issued a warrant to purchase 159,663 shares of our common stock at the price of $8.55 per share expiring October 5, 2020 as well as a warrant to purchase 4,093,567 shares of our common stock at the price of $11.00 per share expiring June 14, 2022. During the nine-month period ended November 30, 2019, 15,432 shares of our common stock were issued upon the exercise of a warrant with an exercise price of $9.32. No warrants were forfeited, and no warrants expired in the nine-month period ended November 30, 2019.
 
17. Interest and Other Finance Costs
 
Interest and other finance costs for the three- and nine-month periods ended November 30, 2020 and 2019 are as follows:
 
 
 
Three Months Ended November 30
 
 
Nine Months Ended November 30
 
 
 
2020
 
 
2019
 
 
2020
 
 
2019
 
  Interest on long-term debt
 $19,185 
 $14,778 
 $57,917 
 $41,840 
  Interest on convertible notes
  - 
  98,000 
  - 
  313,433 
  Accretion expense
  9,387 
  549,090 
  27,044 
  1,584,977 
  Amortization of deferred finance costs
  - 
  19,885 
  - 
  86,212 
  Loss (gain) on revaluation of foreign exchange contracts
  (70,427)
  10,881 
  (58,945)
  10,881 
  Revaluation of warrants
  - 
  - 
  - 
  8,483 
  Gain on conversion of November 2018 Notes
  - 
  - 
  - 
  (232,565)
  Other
  - 
  393 
  - 
  3,830 
 
 $(41,855)
 $693,027 
 $26,016 
 $1,817,091 
 
 
F-17
 
 
18. Commitments and Contingencies
 
Commercial commitments
 
On September 2, 2020, the Company entered into a know-how and engineering agreement (the “Chemtex Agreement”) with Chemtex Global Corporation (“Chemtex”) to license the PET plastic and polyester polymer for fiber manufacturing know-how of INVISTA’s technology and licensing group, INVISTA Performance Technologies (IPT) (“INVISTA”). The total value of the Chemtex Agreement is $4,300,000 and covers the know-how and design of two Infinite Loop™ facilities. Payment terms are based on the completion of certain milestones and total $2,150,000 for each facility. During the three and nine months ended November 30, 2020, $500,000 was paid by the Company.
 
On October 29, 2020, Coca-Cola Cross Enterprise Procurement Group (“CEPG”) advised the Company of its intention to terminate the Master Terms and Conditions Supply Agreement for Loop PET plastic, dated November 14, 2018 (the “MTC”) because the Company did not satisfy its first production milestone from the joint venture facility by July 2020 as required by the MTC.
 
Contingencies
 
On October 13, 2020, the Company and certain of its officers were named as defendants in a proposed class action lawsuit filed in the United States District Court for the Southern District of New York, captioned Olivier Tremblay, Individually and on Behalf of All Other Similarly Situated v. Loop Industries, Inc., Daniel Solomita, and Nelson Gentiletti, Case No. 7:20-cv-0838 (“Tremblay Class Action”). The allegations in the complaint claim that the defendants allegedly violated Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 by allegedly making materially false and/or misleading statements, as well as allegedly failing to disclose material adverse facts about the Company’s business, operations, and prospects, which caused the Company’s securities to trade at artificially inflated prices. Plaintiff seeks unspecified damages on behalf of a class of purchasers of Loop’s securities between September 24, 2018 and October 12, 2020.
 
On October 13, 2020, the Company, Loop Canada Inc. and certain of their officers and directors were named as defendants in a proposed securities class action filed in the Superior Court of Québec (District of Terrebonne, Province of Québec, Canada), in file no. 700-06-000012-205. The Application for authorization of a class action and for authorization to bring an action pursuant to section 225.4 of the Québec Securities Act (“the Application”) was filed by an individual shareholder on behalf of himself and a class of buyers who purchased our securities during the “Class Period” (not defined). Plaintiff alleges that throughout the Class Period, the defendants allegedly made false and/or misleading statements and allegedly failed to disclose material adverse facts concerning the Company’s technology, business model, operations and prospects, thus causing the Company’s stock price to be artificially inflated and thereby causing plaintiff to suffer damages. Plaintiff seeks unspecified damages stemming from losses he claims to have suffered as a result of the foregoing. On December 13, 2020, the Application was amended in order to add allegations regarding specific misrepresentations.
 
On October 28, 2020, the Company and certain of its officers were named as defendants in a second proposed class action lawsuit filed in the United States District Court for the Southern District of New York, captioned Michelle Bazzini, Individually and on Behalf of All Other Similarly Situated v. Loop Industries, Inc., Daniel Solomita, and Nelson Gentiletti, Case No. 7:20-cv-09031-UA. The allegations in this complaint are similar in nature to those made in the Tremblay Class Action.
 
On January 4, 2021, the United States District Court for the Southern District of New York rendered a stipulation and order granting the consolidation of the two class action lawsuits filed in New York as In re Loop Industries, Inc. Securities Litigation, Master File No. 7:20-cv-08538. Sakari Johansson and John Jay Cappa have been appointed as Co-Lead Plaintiffs and Glancy Prongay & Murray LLP and Pomerantz LLP have been appointed as Co-Lead Counsel for the class.
 
Management believes that these cases lack merit and intends to defend them vigorously. No amounts have been provided for in the consolidated financial statements with respect to these claims. Management has not yet determined what effect these lawsuits may have on its financial position or results of operations as they are still in the preliminary stages.
 
19. Subsequent events
 
Subsequent to the end of the quarter, the Company entered into an engineering and equipment supply agreement to acquire PET polymerization equipment from Chemtex Global Corporation to manufacture PET resin at the demonstration plant. This agreement represents a total commitment of $4,200,000.
 
 
F-18
 
 
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
The following information and any forward-looking statements should be read in conjunction with the unaudited financial information and the notes thereto included in this Quarterly Report on Form 10-Q, including those risks identified in the “Risk Factors” section of our most recent Annual Report on Form 10-K, as amended.
 
CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING STATEMENTS
 
This Quarterly Report on Form 10-Q of Loop Industries, Inc., a Nevada corporation (the “Company,” “Loop Industries,” “we,” or “our”), contains “forward-looking statements,” as defined in the United States Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of such terms and other comparable terminology. These forward-looking statements include, without limitation, statements about our market opportunity, our strategies, ability to improve and expand our capabilities, competition, expected activities and expenditures as we pursue our business plan, the adequacy of our available cash resources, regulatory compliance, plans for future growth and future operations, the size of our addressable market, market trends, and the effectiveness of the Company’s internal control over financial reporting. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Actual results may differ materially from the predictions discussed in these forward-looking statements. The economic environment within which we operate could materially affect our actual results. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. These risks and other factors include, but are not limited to, those listed under “Risk Factors.” Additional factors that could materially affect these forward-looking statements and/or predictions include, among other things: (i) commercialization of our technology and products, (ii) our status of relationship with partners, (iii) development and protection of our intellectual property and products, (iv) industry competition, (v) our need for and ability to obtain additional funding, (vi) building our manufacturing facility, (vii) our ability to scale, manufacture and sell our products in order to generate revenues, (viii) our proposed business model and our ability to execute thereon, (ix) adverse effects on the Company’s business and operations as a result of increased regulatory, media or financial reporting scrutiny, practices, rumors or otherwise, (x) disease epidemics and health related concerns, such as the current outbreak of a novel strain of coronavirus (COVID-19), which could result in (and, in the case of the COVID-19 outbreak, has resulted in some of the following) reduced access to capital markets, supply chain disruptions and scrutiny or embargoing of goods produced in affected areas, government-imposed mandatory business closures and resulting furloughs of our employees, travel restrictions or the like to prevent the spread of disease, and market or other changes that could result in noncash impairments of our intangible assets, and property, plant and equipment, (xi) the outcome of the current SEC investigation or recent class action litigation filed against us, (xii) our ability to hire and/or retain qualified employees and consultants and (xiii) other factors discussed in our subsequent filings with the SEC.
 
Management has included projections and estimates in this Form 10-Q, which are based primarily on management’s experience in the industry, assessments of our results of operations, discussions and negotiations with third parties and a review of information filed by our competitors with the SEC or otherwise publicly available.
 
In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as at the date of this Form 10-Q, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely upon these statements.
 
We caution readers not to place undue reliance on any such forward-looking statements, which speak only as at the date made. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.
 
Introduction
 
Loop Industries is a technology company whose mission is to accelerate the world’s shift toward sustainable PET plastic and polyester fiber and away from our dependence on fossil fuels. Loop Industries owns patented and proprietary technology that depolymerizes no and low-value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpets and textiles of any color, transparency or condition and even ocean plastics that have been degraded by the sun and salt, to its base building blocks (monomers). The monomers are filtered, purified and polymerized to create virgin-quality Loop™ branded PET resin suitable for use in food-grade packaging and polyester fiber, thus enabling our customers to meet their sustainability objectives.
 
Industry Background
 
We believe there is an increasing demand for action to address the global plastic crisis, which has been characterized by facts provided by leading academic and not-for profit organizations. In the last few years, governments in North America and Europe have been enacting and proposing laws and regulations mandating the use of minimum recycled content in packaging underlying the strength of this issue in the marketplace. Plastic pollution continues to be one of the most persistently covered environmental issues by media and local and global environmental non-governmental organizations.
 
 
5
 
 
In the last few years, governments in North America and Europe have been enacting and proposing laws and regulations mandating the use of minimum recycled content in packaging underlying the strength of this issue in the marketplace. Plastic pollution continues to be one of the most persistently covered environmental issues by media and local and global environmental non-governmental organizations.
 
Also, global consumer goods companies have made significant commitments to make the transition to a circular plastic economy, namely:
 
i.
In January 2018, Danone’s evian® brand bottled spring water committed to a 100% recycled content package by 2025;
ii.
In October 2018, PepsiCo committed to use an average of 25% recycled plastic in its packaging by 2025; PepsiCo is also aiming to use 50% recycled plastic in its bottles across the European Union by 2030;
iii.
In 2018, L’OCCITANE en Provence committed to a 100% recycled content package by 2025; and
iv.
In March 2019, the L’Oréal Group, a global manufacturer and retailer of natural cosmetics, committed to using 50% recycled or bio-sourced plastic in their packaging by 2025 and in 2020, they committed to using 100% recycled or bio-based plastic in their packaging by 2030.
 
In addition, the global annual market demand for PET plastic and polyester fiber at nearly $130 billion, and the current growth projections from the 2018 IHS Polymer Market Report indicate this will exceed $160 billion by 2022. We believe these trends indicate that the transformation from a linear to a circular plastic economy is underway. We believe this transition will lead to a substantial demand for sustainable products such as Loop™ PET resin.
 
Proprietary Technology and Intellectual Property
 
The power of our technology lies in its ability to use as feedstock waste PET plastic and polyester fiber from landfills, rivers, oceans and natural areas to create Loop™ PET resin. We believe our technology can deliver profitable virgin quality PET resin suitable for use in food-grade packaging and polyester fiber.
 
Our Generation I technology (“GEN I”) is a hydrolysis based depolymerization technology which yielded purified terephthalic acid (“PTA”) and monoethylene glycol (“MEG”), two common monomers of PET, through depolymerization. As the Company evaluated the transition from the Gen I pilot scale to commercial scale, several challenges involving PTA and MEG purification were identified. To overcome the GEN I technology challenges, we embarked on the development of a second generation of our technology. Our Generation II technology (“GEN II”) is a methanolysis based depolymerization technology that uses industrial temperatures below 90 °C to depolymerize waste PET and polyester fiber. The low temperature allows Loop’s technology to depolymerize very low-quality feedstocks which cannot be effectively recycled today, such as carpet fiber, clothing and mixed plastics. The GEN II technology uses only trace amounts of water, eliminates the need for a halogenated solvent and uses a catalyst at low concentration. GEN II allows for the purification of MEG and DMT to be simplified through distillation.
 
This shift, from producing the monomer PTA to the monomer DMT, was a pivotal moment for Loop Industries. We believe that GEN II requires less energy and fewer resource inputs than conventional PET production processes. We also believe it is an environmentally sustainable method for producing virgin quality food-grade PET plastic in the world.
 
During the quarter, we commissioned Kemitek, a College Centre for Technology Transfer specialized in the fields of green chemistry and chemical process scale-up, to validate that our technology at mini-pilot and pilot scale can produce primary building blocks, or monomers: DMT and MEG.
 
Kemitek’s findings through this verification allowed them to attest to the ability of our technology to produce pure monomers within our purity specifications.
 
In connection with our agreements with Suez and Chemtex, and more broadly with the commercialization activities of our future Infinite LoopTM manufacturing facilities, we have decided to convert our pilot plant to an Infinite LoopTM demonstration and training facility in support of the commercialization of our technology. The demonstration facility will be used to showcase the Infinite LoopTM technology to potential partners and customers, and train operational teams in advance of the commissioning of commercial plants. We made investments of $2,325,540 for this project during the three months ended November 30, and we expect this project to be largely completed by third quarter of calendar 2021. In addition, subsequent to the quarter, we have also entered into an agreement to acquire PET polymerization equipment from Chemtex to manufacture limited quantities of Loop™ branded PET resin at our demonstration plant and have the capability to supply select customers.
 
 
To protect our technology, we rely on a combination of patents, trademarks, trade secrets, confidentiality agreements and provisions as well as other contractual provisions to protect our proprietary rights, which are primarily our patents, brand names, product designs and marks.
 
We have two patent families, referred to as GEN I technology and the GEN II technology, with claims relating to our technology for depolymerizing PET.
 
The GEN I portfolio has three issued U.S. patents, all expected to expire on or around July 2035. Internationally, we also have issued patents in Australia, Israel, Taiwan, South Africa, Eurasia and in the members of the Gulf Cooperation Council, and pending patent applications in Argentina, Brazil, Canada, China, Europe, Hong Kong, India, Japan, Korea, Mexico, and the Philippines, all expected to expire, if granted, on or around July 2036.
 
 
6
 
 
The GEN II technology portfolio currently consists of four patent families:
 
o
The first has two issued U.S. patent and a pending U.S. application, all expected to expire on or around September 2037. Internationally, we also have an allowed application in Bangladesh, and pending applications in Argentina, Australia, Bolivia, Brazil, Bhutan, Canada, China, Columbia, Eurasia, Europe, members of the Gulf Countries, Hong Kong, Indonesia, Israel, India, Iraq, Japan, Korea, Kuwait, Laos, Mexico, Philippines, Pakistan, Singapore, Taiwan, Uruguay, Uzbekistan, Venezuela, and South Africa, all expected to expire on or around September 2038, if granted.
 
o
An additional aspect of the GEN II technology is claimed in an issued U.S. patent and a pending U.S. application, and non-PCT country applications in Argentina, Bangladesh, Bolivia, members of the Gulf Cooperation Council, Pakistan, Taiwan, and Uruguay, all expected to expire on or around June 2039, not including any patent term extension.
 
o
A further additional aspect of the GEN II technology is the subject of a U.S. `application and a PCT application. Any patents that would ultimately grant from these applications would be expected to expire on or around March 2040, not including any patent term extension.
 
o
Another further additional aspect of the GEN II technology is the subject of a U.S. application, a PCT application, and non-PCT country applications in Argentina, Bolivia, Bangladesh, members of the Gulf Cooperation Council, Pakistan, Taiwan, and Uruguay. Any patents that would ultimately grant from these applications would be expected to expire on or around March 2040, not including any patent term extension.
 
Government Regulation and Approvals
 
As we seek to further develop and commercialize our business, we will be subject to extensive and frequently developing federal, state, provincial and local laws and regulations. Compliance with current and future regulations could increase our operational costs.
 
Our operations require various governmental permits and approvals. We are in the process of obtaining all necessary permits and approvals for the operation of our business; however, any of these permits or approvals may be subject to denial, revocation or modification under various circumstances. Additionally, due to the impact of the COVID-19 pandemic, we may experience delays in obtaining such permits or approvals. Failure to obtain or comply with the conditions of permits and approvals or to have the necessary approvals in place may adversely affect our operations and may subject us to penalties. See “Risk Factors” below for additional information.
 
We have received from the European Chemicals Agency a confirmation of registration for our MEG on November 17, 2020, and for our DMT on December 7, 2020. The registration under the Registration, Evaluation, Authorization and Restriction of Chemicals (“REACH”) Regulation (EC 1907/2006) confirms that our monomers are of a purity equal to what is currently recognized within Europe and entitles us to manufacture/import the monomers into Europe. It should be noted that MEG and DMT are on the positive list for plastic materials, which means that the two monomers can be used as food contact materials.
 
In addition, as previously disclosed, we are in possession of a legal opinion confirming that our depolymerization technology meets U.S. Food and Drug Administration (“FDA”) requirements to produce suitably pure MEG and DMT for use in food-grade packaging.
 
It should be noted that the levels of monomer purity confirmed by Kemitek’s verification are in line with the data submitted for the REACH registration of our DMT and MEG monomers.
 
Supply Agreements with Global Consumer Brands
 
Consumer brands are seeking a solution to their plastic challenge and they are taking bold action. In the past years we have seen major brands make significant commitments to close the loop on their plastic packaging in two ways, by transitioning their packaging to recyclable materials and by incorporating more recycled content into their packaging. We believe Loop™ PET resin provides the ideal solution for these brands because Loop™ PET resin is recyclable and is made from 100% recycled PET resin with virgin-quality suitable for use in food-grade packaging and polyester fiber.
 
We believe that due to the commitments by large global consumer brands to incorporate more recycled content into their product packaging, the regulatory requirements for minimum recycled content in packaging imposed by governments, the virgin-quality of Loop™ branded PET resin and the marketability of Loop™ PET resin to extoll the sustainability credentials of consumer brands that incorporate Loop™ PET resin, we believe we will be able to sell Loop™ branded PET resin at a premium price relative to virgin and mechanically recycled PET resin.
 
 
7
 
 
In the last years, we have made a number of announcements with some of the world’s leading brands to be supplied from our planned first commercial facility from our joint venture with Indorama Ventures Holdings LP (“Indorama”) in Spartanburg, South Carolina, including:
 
Multi-year supply agreement with Danone SA, one of the world’s leading global food and beverage companies. Danone will purchase 100% sustainable and upcycled Loop™ branded PET for use in brands across its portfolio including evian®, Danone’s iconic natural spring water;
 
Multi-year supply agreement with PepsiCo, one of the largest purchasers of recycled PET plastic, enabling PepsiCo to purchase production capacity and incorporate Loop™ PET resin into its product packaging;
 
Multi-year supply agreement with L’OCCITANE en Provence to supply 100% recycled and sustainable Loop™ PET resin and incorporate Loop™ PET resin into its product packaging; and
 
Multi-year supply agreement with L’Oréal Group, the global leader in the beauty industry, enabling L’Oréal Group to purchase production capacity and incorporate Loop™ PET resin into its product packaging.
 
Turning Waste into Feedstock
 
We use waste PET plastic and polyester fiber as feedstock. Our technology can use PET plastic bottles and packaging of any color, transparency or condition, carpet, clothing and other polyester textiles that may contain colors, dyes or additives, and even PET plastics that have been recovered from the ocean and degraded by exposure to sun and salt. We believe that our ability to use many materials that mechanical recyclers cannot use is an important advantage of Loop™ PET resin over mechanically recycled PET resin. This also means we are creating a new market for materials that have persistently been leaking out of the waste management system and into our shared rivers, oceans and natural areas.
 
In conjunction with the partners with whom we are developing facilities, we are identifying the availability of feedstock to ensure such planned facilities can operate continuously at planned scale. We have identified the sources required for our first joint venture facility with Indorama and we will be focusing on signing supply agreements to secure this feedstock for the long term when the activities of the joint venture resume.
 
We, along with certain of our strategic partners, are also studying certain markets in the United States, Canada, and the European Union to help us evaluate the size and location of future facilities.
 
Commercialization Progress
 
During the nine months ended November 30, 2020, we continued executing our corporate strategy where Loop Industries focused on developing two distinct business models for the commercialization of Loop™ PET resin: 1) from our joint venture with Indorama, and 2) from Infinite LoopTM, our fully integrated waste to PET resin manufacturing technology.
 
In September 2018 we announced a joint venture with Indorama to retrofit their existing PET manufacturing facilities. The joint venture was formed with the objective to manufacture and commercialize sustainable Loop™ PET resin to meet the growing global demand from beverage and consumer packaged goods companies. This partnership brings together Indorama’s manufacturing footprint and Loop Industries’ proprietary technology to become a supplier of 100% sustainable and recycled PET resin.
 
We entered into a Joint Venture Agreement with Indorama through our wholly-owned subsidiary Loop Innovations, LLC, a Delaware limited liability company. Each company has 50/50 equity interest in ILT, which was specifically formed to operate and execute the joint venture. We are contributing to the 50/50 joint venture an exclusive world-wide royalty-free license to use its proprietary technology to produce 100% sustainably produced PET resin in addition to our equity cash contribution. The Joint Venture Agreement details the establishment of an initial 20,700 metric tons per year facility in Spartanburg, South Carolina, in the southeastern United States. As disclosed in our Quarterly Report on Form 10-Q for the period ended August 31, 2019, the joint venture decided to increase the capacity of the planned Spartanburg plant due to customer demand to 40,000 metric tons per year.
 
We have currently contracted for the sale of approximately 15,000 metric tons, which represents almost 40% of the planned capacity, of the expected output of the Spartanburg facility and we will resume discussions for the remaining volume once we have more visibility on the commissioning date of the facility, although we have had and may continue to experience delays as noted under the “Risk Factors”. As part of the Joint Venture Agreement to establish the facility to produce 40,000 metric tons, we are committed to contribute our equity share for the costs under the joint venture agreement to construct the facility. During the nine-month period ended November 30, 2020, we made a contribution of $650,000 and as at November 30, 2020, we have contributed a total of $1,500,000 to the joint venture.
 
 
8
 
 
The joint venture made a decision over the summer that due to the COVID-19 situation it would temporarily delay work on the project. Since then, no expenditures have been incurred by the joint venture. In order to move forward more expeditiously with the Spartanburg facility, Loop is exploring joint venture structures and financing alternatives with Indorama to possibly increase its equity participation in the project.
 
The continued travel restrictions and quarantine requirements between Canada and the US continued to cause disruptions in our timetable. The joint venture is planning to gradually resume certain activities on the project in the first quarter of calendar 2021.
 
The Infinite LoopTM manufacturing technology is the key pillar of our commercialization blueprint. We believe our technology is at the forefront of the global transition away from fossil fuels and petrochemicals and into the circular economy, where PET plastic and polyester fiber are produced from 100% recycled content. The Infinite Loop™ technology is being engineered to support the commitment of global consumer brands to achieve a high level of recycled content in packaging. Infinite Loop™ facilities could be located near large urban centers where more plastic is being consumed and therefore more waste plastic feedstock is likely available.
 
Our objective is to achieve global expansion of the technology through a mix of fully owned facilities, partnerships, and licensing agreements. We believe that industrial companies, which today are not in the business of manufacturing PET resin, will view Infinite Loop™ as a growth opportunity, which offers attractive economic returns either as Loop manufacturing partners or as licensees of the technology.
 
Following a careful evaluation of alternative PET polymerization technologies and our engineering requirements for the development of Infinite LoopTM, we decided not to move forward with our global alliance agreement with ThyssenKrupp Industrial Solutions’ division, Uhde Inventa-Fischer for the use of their PET polymerization technology and engineering services.
 
On September 2, 2020, we entered into a know-how and engineering agreement (the “Chemtex Agreement”) with Chemtex Global Corporation (“Chemtex”) to license the PET plastic and polyester polymer for fiber manufacturing know-how of INVISTA’s technology and licensing group, INVISTA Performance Technologies (IPT) (“INVISTA”). The total value of the Chemtex Agreement is $4,300,000 and covers the know-how and design of two Infinite Loop™ facilities. Payment terms are based on the completion of certain milestones and total $2,150,000 for each facility. During the three and nine months ended November 30, 2020, $500,000 was paid by the Company.
 
During this quarter, we continued to focus on the completion of the Infinite LoopTM engineering design including the integration of our depolymerization process with INVISTA’s polymerization with the assistance of Worley Group Inc. (“Worley”), a leading global engineering, procurement and construction company. We expect Worley may also play a role in the deployment of Loop’s Infinite LoopTM PET manufacturing facilities.
 
We announced on September 10, 2020 a strategic partnership with SUEZ GROUPE (“Suez”), with the objective to build the first Infinite Loop™ manufacturing facility in Europe. With the combination of the Infinite LoopTM technology and the resource management expertise of Suez, this partnership seeks to respond to growth in demand in Europe from global beverage and consumer goods brand companies who we believe are committed to aggressive targets for a high level of recycled content in their products. We, together with Suez, have initiated the work to enable us to make a final investment decision for the project with the current priorities being on the site selection, permitting, and feedstock requirements.
 
The Company is in the planning phase for an Infinite LoopTM manufacturing facility in the province of Québec. As part of this process, subsequent to the end of the quarter, the Company signed a purchase option to acquire approximately 2,000,000 square feet of land in Bécancour, Québec for a purchase price of approximately $1,300,000. The option is for 2 years and carries with it an annual cost of $80,000 which will be credited against the purchase price if the land is acquired.
 
In addition to the capital requirements for our commercialization we plan to continue to allocate available capital to strengthen our intellectual property portfolio, build a core competency in managing strategic relationships and continue enhancing our brand value. Our research and development innovation hub in Terrebonne, Québec, Canada will continue to push forward the development of our technology.
 
Employees
  
We are investing in building a management team to integrate best in class processes and practices while maintaining our entrepreneurial culture. On March 9, 2020, we hired Mr. Stephen Champagne as Chief Technology Officer. Ms. Sheila Morin was hired as Chief Marketing Officer on September 21, 2020 and resigned from her position on December 17, 2020. On January 11, 2021, Mr. Yves Perron was hired as the Company’s Vice-President, Engineering and Construction.
 
In addition, on October 6, 2020, the Company retained the services of Mr. Laurent Auguste in an advisory capacity to oversee all the Company’s European activities.
 
As of November 30, 2020, we had 61 employees of which 28 work in research and development and 20 in engineering and operations.
 
 
9
 
 
Results of Operations
 
The following table summarizes our operating results for the three-month periods ended November 30, 2020 and 2019, in U.S. Dollars.
 
 
 
Three Months Ended November 30
 
 
 
2020
 
 
       2019 
 
 
$ Change
 
Revenues
 $- 
 $- 
 $- 
 
 
 
    
    
    
Operating expenses
    
    
    
Research and development
    
    
    
   Stock-based compensation
  350,393 
  311,353 
  39,040 
   Other research and development
  5,923,890 
  966,819 
  4,957,071 
       Total research and development
  6,274,283 
  1,278,172 
  4,996,111 
 
    
    
    
General and administrative
    
    
    
   Stock-based compensation
  546,601 
  565,440 
  (18,839)
   Other general and administrative
  2,177,415 
  1,260,373 
  917,014 
       Total general and administrative
  2,724,016 
  1,825,813 
  898,203 
 
    
    
    
Write-down and impairment of property, plant and equipment
  5.034,606 
  - 
  5,034,606 
Depreciation and amortization
  104,307 
  219,628 
  (115,321)
Interest and other financial (income) expenses
  (41,855)
  693,027 
  (734,882)
Interest income
  (20,008)
  (171,274)
  151,266 
Foreign exchange loss
  95,644 
  5,533 
  90,111 
Total operating expenses
  14,170,993 
  3,850,899 
  10,320,094 
Net loss
 $(14,170,993)
 $(3,850,899)
 $(10,320,094)
 
Third Quarter Ended November 30, 2020
 
The net loss for the three-month period ended November 30, 2020 increased $10.32 million to $14.17 million, as compared to the net loss for the three-month period ended November 30, 2019 which was $3.85 million. The increase of $10.32 million is primarily attributable to higher research and development expenses of $5.00 million, higher write-down of machinery and equipment of $5.03 million, higher general and administrative expenses of $0.90 million, lower interest income of $0.15 million, and an increase in foreign exchange loss of $0.09 million, offset by lower interest and other financial (income) expenses of $0.73 million and lower depreciation and amortization expenses of $0.12 million.
 
Research and development expenses for the three-month period ended November 30, 2020 amounted to $6.27 million compared to $1.28 million for the three-month period ended November 30, 2019, an increase of $5.00 million, or $4.96 million excluding stock-based compensation. The increase of $4.96 million was primarily attributable to higher purchases of non-capitalizable research and development machinery and equipment of $2.33 million, higher engineering fees of $2.19 million due to external engineering costs for the design of our Infinite LoopTM manufacturing process, higher employee compensation expenses of $0.20 million, higher pilot plant and laboratory consumables and maintenance expenses of $0.19 million, and by lower research and development tax credits of $0.10 million.
 
General and administrative expenses for the three-month period ended November 30, 2020 amounted to $2.72 million compared to $1.83 million for the three-month period ended November 30, 2019, an increase of $0.90 million, or $0.92 million excluding stock-based compensation. The increase of $0.92 million was mainly attributable to higher legal and professional fees of $0.84 million due to costs principally associated with the ongoing SEC investigation disclosed in our 8-K filed on October 16, 2020 and class action suits, and higher insurance expenses of $0.31, offset by lower employee compensation costs of $0.23 million.
 
 
10
 
 
Depreciation and amortization expenses for the three-month period ended November 30, 2020 totaled $0.10 million compared to $0.22 million for the three-month period ended November 30, 2019, a decrease of $0.12 million. This decrease is mainly attributable to the write-down of machinery and equipment assets. The write-down and impairment of property, plant and equipment for the three-month period ended November 30, 2020 totaled $5.03 million compared to nil for the three-month period ended November 30, 2019.
 
The machinery and equipment will continue to be utilized at our demonstration and training facility as it is an integral part of supporting the commercialization of our technology. However, the decision to dedicate the demonstration and training facility to research and development activities requires them to be written off and all future costs associated with the demonstration and training facility will be recognized as a research and development expense in the consolidated statements of operations and comprehensive loss in accordance with ASC 730, Research and Development Costs.
 
Interest and other financial (income) expenses for the three-month period ended November 30, 2020 totaled $(0.04) million compared to $0.69 million the three-month period ended November 30, 2019, a decrease of $0.73 million. The decrease is mainly attributable to a decrease in accretion expense of $0.56 million, a decrease in interest expense on convertible notes of $0.09 million and by an increase in gain on revaluation of foreign exchange contracts of $0.08 million.
 
Nine Months Ended November 30, 2020
 
The following table summarizes our operating results for the nine-month periods ended November 30, 2020 and 2019, in U.S. Dollars.

 
 
      Nine Months Ended November 30
 
 
 
  2020
 
 
  2019
 
 
 $ Change
 
Revenues
 $- 
 $- 
 $- 
 
    
    
    
Operating expenses  
    
    
    
Research and development
    
    
    
   Stock-based compensation
  1,054,682 
  941,142 
  113,540 
   Other research and development
  9,449,411 
  2,305,104 
  7,144,307 
       Total research and development
  10,504,093 
  3,246,246 
  7,257,847 
 
    
    
    
General and administrative
    
    
    
   Stock-based compensation
  1,720,067 
  1,669,669 
  50,398 
   Other general and administrative
  5,006,272 
  3,777,387 
  1,228,885 
       Total general and administrative
  6,726,339 
  5,447,056 
  1,279,283 
 
    
    
    
Write-down and impairment of property, plant and equipment
  5,043,120 
  (22,985
  5,020,135 
Depreciation and amortization
  654,354 
  562,382 
  91,972 
Interest and other financial (income) expenses
  26,016 
  1,817,091 
  (1,791,075)
 Interest income 
  (78,394)
  (363,565)
  285,171 
 Foreign exchange loss  
  275,903 
  15,297 
  260,606 
 Total operating expenses 
  23,151,431 
  10,747,492 
  12,403,939 
 Net loss 
 $(23,151,431)
 $(10,747,492)
 $(12,403,939)
 
The net loss for the nine-month period ended November 30, 2020 increased by $12.40 million to $23.15 million, as compared to the net loss for the nine-month period ended November 30, 2019 of $10.75. The increase of $12.40 million is primarily due to higher research and development expenses of $7.26 million, the write-down of machinery and equipment of $5.02 million, higher general and administrative expenses of $1.28 million, lower interest income of $0.29 million, higher foreign exchange loss of $0.26 million and higher depreciation and amortization expenses of $0.33 million, offset by a decrease in interest and other financial (income) expenses of $1.79 million.
 
Research and development expenses for the nine-month period ended November 30, 2020 amounted to $10.50 million compared to $3.25 million for the nine-month period ended November 30, 2019, an increase of $7.26 million, and $7.14 million excluding stock-based compensation. The increase of $7.14 million was primarily attributable to higher engineering fees of $3.16 million due to external engineering costs for the design of our Infinite LoopTM manufacturing process, higher purchases of non-capitalizable research and development machinery and equipment of $2.33 million, higher employee compensation expenses of $0.53 million, higher plant and laboratory consumables and maintenance expenses of $0.50 million, and by lower research and development tax credits of $0.32 million which was partially offset by a COVID-19-related government wage subsidy of $0.19 million. The increase in non-cash stock-based compensation expense of $0.11 million is mainly attributable to the timing of stock awards provided to certain employees.
 
 
11
 
 
General and administrative expenses for the nine-month period ended November 30, 2020 amounted to $6.73 million compared to $5.45 million for the nine-month period ended November 30, 2019, an increase of $1.28 million, or $1.23 million excluding stock-based compensation. The increase of $1.23 million was mainly attributable to higher insurance expenses of $1.04 million, and higher legal and professional fees of $0.89 million due to costs principally associated with the ongoing SEC investigation disclosed in our 8-K filed on October 16, 2020 and class action suits, offset by lower employee compensation costs of $0.55 million. During the nine-month period ended November 30, 2020, the Company recorded a COVID-19-related government wage subsidy of $0.06 million in general and administrative expenses. Stock-based compensation expense for the nine-month period ended November 30, 2020 amounted to $1.72 million compared to $1.67 million for the nine-month period ended November 30, 2019, representing an increase of $0.05 million, which was mainly attributable lower stock awards provided to executives.
 
Depreciation and amortization expenses for the nine-month period ended November 30, 2020 totaled $0.65 million compared to $0.56 million for the nine-month period ended November 30, 2019, an increase of $0.09 million. This increase is mainly attributable to investment in fixed assets at the Company’s pilot plant and corporate offices. The write-down for machinery and equipment for the nine-month period ended November 30, 2020 totaled $5.04 million compared to $0.02 million for the nine-month period ended November 30, 2019, an increase of $5.02 million.
 
The machinery and equipment will continue to be utilized at our demonstration and training facility as it is an integral part of supporting the commercialization of our technology. However, the decision to dedicate the demonstration and training facility to research and development activities requires them to be written off and all future costs associated with the demonstration and training facility will be recognized as a research and development expense in the consolidated statements of operations and comprehensive loss in accordance with ASC 730, Research and Development Costs.
 
Interest and other financial (income) expenses for the nine-month period ended November 30, 2020 totaled $0.03 million compared to $1.82 million the nine-month period ended November 30, 2019, representing a decrease of $1.80 million. The decrease is mainly attributable to a decrease in accretion expense of $1.64 million and a decrease in interest expense on convertible notes of $0.30 million offset by a decrease in gain on conversion of convertible notes of $0.08 million.
 
LIQUIDITY AND CAPITAL RESOURCES
 
Liquidity
 
We are a development stage company with no revenues, and our ongoing operations and commercialization plans are being financed by raising new equity and debt capital. To date, we have been successful in raising capital to finance our ongoing operations. As at November 30, 2020, we had cash and cash equivalents on hand of $43.61 million.
 
Management continues to pursue our growth strategy and is evaluating our financing plans to continue to raise capital to finance the start-up of commercial operations and continue to fund the further development of our ongoing operations. Although our liquidity position consists of cash and cash equivalents on hand of $43.61 million, in light of the current global COVID-19 pandemic and its impacts on the global capital markets, our liquidity position may change, including the inability to raise new equity and debt, disruption in completing repayments or disbursements to our creditors.
 
On September 21, 2020, we entered into an underwriting agreement (the “Underwriting Agreement”) with Roth Capital Partners, LLC, as underwriter (the “Underwriter”), relating to the sale and issuance of an aggregate of 1,880,000 shares (the “Shares”) of the Company’s common stock. The offering price to the public of the Shares was $12.75 per share, and the Underwriters have agreed to purchase the Shares from the Company pursuant to the Underwriting Agreement at a price of $12.11 per share. Under the terms of the Underwriting Agreement, the Company also granted the Underwriters an option, exercisable for 30 days, to purchase up to an additional 282,000 shares of Common Stock at the same price per share as the Shares which was exercised for 207,000 shares. The net proceeds from the offering, including net proceeds received in connection with the Underwriter’s option to purchase additional shares, were $25.00 million.
 
As reflected in the accompanying interim unaudited condensed consolidated financial statements, we are a development stage company, we have not yet begun commercial operations and we do not have any sources of revenue. Management believes that the Company has sufficient financial resources to fund planned operating and capital expenditures and other working capital needs for at least, but not limited to, the 12-month period from the date of issuance of the November 30, 2020 interim condensed consolidated financial statements. There can be no assurance that any future financing will be available or, if available, that it will be on terms that are satisfactory to us.
 
As at November 30, 2020, we have a long-term debt obligation to a Canadian bank in connection with the purchase, in the year ended February 28, 2018, of the land and building where our pilot plant and corporate offices are located at 480 Fernand-Poitras, Terrebonne, Québec, Canada J6Y 1Y4. On January 24, 2018, the Company obtained a $1,073,455 (CDN$1,400,000) 20-year term instalment loan (the “Loan”), from a Canadian bank. The Loan bears interest at the bank’s Canadian prime rate plus 1.5%. By agreement, the Loan is repayable in monthly payments of $4,472 (CDN$5,833) plus interest, until January 2021, at which time it will be subject to renewal. It includes an option allowing for the prepayment of the Loan without penalty. In January 2021, the Company and the Canadian bank agreed to maintain the same repayment amount and interest rate until January 2022.
 
We also have a long-term debt obligation to Investissement Québec in connection with a financing facility equal to 63.45% of all eligible expenses incurred for the expansion of its Pilot Plant up to a maximum of $3,527,066 (CDN$4,600,000). We received the first disbursement in the amount of $1,693,938 (CDN$2,209,234) on February 21, 2020. There is a 36-month moratorium on both capital and interest repayments as of the first disbursement date. At the end of the 36-month moratorium, capital and interest will be repayable in 84 monthly installments. The loan bears interest at 2.36%. We have also agreed to issue to Investissement Québec warrants to purchase shares of our common stock in an amount equal to 10% of each disbursement up to a maximum aggregate amount of $352,707 (CDN$460,000). The warrants will be issued at a price per share equal to the higher of (i) $11.00 per share and (ii) the ten-day weighted average closing price of Loop Industries shares of common stock on the Nasdaq stock market for the 10 days prior to the issue of the warrants. The warrants can be exercised immediately upon grant and will have a term of three years from the date of issuance. The loan can be repaid at any time by us without penalty. On February 21, 2020, upon the receipt of the first disbursement under this facility, we issued a warrant to purchase 15,153 shares of common stock at a price of $11.00 to Investissement Québec.
 
 
12
 
 
Flow of Funds
 
Summary of Cash Flows
 
A summary of cash flows for the nine-month period ended November 30, 2020 and 2019 was as follows:
 
 
 
Nine Months Ended November 30
 
 
 
2020
 
 
2019
 
Net cash used in operating activities
 $(14,544,251)
 $(6,819,748)
Net cash used in investing activities
  (2,386,593)
  (2,592,921)
Net cash provided (used) by financing activities
  26,616,472 
  39,127,875 
Effect of exchange rate changes on cash and cash equivalents
  210,516 
  (57,105)
Net increase (decrease) in cash and cash equivalents
 $9,896,144 
 $29,658,101 
 
Net Cash Used in Operating Activities
 
During the nine months ended November 30, 2020, we used $14.54 million in operations compared to $6.82 million during the nine months ended November 30, 2019. The increase in cash used in operations of $7.08 million is mainly attributable to higher external engineering costs paid of $2.47 million for our Infinite LoopTM process, higher investments of non-capitalizable machinery and equipment of $2.33 million, higher directors’ and officers’ insurance premiums paid of $0.89 million, deposits on machinery and equipment of $0.75 million, increased professional fees of $0.59 million and increased research and development expenses. The variation in the amount for prepaid directors and officers insurance is due to an increase of $1.30 million of the annual premium as well as a change in the payment structure compared to the prior year.
 
Net Cash Used in Investing Activities
 
During the nine months ended November 30, 2020, the Company made capitalizable investments of $1.58 million in property, plant and equipment as compared to $1.7 million for the nine months ended November 30, 2019, primarily in connection with the upgrade of its pilot plant. Additionally, the Company made deposits on equipment of $0.42 million as at November 30, 2020 compared to nil at November 30, 2019.
 
During the nine months ended November 30, 2020, the Company made investments in intangible assets of $0.16 million as compared to $0.09 million for the nine months ended November 30, 2019, principally for its GEN II patents.
 
During the nine months ended November 30, 2020, the Company also made a contribution of $0.65 million to Indorama Loop Technologies, LLC, the joint venture with Indorama Ventures Holdings LP, USA compared to $0.85 million for the nine months ended November 30, 2019.
 
Net Cash Provided from (Used in) Financing Activities
 
During the nine months ended November 30, 2020, the Company sold 2,087,000 shares of its common stock at an offering price of $12.75 for total net proceeds of $25.00 million pursuant to the “Underwriting Agreement”. In the same period, the Company also received net proceeds of $1.65 million upon the exercise of warrants for 190,529 shares of its common stock.
 
During the nine months ended November 30, 2020, we repaid $0.03 million of long-term debt.
 
Off-Balance Sheet Arrangements
 
As at November 30, 2020, we did not have any off-balance sheet arrangements as defined in the rules and regulations of the SEC.
 
As at November 30, 2020, we did not have any significant lease obligations to third parties.
 
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
 
We are subject to risks associated with currency fluctuations and changes in foreign currency exchange rates as well as fluctuations in the supply and price of raw materials and commodity prices. 
 
Foreign Currency Exchange Risk
 
We operate mainly through two entities, Loop Industries, Inc., which is a Nevada corporation and has a U.S. dollar functional currency, and our wholly-owned subsidiary, Loop Canada Inc. (“Loop Canada”), which is based in Terrebonne, Québec, Canada and has a Canadian dollar functional currency. Our reporting currency is the U.S. dollar.
 
 
13
 
  
We mainly finance our operations through the sale and issuance of shares of common stock and debt of Loop Industries, Inc. in U.S. dollars while our operations are concentrated in our wholly-owned subsidiary, Loop Canada. Accordingly, we are exposed to foreign exchange risk as we maintain bank accounts in U.S. dollars and a significant portion of our operational costs (including payroll, site costs, costs of locally sourced supplies and income taxes) are denominated in Canadian dollars.
 
Significant fluctuations in the U.S. dollar to the Canadian dollar exchange rates could materially affect our result of operations, cash position and funding requirements. To the extent that fluctuations in currency exchange rates cause our results of operations to differ materially from our expectations or the expectations of our investors, the trading price of our common stock could be adversely affected.
 
From time to time, we may engage in exchange rate hedging activities in an effort to mitigate the impact of exchange rate fluctuations. As part of our risk management program, we may enter into foreign exchange forward contracts to lock in the exchange rates for future foreign currency transactions, which is intended to reduce the variability of our operating costs and future cash flows denominated in currencies that differs from our functional currencies. We do not enter into these contracts for trading purposes or speculation, and our management believes all such contracts are entered into as hedges of underlying transactions. Nonetheless, these instruments involve costs and have risks of their own in the form of transaction costs, credit requirements and counterparty risk. If our hedging program is not successful, or if we change our hedging activities in the future, we may experience significant unexpected expenses from fluctuations in exchange rates. Any hedging technique we implement may fail to be effective. If our hedging activities are not effective, changes in currency exchange rates may have a more significant impact on the trading price of our common stock.
 
Commodity Price Risk
 
The plastics manufacturing industry is extremely price competitive because of the commodity like nature of PET resin and its correlation to the price of crude oil. The demand for recycled PET has fluctuated with the price of crude oil. If crude oil prices decline, the cost to manufacture recycled PET may become comparatively higher than the cost to manufacture virgin PET. Our ability to penetrate the market will depend in part on the cost of manufacturing virgin PET and if we do not successfully distinguish our product from those of virgin PET manufacturers, our entry into the market and our ability to secure customer contracts can be adversely affected.
 
Raw Material Price Risk
 
We purchase raw materials and packaging supplies from several sources. While all such materials are available from independent suppliers, raw materials are subject to fluctuations in price and availability attributable to a number of factors, including general economic conditions, commodity price fluctuations, the demand by other industries for the same raw materials and the availability of complementary and substitute materials. The profitability of our business also depends on the availability and proximity of these raw materials to our factories. The choice of raw materials to be used at our facility is determined primarily by the price and availability, the yield loss of lower quality raw materials, and the capabilities of the producer’s production facility. Additionally, the high cost of transportation could favor suppliers located in close proximity to our factories. If the quality of these raw materials is lower, the quality of our product may suffer. Economic and financial factors could impact our suppliers, thereby causing supply shortages. Increases in raw material costs could have a material adverse effect on our business, financial condition or results of operations. Our hedging procedures may be insufficient, and our results could be materially impacted if costs of materials increase. In light of the uncertain and evolving situation relating to the global COVID-19 pandemic, our access to raw materials, the quality and proximity of such materials may be disrupted. We currently cannot predict the impact that the global COVID-19 pandemic will have on our access to raw materials.
 
ITEM 4. CONTROLS AND PROCEDURES
 
Management’s Evaluation of our Disclosure Controls and Procedures
 
A.
Evaluation of Disclosure Controls and Procedures
 
Disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in our reports that we file or submit under the Securities Exchange Act of 1934 is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.
 
As of the end of the period covered by this Quarterly Report, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), pursuant to Rule 13a-15(b) of the Exchange Act. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of November 30, 2020.
 
B.
Changes in Internal Control over Financial Reporting
 
There were no changes in our internal control over financial reporting during the nine-month period ended November 30, 2020 that materially affected, or were reasonably likely to materially affect, our internal control over financial reporting.
 
 
14
 
 
PART II. OTHER INFORMATION
 
ITEM 1. LEGAL PROCEEDINGS
 
SEC Investigation
 
As previously disclosed in our Current Report on Form 8-K filed with the SEC on October 16, 2020, on October 15, 2020, we received a subpoena from the SEC requesting certain information from us, including information regarding testing, testing results and details of results from our GEN I and GEN II technologies and certain of our partnerships and agreements. Prior to its receipt, there had been no previous communication between us and the SEC on this issue and we were unaware of this investigation. The SEC informed us that its investigation does not mean that the SEC has concluded that anyone has violated the law and that the investigation does not mean that the SEC has a negative opinion of us. We cannot predict when this matter will be resolved or what, if any, action the SEC may take following the conclusion of the investigation.
 
Litigation
 
On October 13, 2020, the Company and certain of its officers were named as defendants in a proposed class action lawsuit filed in the United States District Court for the Southern District of New York, captioned Olivier Tremblay, Individually and on Behalf of All Other Similarly Situated v. Loop Industries, Inc., Daniel Solomita, and Nelson Gentiletti, Case No. 7:20-cv-0838 (“Tremblay Class Action”). The allegations in the complaint claim that the defendants allegedly violated Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 by allegedly making materially false and/or misleading statements, as well as allegedly failing to disclose material adverse facts about the Company’s business, operations, and prospects, which caused the Company’s securities to trade at artificially inflated prices. Plaintiff seeks unspecified damages on behalf of a class of purchasers of Loop’s securities between September 24, 2018 and October 12, 2020.
 
On October 13, 2020, the Company, Loop Canada Inc. and certain of their officers and directors were named as defendants in a proposed securities class action filed in the Superior Court of Québec (District of Terrebonne, Province of Québec, Canada), in file no. 700-06-000012-205. The Application for authorization of a class action and for authorization to bring an action pursuant to section 225.4 of the Québec Securities Act (the “Application”) was filed by an individual shareholder on behalf of himself and a class of buyers who purchased our securities during the “Class Period” (not defined). Plaintiff alleges that throughout the Class Period, the defendants allegedly made false and/or misleading statements and allegedly failed to disclose material adverse facts concerning the Company’s technology, business model, operations and prospects, thus causing the Company’s stock price to be artificially inflated and thereby causing plaintiff to suffer damages. Plaintiff seeks unspecified damages stemming from losses he claims to have suffered as a result of the foregoing. On December 13, 2020, the Application was amended in order to add allegations regarding specific misrepresentations.
 
On October 28, 2020, the Company and certain of its officers were named as defendants in a second proposed class action lawsuit filed in the United States District Court for the Southern District of New York, captioned Michelle Bazzini, Individually and on Behalf of All Other Similarly Situated v. Loop Industries, Inc., Daniel Solomita, and Nelson Gentiletti, Case No. 7:20-cv-09031-UA. The allegations in this complaint are similar in nature to those made in the Tremblay Class Action.
 
On January 4, 2021, the United States District Court for the Southern District of New York rendered a stipulation and order granting the consolidation of the two class action lawsuits filed in New York as In re Loop Industries, Inc. Securities Litigation, Master File No. 7:20-cv-08538. Sakari Johansson and John Jay Cappa have been appointed as Co-Lead Plaintiffs and Glancy Prongay & Murray LLP and Pomerantz LLP have been appointed as Co-Lead Counsel for the class.
 
From time to time, we may become involved in various lawsuits and legal proceedings or investigations which arise in the ordinary course of business. Except as noted above, we are not presently a party to any legal proceedings, government actions, administrative actions, investigations or claims that are pending against us or involve us that, in the opinion of our management, could reasonably be expected to have a material adverse effect on our business, financial condition or operating results. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.
 
It is possible that we may expend financial and managerial resources in the defense of our intellectual property rights in the future if we believe that our rights have been violated. It is also possible that we may expend financial and managerial resources to defend against claims that our products and services infringe upon the intellectual property rights of third parties.
 
 
15
 
 
ITEM 1A. RISK FACTORS
 
We are subject to various risks and uncertainties in the course of our business. Risk factors relating to us are set forth under “Risk Factors” in our Annual Report on Form 10-K, filed on May 5, 2020 and amended on May 6, 2020 and September 21, 2020. Other than as included below no material changes to such risk factors have occurred during the nine months ended November 30, 2020.
 
Risks related to our business and commercialization
 
The global COVID-19 pandemic has adversely affected, and may in the future adversely affect, our business, results of operations and financial condition.
 
The COVID-19 pandemic has disrupted business operations for us and our customers, suppliers, vendors and other parties with whom we do business and such disruptions are expected to continue for an indefinite period of time.  In an effort to control the spread of COVID-19, governments and municipalities around the world have instituted restrictive measures, including orders to shelter-in-place, travel restrictions, mandated business closures and social distancing. The pandemic and resulting governmental restrictions and regulations have adversely affected businesses, economies, and financial markets globally, leading to an economic downturn, a sharp increase in unemployment and increased market volatility of uncertain severity and duration. Additionally, as a result the disruption to the global economy, we may experience a decline in the consumption of our products as a result of change of consumer preference, perception or confidence and spending habits. Any continued disruption or prolonged change in consumer spending habits could adversely affect our business.
 
The uncertain duration of these measures has had and may continue to have increasingly negative effects on critical development and commercialization efforts.  In particular, although we were able to take advantage of exemptions in the order from Québec provincial government closing all non-essential business and commercial activity in the province during the shutdown period between March 25, 2020 and May 11, 2020 to continue reduced operations at our pilot plant, the situation in the United States and the continued border closures and quarantine requirements between Canada and the United States have caused disruptions in our timetable of our joint venture with Indorama in the development of our Spartanburg facility and commercialization of our technology. We cannot ensure whether there will be further delays in light of the COVID-19 pandemic and further impact on the development and commercialization of our technology could have a material adverse effect on our results of operations and cash flows. 
 
In addition, as a result of COVID-19 and the measures designed to contain the spread of the virus, we may experience further restrictions on the movement of employees, disruption of supply chains, shipping of raw materials, restrictions on manufacturing and decline in value of assets held by us, including property and equipment.  In particular, the COVID-19 outbreak has caused disruption to our business, including our furloughing a number of employees, which have now returned to work.  Additionally, our management team has, and will likely continue, to spend time, attention and resources monitoring the COVID-19 pandemic and seeking to manage its effects on our business and workforce.  Further, we are in the process of obtaining all necessary permits and approvals for the operation of our business, which processes may be delayed due to the impact of the COVID-19 pandemic.
 
Although we continue to monitor the situation and may adjust our current policies as more information and public health guidance become available, the COVID-19 pandemic is ongoing, and its dynamic nature, including uncertainties relating to the ultimate spread of the virus, the severity of the disease, the duration of the outbreak and actions that may be taken by governmental authorities to contain the outbreak or to treat its impact, makes it difficult to accurately forecast any effects on our results of operations for 2021 and beyond.  Additionally, our efforts to mitigate the impact of COVID-19 on our business, employees and the community in which we operate efforts may not be successful and may require additional costs and have a material adverse effect on our results of operations and cash flows.
 
We face business risks due to our relationships with strategic partners.
 
We rely on our strategic partner relationships for the scaling, manufacturing and commercialization of our technology. We have various arrangements with Indorama and Suez to commercially scale our technology in Spartanburg and Europe respectively and with Chemtex and our external engineering firm Worley. We also have various supply agreements with Danone, Pepsi, L’Oreal and L’OCCITANE en Provence for our planned Spartanburg facility. Termination of any of these agreements could have an adverse effect on our business. In particular, certain of our agreements with our strategic partners have termination rights related to the satisfaction of milestones, some of which we have not achieved. Other than as noted below and though we have not received any indication from our strategic partners as to their indication to terminate, we cannot provide assurance that these strategic partners with whom we have entered into such agreements will not exercise their applicable termination rights, which are not within our control. For example, we previously announced that Coca-Cola Cross Enterprise Procurement Group (“CEPG”) advised us that it was terminating our Master Terms and Conditions Supply Agreement for Loop PET plastic, dated November 14, 2018 (the “MTC”) because we did not satisfy our first production milestone from the joint venture facility by July 2020 as required by the MTC. CEPG indicated in its notice that it is open and interested in exploring a new framework agreement with us for North America and/or Europe. We intend to engage with CEPG regarding the joint venture facility when we have more clarity on the commissioning as well as for our planned Infinite Loop European project. We cannot provide any assurances that we will be able to enter into a new agreement with CEPG on terms that are favorable to us or at all. 
 
Any failure of our strategic partners or us to meet our required commitments, whether financial or otherwise, could result in a termination of such agreements as described above, operational issues, increased expenditures or damage to our reputation or loss of clients or customers, any of which could adversely affect our business and operations, financial performance or prospects.
 
 
16
 
 
Risk related to adverse litigation, investigations and other proceedings
 
We are subject to certain risks related to litigation filed by or against us and investigations we are subject to, and adverse results may harm our business.
 
We cannot predict with certainty the cost of defense, of prosecution or of the ultimate outcome of litigation, investigations and other proceedings filed by or against us, including penalties or other civil or criminal sanctions, or remedies or damage awards, and adverse results in any litigation and other proceedings may materially harm our business, including the subpoena we received from the SEC in October 2020 requesting certain information regarding testing, testing results and details of results from our GEN I and GEN II technologies and certain of our partnerships and agreements. Litigation and other proceedings may include, but are not limited to, actions relating to intellectual property, international trade, commercial arrangements, product liability, environmental, health and safety, joint venture agreements, labor and employment or other harms resulting from the actions of individuals or entities outside of our control. In the case of intellectual property litigation and proceedings, adverse outcomes could include the cancellation, invalidation or other loss of material intellectual property rights used in our business and injunctions prohibiting our use of business processes or technology that are subject to third-party patents or other third-party intellectual property rights. We expect legal fees to continue to increase in relation to litigation, investigations and other proceedings.
 
If we are unable to successfully scale our manufacturing processes, we may not meet customer demand.
 
To be successful, we will have to scale our manufacturing processes while maintaining high product quality and reliability. If we cannot maintain high product quality at a large scale, our business will be adversely affected. Even if we are successful in developing our manufacturing capability, we do not know whether we will do so in time to satisfy the requirements of our customers. The current manufacturing facility is a pilot plant with limited production capacity used principally for research and development. In order to fully implement our business plan, we will need to scale the operations to a larger industrial commercial facility, develop strategic partnerships or find other means to produce greater volumes of finished product. We, however, have not yet tested our technology at the scale that will be required for large commercial use nor at a scale sufficient to conclude the success of our technology.
 
Risks related to regulatory approvals
 
We are subject to various federal, state and local laws and regulations and failure to secure and maintain permits could result in costs that have a material adverse effect on our business, results of operations and financial condition.
 
Many federal, state and local regulations govern plants and facilities and licenses to be held by individuals. We are in the process of obtaining all necessary permits and approvals for the operation of our business; however, any of these permits or approvals may be subject to denial, revocation or modification under various circumstances. The requirements for such permits vary depending on the location where our regulated activities are operated. As these are governmental permitting processes, there is a degree of uncertainty as to whether a permit will be granted, the time it will take for a permit to be issued, the duration of the permit and the conditions that may be imposed in connection with the granting of the permit.
 
We believe that we have all licenses required to conduct our operations and are in material compliance with applicable regulatory requirements. Failure to comply with applicable regulations could result in substantial fines or revocation of our permits and licenses or an inability to perform work, which could adversely affect our business.
 
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
 
On May 12, 2020, we issued a warrant to acquire 25,000 shares of common stock at a strike price of $9.43 per share.
 
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
 
None.
 
ITEM 4. MINE SAFETY DISCLOSURES
 
Not applicable.
 
ITEM 5. OTHER INFORMATION
 
None.
 
 
 
17
 
 
ITEM 6. EXHIBITS
 
The following Exhibits, as required by Item 601 of Regulation SK, are attached or incorporated by reference, as stated below.
Exhibit Index
 
 
 
 
 
Incorporated by Reference
 
 
Number
 
Description
 
Form
 
File No.
 
Filing Date
 
Exhibit No.
 
Termination of a Material Definitive Agreement, by and between Loop Industries, Inc. and Coca-Cola Cross Enterprise Procurement Group.
 
8-K
 
001-38301
 
4-Nov-20
 
 
 
Amendment to Securities Purchase Agreement dated June 14, 2019 between Loop Industries, Inc. and the Purchaser identified therein.
 
8-K
 
001-38301
 
14-Jun-19
 
10.1
 
Employment Agreement, dated August 26, 2020, by and between Loop Canada Inc. and Sheila Morin
 
10-Q
 
000-54768
 
10-July-20
 
10.1
10.2
 
Know-how and Engineering Agreement, dated September 2, 2020, by and between Loop Canada Inc. and Chemtex Global Corporation
 
10-Q
 
000-54768
 
10-July-20
 
10.2
10.3
 
Enhanced Recycling Partnership Agreement, dated September 10, 2020, by and between Loop Industries, Inc. and Suez Groupe
 
10-Q
 
000-54768
 
10-July-20
 
10.3
24.1
 
Power of Attorney (contained on signature page to the previously filed Annual Report on Form 10-K)
 
10-K
 
000-54768
 
05-May-19
 
24.1
 
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
 
Filed herewith
 
 
 
 
 
Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
 
Filed herewith
 
 
 
 
 
Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
 
Furnished herewith
 
 
 
 
 
Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
 
Furnished herewith
 
 
 
 
101.INS
 
XBRL Instance Document
 
 
 
Filed herewith
 
 
 
 
101.SCH
 
XBRL Taxonomy Extension Schema Document
 
 
 
Filed herewith
 
 
 
 
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
 
Filed herewith
 
 
 
 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document
 
 
 
Filed herewith
 
 
 
 
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document
 
 
 
Filed herewith
 
 
 
 
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
 
Filed herewith
 
 
 
 
 
 
18
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.
 
Date: January 14, 2021
By:
/s/ Daniel Solomita
 
 
Name:
Daniel Solomita
 
 
Title:
President and Chief Executive Officer, and Director (Principal Executive Officer)
 
 
 
 
 
Date: January 14, 2021
By:
/s/ Nelson Gentiletti
 
 
Name:
Nelson Gentiletti
 
 
Title:
Chief Financial Officer and Treasurer (Principal Accounting Officer and Principal Financial Officer)
 
 
 
 
 
 
 
 
19
EX-31.1 2 lpi_ex311.htm CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF THE SARBANES-OXLY ACT OF 2002 lpi_ex311
 
EXHIBIT 31.1
 
SECTION 302 CERTIFICATION
 
I, Daniel Solomita, certify that:
 
1.
I have reviewed this quarterly report on Form 10-Q of Loop Industries, Inc.;
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:
 
 
 
 
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
 
 
 
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
 
 
 
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
 
 
 
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
 
 
5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
 
 
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
 
 
 
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
 
 
Date: January 14, 2021
 
/s/ Daniel Solomita
 
 
 
Daniel Solomita
 
 
 
President and Chief Executive Officer (principal executive officer)
 
 
 
EX-31.2 3 lpi_ex312.htm CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF THE SARBANES-OXLY ACT OF 2002 lpi_ex312
 
EXHIBIT 31.2
 
SECTION 302 CERTIFICATION
 
I, Nelson Gentiletti, certify that:
 
1.
I have reviewed this quarterly report on Form 10-Q of Loop Industries, Inc.;
 
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
 
4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:
 
 
 
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
 
 
 
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
 
 
 
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
 
 
 
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
 
 
5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
 
 
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
 
 
 
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
 
 
Date: January 14, 2021
 
/s/Nelson Gentiletti
 
 
 
Nelson Gentiletti
 
 
 
Chief Financial Officer and Treasurer (principal financial officer and principal accounting officer)
 
 
 
EX-32.1 4 lpi_ex321.htm CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 lpi_ex321
 
EXHIBIT 32.1
 
SECTION 906 CERTIFICATION
 
In connection with the accompanying Quarterly Report on Form 10-Q of Loop Industries, Inc. for the quarter ended November 30, 2020, the undersigned, Daniel Solomita, President and Chief Executive Officer of Loop Industries, Inc., does hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)
such Quarterly Report on Form 10-Q for the quarter ended November 30, 2020, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
 
(2)
the information contained in such Quarterly Report on Form 10-Q for the quarter ended November 30, 2020, fairly presents, in all material respects, the financial condition and results of operations of Loop Industries, Inc.
 
 
Date: January 14, 2021
 
/s/ Daniel Solomita
 
 
 
Daniel Solomita
 
 
 
President and Chief Executive Officer (principal executive officer)
 
 
 
EX-32.2 5 lpi_ex322.htm CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 lpi_ex322
 
EXHIBIT 32.2
 
SECTION 906 CERTIFICATION
 
In connection with the accompanying Quarterly Report on Form 10-Q of Loop Industries, Inc. for the quarter ended November 30, 2020, the undersigned, Nelson Gentiletti, Chief Financial Officer of Loop Industries, Inc., does hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1)
such Quarterly Report on Form 10-Q for the quarter ended November 30, 2020, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
 
(2)
the information contained in such Quarterly Report on Form 10-Q for the quarter ended November 30, 2020, fairly presents, in all material respects, the financial condition and results of operations of Loop Industries, Inc.
 
Date: January 14, 2021
 
/s/ Nelson Gentiletti
 
 
 
Nelson Gentiletti
 
 
 
Chief Financial Officer and Treasurer (principal financial officer and principal accounting officer)
 
 
 
GRAPHIC 6 lpi_10q000.jpg IMAGE begin 644 lpi_10q000.jpg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end EX-101.INS 7 loop-20201130.xml XBRL INSTANCE DOCUMENT 0001504678 2020-03-01 2020-11-30 0001504678 2020-11-30 0001504678 2020-02-29 0001504678 us-gaap:CommonStockMember 2020-02-29 0001504678 us-gaap:CommonStockMember 2020-11-30 0001504678 us-gaap:PreferredStockMember 2020-11-30 0001504678 us-gaap:AdditionalPaidInCapitalMember 2020-11-30 0001504678 LOOP:CommonStockIssuableMember 2020-11-30 0001504678 us-gaap:RetainedEarningsMember 2020-11-30 0001504678 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-11-30 0001504678 us-gaap:CommonStockMember 2019-03-01 2019-11-30 0001504678 us-gaap:AdditionalPaidInCapitalMember 2019-03-01 2019-11-30 0001504678 LOOP:CommonStockIssuableMember 2019-03-01 2019-11-30 0001504678 us-gaap:RetainedEarningsMember 2019-03-01 2019-11-30 0001504678 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-01 2019-11-30 0001504678 us-gaap:CommonStockMember 2020-03-01 2020-11-30 0001504678 us-gaap:AdditionalPaidInCapitalMember 2020-03-01 2020-11-30 0001504678 us-gaap:RetainedEarningsMember 2020-03-01 2020-11-30 0001504678 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-01 2020-11-30 0001504678 LOOP:EquityIncentiveplanMember 2020-02-29 0001504678 LOOP:EquityIncentiveplanMember 2020-11-30 0001504678 us-gaap:BuildingMember 2020-02-29 0001504678 us-gaap:LandMember 2020-02-29 0001504678 us-gaap:BuildingImprovementsMember 2020-02-29 0001504678 us-gaap:MachineryAndEquipmentMember 2020-02-29 0001504678 LOOP:OfficeEquipmentAndFurnitureMember 2020-02-29 0001504678 us-gaap:BuildingMember 2020-11-30 0001504678 us-gaap:LandMember 2020-11-30 0001504678 us-gaap:BuildingImprovementsMember 2020-11-30 0001504678 us-gaap:MachineryAndEquipmentMember 2020-11-30 0001504678 LOOP:OfficeEquipmentAndFurnitureMember 2020-11-30 0001504678 us-gaap:RestrictedStockUnitsRSUMember 2020-03-01 2020-11-30 0001504678 us-gaap:RestrictedStockUnitsRSUMember 2019-03-01 2019-11-30 0001504678 LOOP:EquityIncentiveplanMember 2020-03-01 2020-11-30 0001504678 us-gaap:RestrictedStockUnitsRSUMember 2020-11-30 0001504678 LOOP:AdditionalPaidInCapitalWarrantsMember 2019-03-01 2019-11-30 0001504678 LOOP:AdditionalPaidInCapitalWarrantsMember 2020-03-01 2020-11-30 0001504678 LOOP:AdditionalPaidInCapitalWarrantsMember 2020-11-30 0001504678 LOOP:AdditionalPaidInCapitalWarrantsBeneficialConversionFeatureMember 2020-11-30 0001504678 LOOP:EquityIncentiveplanMember 2019-03-01 2019-11-30 0001504678 us-gaap:WarrantMember 2020-03-01 2020-11-30 0001504678 us-gaap:WarrantMember 2019-03-01 2019-11-30 0001504678 2019-03-01 2019-11-30 0001504678 2019-03-01 2020-02-29 0001504678 2019-11-30 0001504678 us-gaap:RestrictedStockUnitsRSUMember 2019-11-30 0001504678 us-gaap:CommonStockMember 2019-02-28 0001504678 us-gaap:CommonStockMember 2019-11-30 0001504678 us-gaap:PreferredStockMember 2019-02-28 0001504678 us-gaap:PreferredStockMember 2019-11-30 0001504678 us-gaap:AdditionalPaidInCapitalMember 2019-02-28 0001504678 us-gaap:AdditionalPaidInCapitalMember 2019-11-30 0001504678 LOOP:AdditionalPaidInCapitalWarrantsMember 2019-02-28 0001504678 LOOP:AdditionalPaidInCapitalWarrantsMember 2019-11-30 0001504678 LOOP:AdditionalPaidInCapitalWarrantsBeneficialConversionFeatureMember 2019-02-28 0001504678 LOOP:AdditionalPaidInCapitalWarrantsBeneficialConversionFeatureMember 2019-11-30 0001504678 LOOP:CommonStockIssuableMember 2019-02-28 0001504678 LOOP:CommonStockIssuableMember 2019-11-30 0001504678 us-gaap:RetainedEarningsMember 2019-02-28 0001504678 us-gaap:RetainedEarningsMember 2019-11-30 0001504678 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-02-28 0001504678 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-11-30 0001504678 2019-02-28 0001504678 us-gaap:PreferredStockMember 2020-02-29 0001504678 us-gaap:AdditionalPaidInCapitalMember 2020-02-29 0001504678 LOOP:AdditionalPaidInCapitalWarrantsMember 2020-02-29 0001504678 LOOP:AdditionalPaidInCapitalWarrantsBeneficialConversionFeatureMember 2020-02-29 0001504678 LOOP:CommonStockIssuableMember 2020-02-29 0001504678 us-gaap:RetainedEarningsMember 2020-02-29 0001504678 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-02-29 0001504678 us-gaap:StockOptionMember 2020-03-01 2020-11-30 0001504678 us-gaap:StockOptionMember 2019-03-01 2019-11-30 0001504678 us-gaap:RestrictedStockUnitsRSUMember 2020-03-01 2020-11-30 0001504678 us-gaap:RestrictedStockUnitsRSUMember 2019-03-01 2019-11-30 0001504678 us-gaap:WarrantMember 2020-03-01 2020-11-30 0001504678 us-gaap:WarrantMember 2019-03-01 2019-11-30 0001504678 us-gaap:LongTermDebtMember us-gaap:FairValueInputsLevel2Member 2020-02-29 0001504678 us-gaap:LongTermDebtMember us-gaap:FairValueInputsLevel2Member 2020-11-30 0001504678 LOOP:InvestissementQuebecFinancingFacilityMember 2020-11-30 0001504678 LOOP:InvestissementQuebecFinancingFacilityMember 2020-02-29 0001504678 LOOP:TermLoanMember 2020-11-30 0001504678 LOOP:TermLoanMember 2020-02-29 0001504678 LOOP:InvestissementQuebecFinancingFacilityMember 2020-03-01 2020-11-30 0001504678 LOOP:InvestissementQuebecFinancingFacilityMember 2019-03-01 2019-11-30 0001504678 LOOP:TermLoanMember 2020-03-01 2020-11-30 0001504678 LOOP:TermLoanMember 2019-03-01 2019-11-30 0001504678 LOOP:EquityIncentiveplanMember 2019-02-28 0001504678 LOOP:EquityIncentiveplanMember 2019-11-30 0001504678 us-gaap:ResearchAndDevelopmentExpenseMember 2020-03-01 2020-11-30 0001504678 us-gaap:ResearchAndDevelopmentExpenseMember 2019-03-01 2019-11-30 0001504678 us-gaap:GeneralAndAdministrativeExpenseMember 2020-03-01 2020-11-30 0001504678 us-gaap:GeneralAndAdministrativeExpenseMember 2019-03-01 2019-11-30 0001504678 us-gaap:CommonStockMember 2019-09-01 2019-11-30 0001504678 us-gaap:CommonStockMember 2019-08-31 0001504678 us-gaap:PreferredStockMember 2019-08-31 0001504678 us-gaap:AdditionalPaidInCapitalMember 2019-09-01 2019-11-30 0001504678 us-gaap:AdditionalPaidInCapitalMember 2019-08-31 0001504678 LOOP:AdditionalPaidInCapitalWarrantsMember 2019-08-31 0001504678 LOOP:AdditionalPaidInCapitalWarrantsBeneficialConversionFeatureMember 2019-08-31 0001504678 LOOP:CommonStockIssuableMember 2019-08-31 0001504678 us-gaap:RetainedEarningsMember 2019-09-01 2019-11-30 0001504678 us-gaap:RetainedEarningsMember 2019-08-31 0001504678 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-01 2019-11-30 0001504678 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-08-31 0001504678 2019-09-01 2019-11-30 0001504678 2019-08-31 0001504678 us-gaap:CommonStockMember 2020-09-01 2020-11-30 0001504678 us-gaap:CommonStockMember 2020-08-31 0001504678 us-gaap:PreferredStockMember 2020-08-31 0001504678 us-gaap:AdditionalPaidInCapitalMember 2020-09-01 2020-11-30 0001504678 us-gaap:AdditionalPaidInCapitalMember 2020-08-31 0001504678 LOOP:AdditionalPaidInCapitalWarrantsMember 2020-09-01 2020-11-30 0001504678 LOOP:AdditionalPaidInCapitalWarrantsMember 2020-08-31 0001504678 LOOP:AdditionalPaidInCapitalWarrantsBeneficialConversionFeatureMember 2020-08-31 0001504678 LOOP:CommonStockIssuableMember 2020-08-31 0001504678 us-gaap:RetainedEarningsMember 2020-09-01 2020-11-30 0001504678 us-gaap:RetainedEarningsMember 2020-08-31 0001504678 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-01 2020-11-30 0001504678 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-08-31 0001504678 2020-09-01 2020-11-30 0001504678 2020-08-31 0001504678 LOOP:ForeignExchangeContractsMember us-gaap:FairValueInputsLevel2Member 2020-11-30 0001504678 LOOP:ForeignExchangeContractsMember us-gaap:FairValueInputsLevel2Member 2020-02-29 0001504678 LOOP:ExternalEngineeringMember 2020-09-01 2020-11-30 0001504678 us-gaap:MachineryAndEquipmentMember 2020-09-01 2020-11-30 0001504678 LOOP:EmployeeCompensationMember 2020-09-01 2020-11-30 0001504678 LOOP:PilotPlantAndLabOperatingExpensesMember 2020-09-01 2020-11-30 0001504678 LOOP:OtherResearchAndDevelopmentExpenseMember 2020-09-01 2020-11-30 0001504678 LOOP:ExternalEngineeringMember 2019-09-01 2019-11-30 0001504678 us-gaap:MachineryAndEquipmentMember 2019-09-01 2019-11-30 0001504678 LOOP:EmployeeCompensationMember 2019-09-01 2019-11-30 0001504678 LOOP:PilotPlantAndLabOperatingExpensesMember 2019-09-01 2019-11-30 0001504678 LOOP:OtherResearchAndDevelopmentExpenseMember 2019-09-01 2019-11-30 0001504678 LOOP:ExternalEngineeringMember 2020-03-01 2020-11-30 0001504678 us-gaap:MachineryAndEquipmentMember 2020-03-01 2020-11-30 0001504678 LOOP:EmployeeCompensationMember 2020-03-01 2020-11-30 0001504678 LOOP:PilotPlantAndLabOperatingExpensesMember 2020-03-01 2020-11-30 0001504678 LOOP:OtherResearchAndDevelopmentExpenseMember 2020-03-01 2020-11-30 0001504678 LOOP:ExternalEngineeringMember 2019-03-01 2019-11-30 0001504678 us-gaap:MachineryAndEquipmentMember 2019-03-01 2019-11-30 0001504678 LOOP:EmployeeCompensationMember 2019-03-01 2019-11-30 0001504678 LOOP:PilotPlantAndLabOperatingExpensesMember 2019-03-01 2019-11-30 0001504678 LOOP:OtherResearchAndDevelopmentExpenseMember 2019-03-01 2019-11-30 0001504678 us-gaap:RestrictedStockUnitsRSUMember 2020-09-01 2020-11-30 0001504678 us-gaap:RestrictedStockUnitsRSUMember 2019-09-01 2019-11-30 0001504678 us-gaap:ResearchAndDevelopmentExpenseMember 2020-09-01 2020-11-30 0001504678 us-gaap:ResearchAndDevelopmentExpenseMember 2019-09-01 2019-11-30 0001504678 us-gaap:GeneralAndAdministrativeExpenseMember 2020-09-01 2020-11-30 0001504678 us-gaap:GeneralAndAdministrativeExpenseMember 2019-09-01 2019-11-30 0001504678 LOOP:InvestissementQuebecFinancingFacilityMember 2020-09-01 2020-11-30 0001504678 LOOP:InvestissementQuebecFinancingFacilityMember 2019-09-01 2019-11-30 0001504678 LOOP:TermLoanMember 2020-09-01 2020-11-30 0001504678 LOOP:TermLoanMember 2019-09-01 2019-11-30 0001504678 2021-01-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure Loop Industries, Inc. 0001504678 10-Q 2020-11-30 false --02-28 Yes Non-accelerated Filer Q3 2021 false true false Yes NV 000-54768 46026364 34523441 1230442 141226 1182107 664544 43613815 33717671 35491491 5833390 631590 202863 3355410 7260254 1717159 264868 519816 4658730 99681 1730830 236360 1223602 0 164618 1500000 850000 51513364 42836558 4142139 2134824 53992 52126 0 0 53992 52126 4088147 2082698 2336374 2238026 1463511 1356228 872863 881798 6478513 4372850 2290152 2390366 -25797 26840 -89879 -388449 -76468478 -53317047 9475996 9785799 112112970 82379413 4242 3992 0 0 45034851 38463708 3992 4242 0 112112970 0 -76468478 -89879 9475996 0 36316469 3381 3923 0 0 38966208 75290970 757704 9700102 1200915 1200915 800000 0 -38811592 -49559084 -290224 -320357 2626392 0 82379413 9785799 0 0 -53317047 -388449 3903 0 74414197 9700102 1200915 0 -45708185 -327909 39283023 3994 0 84172723 9870241 0 0 -62297485 -156049 31593424 51513364 42836558 .0001 0.0001 25000000 25000000 1 1 1 1 0.0001 0.0001 250000000 250000000 42412739 39910774 42412739 39910774 0 0 0 0 23151431 10747492 3850899 14170993 -275903 -15297 -5533 -95644 78394 363565 171274 20008 26016 1817091 693027 -41855 654354 562382 219628 104307 5043120 22985 0 5034606 6726339 5447056 1825813 2724016 10504093 3246246 1278172 6274283 2224910 2325540 1214434 399031 110368 33131 0 973679 166753 104610 3241959 2325540 3094151 1537271 305172 83462 0 2453743 456942 252099 -23151431 -10747492 -23151431 -10747492 -3850899 -3850899 -14170993 -14170993 298570 -30133 7552 66170 -22852861 -10777625 -3843347 -14104823 -0.57 -0.29 -0.10 -0.34 40515885 37404165 39133627 41715806 39910774 42412739 1 33805706 39232528 1 1 1 39032528 1 39935210 1 243932 224436 200000 200000 0 24 799976 -800000 22 -22 0 20 -20 0 20 -20 0 1662155 1628897 1662155 1628897 549810 549810 551720 551720 1028152 981914 1028152 981914 326983 326983 345274 345274 298570 -30133 298570 -30133 7552 7552 66170 66170 4693567 2087000 2087000 24996628 469 30359394 209 24996419 8663769 39023632 209 24996419 24996628 15432 190529 190529 1652627 1 182048 19 2046853 -38300 -394245 143749 19 2046854 -394245 1652628 84442 84442 150000 15 -15 0 319326 32 2372549 316929 2689510 4565 1 -1 0 -14544251 -6819748 1690789 -1054967 1075291 -52649 -477855 -37536 58945 -10881 -10881 70427 0 232565 0 -86212 0 -8483 -56259 -1898409 2774749 1028152 981914 2610811 1054682 941142 1720067 1669669 345274 326983 350393 311353 546601 565440 654354 562382 -2386593 -2592921 155798 95488 1580795 1647433 650000 850000 26616472 39127875 32781 39506 32781 39506 13497 13168 26649253 39167381 9896144 29658101 210516 -57105 78394 363565 28613 45668 0 0 <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>The Company</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Loop Industries, Inc.&#160;(the &#8220;Company,&#8221; &#8220;Loop Industries,&#8221; &#8220;we,&#8221; or &#8220;our&#8221;) is a technology company that owns patented and proprietary technology that depolymerizes no and low-value waste PET plastic and polyester fiber to its base building blocks (monomers).&#160; The monomers are filtered, purified and polymerized to create virgin-quality Loop&#8482; branded PET resin suitable for use in food-grade packaging and polyester fiber.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 20, 2017, Loop Industries commenced trading on the NASDAQ Global Market under its new trading symbol, &#8220;LOOP.&#8221; From April 10, 2017 to November 19, 2017, our common stock&#160;was&#160;quoted on the OTCQX tier of the OTC Markets Group Inc. under the symbol &#8220;LLPP.&#8221;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Basis of presentation</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited interim condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (&#8220;US GAAP&#8221;) and applicable rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) regarding interim financial reporting. Certain information and note disclosures included in these unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended February 29, 2020, filed with the SEC on May 5, 2020. The unaudited interim condensed consolidated financial statements comprise the consolidated financial position and results of operations of Loop Industries, Inc. and its subsidiaries, Loop Innovations, LLC and Loop Canada Inc. All subsidiaries are, either directly or indirectly, wholly owned subsidiaries of Loop Industries, Inc. (collectively, the &#8220;Company&#8221;). The Company also owns, through Loop Innovations, LLC, a 50% interest in a joint venture, Indorama Loop Technologies, LLC, which is accounted for under the equity method.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Intercompany balances and transactions are eliminated on consolidation. The condensed consolidated balance sheet as of February 29, 2020, included herein, was derived from the audited financial statements as of that date, but does not include all disclosures including certain notes required by GAAP on an annual reporting basis. In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements present fairly the financial position, results of operations, comprehensive loss and cash flows for the interim periods. The results for the three- and nine-month periods ended November 30, 2020 are not necessarily indicative of the results to be expected for any subsequent quarter, the fiscal year ending February 28, 2021, or any other period.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Use of estimates</u></i></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for depreciable lives of property, plant and equipment, intangible assets, analysis of impairments of long-lived assets and intangible assets, accruals for potential liabilities and assumptions made in calculating the fair value of stock-based compensation and other equity instruments.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The COVID-19 pandemic has disrupted business operations for us and our customers, suppliers, vendors and other parties with whom we do business, and such disruptions are expected to continue for an indefinite period of time. The uncertain duration of these measures has had and may continue to have an effect on our development and commercialization efforts. In particular, as previously disclosed, the situation in the United States and the continued travel restrictions and quarantine requirements between Canada and the United States have caused disruptions in our timetable of our joint venture with Indorama in the development of our Spartanburg facility and commercialization of our technology.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Although the Company continues to monitor the situation and may adjust the Company&#8217;s current policies as more information and public health guidance become available, the COVID-19 pandemic is ongoing, and its dynamic nature, including uncertainties relating to the ultimate spread of the virus, the severity of the disease, the duration of the outbreak and actions that may be taken by governmental authorities to contain the outbreak or to treat its impact, makes it difficult to assess whether there will be further impact on the development and commercialization of the Company&#8217;s technology which could have a material adverse effect on the Company&#8217;s results of operations and cash flows.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Foreign currency translations and transactions</u></i></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars, the reporting currency of the Company. Assets and liabilities of subsidiaries that have a functional currency other than that of the Company are translated to U.S. dollars at the exchange rate as at the balance sheet date. Income and expenses are translated at the average exchange rate of the period. The resulting translation adjustments are included in other comprehensive income (loss) (&#8220;OCI&#8221;). As a result, foreign currency exchange fluctuations may impact operating expenses. The Company currently has not engaged in any currency hedging activities.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For transactions and balances, monetary assets and liabilities denominated in foreign currencies are translated into the functional currency of the entity at the prevailing exchange rate at the reporting date. Non-monetary assets and liabilities, and revenue and expense items denominated in foreign currencies are translated into the functional currency using the exchange rate prevailing at the dates of the respective transactions. Foreign exchange gains and losses resulting from the settlement of such transactions are recognized in the consolidated statements of operations and comprehensive loss, except for gains or losses arising from the translation of intercompany balances denominated in foreign currencies that forms part in the net investment in the subsidiary which are included in OCI.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Stock-based compensation</u></i></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company periodically issues stock options, warrants and restricted stock units to employees and non-employees in non-capital raising transactions for services and financing expenses. The Company accounts for stock options granted to employees based on the authoritative guidance provided by the FASB wherein the fair value of the award is measured on the grant date and where there are no performance conditions, recognized as compensation expense on the straight-line basis over the vesting period and where performance conditions exist, recognize compensation expense when it becomes probable that the performance condition will be met. Forfeitures on share-based payments are accounted for by recognizing forfeitures as they occur.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for stock options and warrants granted to non-employees in accordance with the authoritative guidance of the FASB wherein the fair value of the stock compensation is based upon the measurement date determined as the earlier of the date at which either a)&#160;a&#160;commitment is reached with the counterparty for performance or b) the counterparty completes its performance.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company estimates the fair value of restricted stock unit awards to employees and directors based on the closing market price of its common stock on the date of grant.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of the stock options granted are estimated using the Black-Scholes-Merton Option Pricing (&#8220;Black-Scholes&#8221;) model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options, and future dividends. Stock-based compensation expense is recorded based on the value derived from the Black-Scholes model and on actual experience. The assumptions used in the Black-Scholes model could materially affect stock-based compensation expense recorded in the current and future periods.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Income taxes</u></i></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company calculates its provision for income tax on the basis of the tax laws enacted at the balance sheet date in the countries where the Company and its subsidiaries operate and generate taxable income, in accordance with FASB ASC 740, <i>Income Taxes</i>. The Company uses an asset and liability approach for financial accounting and reporting for income taxes that allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The Company&#8217;s policy is to recognize interest and/or penalties related to income tax matters in income tax expense.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Research and development expenses</u></i></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development expenses relate primarily to the development, design, testing of preproduction samples, prototypes and models, compensation, and consulting fees, and are expensed as incurred. Starting in the current quarter, machinery and equipment purchases related to the pilot plant which is now dedicated solely to research and development activities with no alternative use are also expensed as incurred. Total research and development costs recorded during the three- and nine-month periods ended November 30, 2020 amounted to $6,724,283 and $10,504,093 (2019 &#8211; $1,278,172 and $3,246,246), respectively, and are net of government research and development tax credits and government grants from the federal and provincial taxation authorities accrued and recorded based on qualifying expenditures incurred during the fiscal periods.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;<i><u>Net earnings (loss) per share</u></i></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company computes net loss per share in accordance with FASB ASC 260, <i>Earnings Per Share</i>. Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year. The Company includes common stock issuable in its calculation. Diluted earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation if their effect is antidilutive.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three- and nine-month periods ended November 30, 2020 and 2019, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have an antidilutive effect. As at November 30, 2020, the potentially dilutive securities consisted of 1,590,470 outstanding stock options (November 30, 2019 &#8211; 1,657,081), 4,171,609 outstanding restricted stock units (November 30, 2019 &#8211; 4,219,753) and 4,693,802 outstanding warrants (November 30, 2019 &#8211; 5,040,267).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Recently adopted accounting pronouncements</u></i></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2018, the FASB issued ASU 2018-15, &#8220;Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that Is a Service Contract,&#8221; which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). This update is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The adoption of the standard had no impact on the consolidated financial statements of the Company.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2018, the FASB issued ASU 2018-02, <i>Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</i>, which permits entities to reclassify the disproportionate income tax effects of the Tax Reform Act on items within accumulated other comprehensive income (loss) (&#8220;AOCI&#8221;) to retained earnings. These disproportionate income tax effect items are referred to as &#34;stranded tax effects.&#34; Amendments in this update only relate to the reclassification of the income tax effects of the Tax Reform Act. Other accounting guidance that requires the effect of changes in tax laws or rates to be included in net income from continuing operations is not affected by this update. ASU 2018-02 should be applied either in the period of adoption or retrospectively to each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Reform Act is recognized. ASU 2018-02 is applicable beginning March 1, 2020. The adoption of the standard had no impact on the consolidated financial statements of the Company.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the FASB issued ASU 2016-02, &#8220;Leases,&#8221; amended in July by ASU 2018-10, &#8220;Codification Improvements to Topic 842, Leases,&#8221; ASU 2018-11, &#8220;Targeted Improvements,&#8221; and ASU 2018-20, &#8220;Narrow-Scope Improvements for Lessors,&#8221; which requires lessees to recognize leases on the balance sheet while continuing to recognize expenses in the income statement in a manner similar to current accounting standards. For lessors, the new standard modifies the classification criteria and the accounting for sales-type and direct financing leases. Enhanced disclosures will also be required to give financial statement users the ability to assess the amount, timing, and uncertainty of cash flows arising from leases. This ASU may either be adopted on a modified retrospective approach at the beginning of the earliest comparative period, or through a cumulative-effect adjustment at the adoption date. This update is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company adopted these standards effective March 1, 2020. The adoption of the standard had no impact on the consolidated financial statements of the Company. The Company elected to apply the package of practical expedients that allows us not to reassess whether expired or existing contracts contain leases, the classification of these leases and whether previously capitalized initial direct costs would qualify for capitalization under Accounting Standards Codification (or &#8220;<i>ASC</i>&#8221;) 842. Furthermore, we elected to use hindsight in determining the lease term and assessing impairment of the right-of-use assets.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Recently issued accounting pronouncements not yet adopted</u></i></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2019, the FASB issued ASU 2019-12, &#8220;Simplifying the Accounting for Income Taxes,&#8221; which removes specific exceptions to the general principles in ASC 740, &#8220;Income Taxes,&#8221; and clarifies certain aspects of the existing guidance. This update is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years, with early adoption being permitted as of the beginning of an interim or annual reporting period. All amendments to this ASU must be adopted in the same period on a prospective basis, with certain exceptions. We are still evaluating the impact of this accounting guidance on our results of operations and financial position.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2016, the FASB issued ASU 2016-13, &#8220;Financial Instruments&#8212;Credit Losses&#8221;. This ASU added a new impairment model (known as the current expected credit loss (&#8220;CECL&#8221;) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes an allowance for its estimate of expected credit losses and applies to most debt instruments, trade receivables, lease receivables, financial guarantee contracts, and other loan commitments. The CECL model does not have a minimum threshold for recognition of impairment losses and entities will need to measure expected credit losses on assets that have a low risk of loss. This update is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years for smaller reporting companies. We are still evaluating the impact of this accounting guidance on our results of operations and financial position.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Sales tax, research and development tax credits and other receivables as at November 30, 2020 and February 29, 2020 were as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>November 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">February 29, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%; padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Sales tax</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">669,966</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">180 971</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Research and development tax credits</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">390,885</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">447,843</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Other receivables</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">121,256</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">35,730</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">1,182,107</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">664,544</font></td> <td style="padding-bottom: 3pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prepaid expenses and deposits as at November 30, 2020 and February 29, 2020 were as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>November 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">February 29, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%; text-align: justify"><font style="font-size: 8pt">Deposits on machinery and equipment</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">747,250</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">-</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Insurance</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">427,013</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">61,891</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Other prepaid expenses</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">56,179</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">79,335</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">1,230,442</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">141,226</font></td> <td style="padding-bottom: 3pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Non-refundable cash deposits on machinery and equipment that will be used in research and development activities will be expensed, and classified as research and development expenses, in the period the equipment is received and placed into use.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>November 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">February 29, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%; text-align: justify"><font style="font-size: 8pt">Intangible assets, at cost - beginning of period</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">225,174</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">127,672</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Intangible assets, accumulated depreciation &#8211; beginning of period</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(22,311</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">202,863</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">127,672</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Additions in the period</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">452,758</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">99,972</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Amortization of intangibles</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">(30,165</font></td> <td><font style="font-size: 8pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">(22,631</font></td> <td><font style="font-size: 8pt">)</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Foreign exchange effect &#8211; increase (decrease)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">6,133</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(2,150</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">631,589</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">202,863</font></td> <td style="padding-bottom: 3pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Amortization expense for the three- and nine-month periods ended November 30, 2020 amounted to $11,301 and $30,165, respectively (2019 - $6,660 and $15,202, respectively), and is recorded as an expense in the unaudited condensed consolidated statements of operations and comprehensive loss.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following tables present the fair value of the Company&#8217;s financial (assets) liabilities as at November 30, 2020 and February 29, 2020:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Fair Value Measurements as at November 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Carrying Amount</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Fair Value</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Level in the hierarchy</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Instruments measured at fair value on a recurring basis:</font></td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 62%; padding-left: 9pt; text-align: justify"><font style="font-size: 8pt">Foreign exchange contracts</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">(25,797</font></td> <td style="width: 1%"><font style="font-size: 8pt">)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">(25,797</font></td> <td style="width: 1%"><font style="font-size: 8pt">)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">Level 2</font></td> <td style="width: 3%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Instruments measured at amortized cost:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify"><font style="font-size: 8pt">Long-term debt</font></td> <td>&#160;</td> <td><font style="font-size: 8pt">$</font></td> <td style="text-align: right"><font style="font-size: 8pt">2,390,366</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 8pt">$</font></td> <td style="text-align: right"><font style="font-size: 8pt">2,400,897</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">Level 2</font></td> <td>&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Fair Value Measurements at February 29, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Carrying Amount</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Fair Value</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Level in the hierarchy</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Instruments measured at fair value on a recurring basis:</font></td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 62%; padding-left: 9pt; text-align: justify"><font style="font-size: 8pt">Foreign exchange contracts</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">26,840</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">26,840</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">Level 2</font></td> <td style="width: 3%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Instruments measured at amortized cost:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify"><font style="font-size: 8pt">Long-term debt</font></td> <td>&#160;</td> <td><font style="font-size: 8pt">$</font></td> <td style="text-align: right"><font style="font-size: 8pt">2,290,152</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 8pt">$</font></td> <td style="text-align: right"><font style="font-size: 8pt">2,291,109</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">Level 2</font></td> <td>&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts payable and accrued liabilities as at November 30, 2020 and February 29, 2020 were as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>November 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">February 29, 2020</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%; text-align: justify"><font style="font-size: 8pt">Trade accounts payable</font></td> <td style="width: 1%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">1,514,881</font></td> <td style="width: 1%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">814,081</font></td> <td style="width: 1%"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Accrued engineering fees</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">686,061</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Accrued employee compensation and payroll taxes</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">678,925</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">873,242</font></td> <td><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Accrued professional fees</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">676,153</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">133,038</font></td> <td><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Accrued cost of machinery and equipment</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">&#160;415,522</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">&#160;92,126</font></td> <td><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Other accrued liabilities</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">116,605</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">170,211</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 3pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">4,088,147</font></td> <td style="padding-bottom: 3pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 3pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">2,082,698</font></td> <td style="padding-bottom: 3pt"><font style="font-size: 8pt">&#160;</font></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 15, 2018, the Company, through its wholly-owned subsidiary Loop Innovations, LLC, a Delaware limited liability company, entered into a Joint Venture Agreement (the &#8220;Joint Venture Agreement&#8221;) with Indorama Ventures Holdings LP, USA, an indirect subsidiary of Indorama Ventures Public Company Limited, to manufacture and commercialize sustainable polyester resin. Each company has a 50/50 equity interest in Indorama Loop Technologies, LLC (&#8220;ILT&#8221;), which was specifically formed to operate and execute the joint venture.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the Joint Venture Agreement, Indorama Ventures is contributing manufacturing knowledge and Loop Industries is required to contribute its proprietary science and technology. Specifically, the Company is contributing an exclusive world-wide royalty-free license to ILT to use its proprietary technology to produce 100% sustainably produced PET resin and polyester fiber.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ILT meets the accounting definition of a joint venture where neither party has control of the joint venture entity&#160;and both parties have joint control over the decision-making process in ILT. As such, the Company uses the equity method of accounting to account for its share of the investment in ILT. There were no operations in ILT from the date of inception of September 24, 2018 to November 30, 2020 and, as at November 30, 2020, the carrying value of the equity investment was $1,500,000, which is the total of the cash contributions we have made to ILT. During the three- and nine-month periods ended November 30, 2020, we made contributions to ILT of nil and $650,000 respectively (2019 &#8211; $350,000 and $850,000). These contributions to ILT, which have been matched by Indorama Ventures, were used to fund engineering design costs which have been capitalized in ILT.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #333333">The joint venture made a decision in July that due to the COVID-19 situation it would delay work on the project. Since then, no expenditures have been incurred by the joint venture.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>November 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">February 29, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Investissement Qu&#233;bec financing facility:</font></td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%; padding-left: 9pt; text-align: justify"><font style="font-size: 8pt">Principal amount</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">1,703,998</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">1,645,122</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify"><font style="font-size: 8pt">Unamortized discount</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">(272,036</font></td> <td><font style="font-size: 8pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">(289,852</font></td> <td><font style="font-size: 8pt">)</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify"><font style="font-size: 8pt">Accrued interest</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">31,549</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">958</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27pt; text-align: justify"><font style="font-size: 8pt">Total Investissement Qu&#233;bec financing facility</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,463,511</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,356,228</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Term loan</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify"><font style="font-size: 8pt">Principal amount</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">926,855</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">933,924</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify"><font style="font-size: 8pt">Less: current portion</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(53,992</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(52,126</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27pt"><font style="font-size: 8pt">Total term loan, net of current portion</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">872,863</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">881,798</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt">Long-term debt, net of current portion</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">2,336,374</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">2,238,026</font></td> <td style="padding-bottom: 3pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Investissement Qu&#233;bec financing facility</i></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 21, 2020, the Company received $1,703,998 (CDN$2,209,234) from Investissement Qu&#233;bec as the first disbursement of our financing facility, out of a maximum of $3,548,014 (CDN$4,600,000) (the &#8220;Financing Facility&#8221;). The loan bears interest at 2.36% and there is a 36-month moratorium on both capital and interest repayments starting on the date of the first disbursement, after which capital and interest is repayable in 84 monthly installments.&#160;The Company established the fair value of the loan for the first disbursement at $1,354,408 based on a discount rate of 5.45%, which reflected a debt discount of $290,714. The discount rate used was based on the external financing from a Canadian bank.&#160;The Company, under the loan agreement, was required to pay fees representing 1% of the loan amount, $35,480 (CDN$46,000) to Investissment Qu&#233;bec which we deferred and recorded as a reduction of the Financing Facility. Debt discount and deferred financing expenses are amortized to &#8220;Interest and other financial expenses&#8221; in our&#160;Consolidated Statements of Operations and Comprehensive Loss.&#160;The Company recorded interest expense on the Investissement Qu&#233;bec loan for the three- and nine-month periods ended November 30, 2020 in the amount of $10,003 and $28,816 respectively (2019 &#8211; nil and nil) and an accretion expense of $9,387 and $27,045 respectively (2019 &#8211; nil and nil).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has also agreed to issue to Investissement Qu&#233;bec warrants to purchase shares of common stock of the Company in an amount equal to 10% of each disbursement up to a maximum aggregate amount of $354,801 (CDN$460,000). The exercise price of the warrants is equal to the higher of (i) $11.00 per share and (ii) the ten-day weighted average closing price of Loop Industries shares of common stock on the Nasdaq stock market for the 10 days prior to the issue of the warrants. The warrants can be exercised immediately upon grant and will have a term of three years from the date of issuance. The loan can be repaid at any time by the Company without penalty. In connection the first disbursement of the Financing Facility, the Company issued a warrant (&#8220;First Disbursement Warrant&#8221;) to acquire 15,153 shares of common stock at a strike price of $11.00 per share to Investissement Qu&#233;bec. The Company determined the fair value of the warrants using the Black-Scholes pricing formula. The fair value of the First Disbursement Warrant was determined to be $77,954 and is included in &#8220;Additional paid-in capital &#8211; Warrants&#8221; in our Condensed Consolidated Balance Sheets. The First Disbursement Warrant remains outstanding as at November 30, 2020.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The remaining amount available under the financing facility is $1,844,015 (CDN$2,390,766) to be received in a maximum of two additional disbursements.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Term loan</i></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 24, 2018, the Company obtained a $1,079,830 (CDN$1,400,000) 20-year term instalment loan (the &#8220;Loan&#8221;), from a Canadian bank. The Loan bears interest at the bank&#8217;s Canadian prime rate plus 1.5%. By agreement, the Loan is repayable in monthly payments of $4,499 (CDN$5,833) plus interest, until January 2021, at which time the monthly repayment amount and interest rate will be subject to renewal. It includes an option allowing for the prepayment of the Loan without penalty. In January 2021, the Company and the Canadian bank agreed to maintain the same repayment amount and interest rate until January 2022. During the three- and nine-month periods ended November 30, 2020, we repaid $13,497 and $32,781 respectively (2019 &#8211; $13,168 and $39,506) on the principal balance of the Loan and interest paid amounted to $9,172 and $29,102 and (2019 - $14,778 and $41,840). The terms of the credit facility require the Company to comply with certain financial covenants. As at November 30, 2020 and 2019, the Company was in compliance with its financial covenants.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Principal repayments due on the Company&#8217;s long-term debt over the next five years are as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-indent: 9pt"><font style="font-size: 8pt"><b>Years ending</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Amount</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 88%; text-indent: 9pt"><font style="font-size: 8pt">February 28, 2021</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">13,498</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 9pt"><font style="font-size: 8pt">February 28, 2022</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">53,992</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 9pt"><font style="font-size: 8pt">February 28, 2023</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">53,992</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 9pt"><font style="font-size: 8pt">February 29, 2024</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">297,416</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 9pt"><font style="font-size: 8pt">February 28, 2025</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">297,416</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 9pt"><font style="font-size: 8pt">Thereafter</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">1,901,043</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 9pt"><font style="font-size: 8pt"><b>Total</b></font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">2,617,355</font></td> <td style="padding-bottom: 3pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Employment Agreement</u></i></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 29, 2015, the Company entered into an employment agreement with Mr. Daniel Solomita, the Company&#8217;s President and Chief Executive Officer (&#8220;CEO&#8221;). The employment agreement is for an indefinite term.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 13, 2018, the Company and Mr. Solomita entered into an amendment and restatement of the employment agreement which provided for a long-term incentive grant of 4,000,000 shares of the Company&#8217;s common stock, in tranches of one million shares each, upon the achievement of four performance milestones. This was modified to provide a grant of 4,000,000 restricted stock units (&#8220;RSUs&#8221;) covering 4,000,000 shares of the Company&#8217;s common stock while the performance milestones remained the same. The grant of the restricted stock units became effective upon approval by the Company&#8217;s shareholders at the Company&#8217;s 2019 annual meeting, of an increase in the number of shares available for grant under the Plan.&#160; Such approval was granted by the Company&#8217;s shareholders at the Company&#8217;s 2019 annual meeting.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 30, 2020, the Company and Mr. Solomita entered into an amendment of Mr. Solomita&#8217;s employment agreement.&#160;&#160;The amendment clarified the milestones consistent with the shift in the Company&#8217;s business from the production of terephthalate to the production of dimethyl terephthalate, another proven monomer of PET plastic.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As at November 30, 2020, 3,600,000 (2019 &#8211; 3,800,000) of Mr. Solomita&#8217;s RSUs were outstanding of which 600,000 were vested (2019 &#8211; 800,000). The vested units are settled annually in tranches of 200,000 units. During the three- and nine-month periods ended November 30, 2020 and November 30, 2019, no outstanding milestones were probable of being met&#160;based on the authoritative guidance provided by the FASB and, accordingly, the Company did not record any additional compensation expense. When a milestone becomes probable, the corresponding expense will be valued based on the grant date fair value on April 30, 2020, the date of the last modification of Mr. Solomita&#8217;s employment agreement. The closing price of the Company&#8217;s common stock on the Nasdaq on April 30, 2020 was $7.74 per share.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Common Stock</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt"><b>For the period ended November 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Number of shares</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Amount</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%; padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Balance, February 29, 2020</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">39,910,774</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">3,992</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Issuance of shares for cash</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">2,087,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">209</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Issuance of shares upon the exercise of warrants</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">190,529</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">19</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Issuance of shares upon settlement of restricted stock units</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">224,436</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">22</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"><font style="font-size: 8pt">Balance, November 30, 2020</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double">&#160;</td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">42,412,739</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">4,242</font></td> <td style="padding-bottom: 3pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt"><b>For the period ended November 30, 2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Number of shares</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Amount</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%; padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Balance, February 28, 2019</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">33,805,706</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">3,381</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Issuance of shares for cash</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">4,693,567</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">469</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Issuance of shares upon vesting of restricted stock units</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">243,932</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">24</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Issuance of shares upon the cashless exercise of stock options</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">4,565</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Issuance of shares upon the exercise of warrants</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">15,432</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Issuance of shares upon settlement of legal matter</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">150,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">15</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Issuance of shares upon conversion of Convertible notes</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">319,326</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">32</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"><font style="font-size: 8pt">Balance, November 30, 2019</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double">&#160;</td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">39,232,528</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">3,923</font></td> <td style="padding-bottom: 3pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended November 30, 2020, the Company recorded the following common stock transaction:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="3" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: top; width: 36px"><font style="font-size: 8pt">(i)</font></td> <td style="text-align: justify"><font style="font-size: 8pt">On September 23, 2020 and October 1, 2020, the Company sold 1,880,000 and 207,000 shares, respectively of its common stock at an offering price of $12.75 per share in a registered direct offering, for total gross proceeds of $26,609,250.</font></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="3" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: top; width: 36px"><font style="font-size: 8pt">(ii)</font></td> <td><font style="font-size: 8pt">The company issued 192,529 shares of its common stock upon the exercise of warrants.</font></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p> <table cellspacing="3" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: top; width: 36px"><font style="font-size: 8pt">(iii)</font></td> <td><font style="font-size: 8pt">On October 15, 2020, the Company issued 200,000 shares of common stock to settle restricted stock units related to the President and Chief Executive Officer.</font></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="3" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: top; width: 36px"><font style="font-size: 8pt">(iv)</font></td> <td style="text-align: justify"><font style="font-size: 8pt">The Company issued 24,436 shares of its common stock to settle restricted stock units that vested in the period.</font></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended November 30, 2019, the Company recorded the following common stock transactions:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="3" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: top; width: 36px"><font style="font-size: 8pt">(i)</font></td> <td style="text-align: justify"><font style="font-size: 8pt">On March 1, 2019, the Company sold 600,000 shares of its common stock at an offering price of $8.55 per share in a registered direct offering, for gross proceeds of $5,130,000.</font></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="3" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: top; width: 36px"><font style="font-size: 8pt">(ii)</font></td> <td><font style="font-size: 8pt">On March 8, 2019 and March 11, 2019, the Company issued 150,000 shares of its common stock in settlement of a legal matter.</font></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="3" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: top; width: 36px"><font style="font-size: 8pt">(iii)</font></td> <td><font style="font-size: 8pt">On April 9, 2019, the Company converted Convertible notes with a face value of $2,650,000 plus accrued interest of $80,241 at a conversion price of $8.55, into 319,326 common shares.</font></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="3" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: top; width: 36px"><font style="font-size: 8pt">(iv)</font></td> <td><font style="font-size: 8pt">On June 14, 2019, the Company sold 4,093,567 shares of its common stock at an offering price of $8.55 per share in a registered direct offering, for gross proceeds of $35,000,000.</font></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="3" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: top; width: 36px"><font style="font-size: 8pt">(v)</font></td> <td><font style="font-size: 8pt">On June 21, 2019, the Company issued 7,043 shares of common stock upon the vesting of restricted stock units related to an employee.</font></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="3" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: top; width: 36px"><font style="font-size: 8pt">(vi)</font></td> <td><font style="font-size: 8pt">On July 2, 2019 and July 3, 2019, the Company issued 23,547 shares of common stock upon the vesting of restricted stock units related to current and former Directors.</font></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="3" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: top; width: 36px"><font style="font-size: 8pt">(vii)</font></td> <td><font style="font-size: 8pt">On July 12, 2019, the Company issued 4,565 shares of common stock upon the cashless exercise of stock options related to an employee.</font></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="3" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: top; width: 36px"><font style="font-size: 8pt">(viii)</font></td> <td><font style="font-size: 8pt">On July 15, 2019, the Company issued 13,342 shares of common stock upon the vesting of restricted stock units related to a former Director.</font></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="3" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: top; width: 36px"><font style="font-size: 8pt">(ix)</font></td> <td><font style="font-size: 8pt">On July 17, 2019, the Company issued 15,432 shares of common stock upon the exercise of warrants.</font></td></tr> </table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="3" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr> <td style="vertical-align: top; width: 36px"><font style="font-size: 8pt">(x)</font></td> <td style="text-align: justify"><font style="font-size: 8pt">On October 15, 2019, the Company issued 200,000 shares of common stock to settle restricted stock units related to the President and Chief Executive Officer.</font></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development expenses for the three months ended November 30, 2020 and 2019 were as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>November 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">November 30, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%"><font style="font-size: 8pt">External engineering</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">2,224,910</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">33,131</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt">Machinery and equipment expenditures</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">2,325,540</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt">Employee compensation</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,214,434</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">973,679</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt">Pilot plant operating expenses</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">399,031</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">166,753</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt">Other</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">110,368</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">104,610</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">6,274,283</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">1,278,173</font></td> <td style="padding-bottom: 3pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development expenses for the nine months ended November 30, 2020 and 2019 were as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>November 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">&#160;November 30, 2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%"><font style="font-size: 8pt">External engineering</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">3,241,959</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">83,462</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt">Employee compensation</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">3,094,151</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">2,453,743</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt">Machinery and equipment expenditures</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">2,325,540</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt">Pilot plant operating expenses</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,537,271</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">456,942</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt">Other</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">305,172</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">252,099</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">10,504,093</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">3,246,246</font></td> <td style="padding-bottom: 3pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Stock Options</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three- and nine-month period ended November 30, 2020, the Company granted 3,389 stock options (2019 &#8211; nil) with a weighted average exercise price of $8.78 (2019 &#8211; nil), no stock options were forfeited (2019 &#8211; 39,902; weighted average exercise price: $9.67) or exercised (2019 &#8211; 5,000; weighted average exercise price: $0.80) and no stock options expired (2019 &#8211; 260,417; weighted average exercise price: $13.59).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company applies the fair value method of accounting for stock-based compensation awards granted. Fair value is calculated based on a Black-Scholes option pricing model. The principal components of the pricing model were as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%; padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Exercise price</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">8.78</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">-</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Risk-free interest rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1.05</font></td> <td><font style="font-size: 8pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Expected dividend yield</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">0.00</font></td> <td><font style="font-size: 8pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Expected volatility</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">75.95</font></td> <td><font style="font-size: 8pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td></tr> <tr> <td style="vertical-align: bottom; padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Expected life</font></td> <td style="vertical-align: bottom"> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 6.75pt 0 0; text-align: right"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td> <td style="vertical-align: bottom">&#160;</td> <td style="text-align: right; vertical-align: bottom">&#160;<font style="font: 8pt Times New Roman, Times, Serif">7.5 years</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 8pt"></font></td> <td style="vertical-align: bottom">&#160;</td> <td>&#160;</td> <td style="text-align: right; vertical-align: bottom">&#160;<font style="font: 8pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The total number of stock options outstanding as at November 30, 2020 was 1,587,081 (2019 &#8211; 1,657,081) with a weighted average exercise price of $6.81 (2019 - $6.55), of which 1,132,498 were exercisable (2019 &#8211; 1,007,498) with a weighted average exercise price of $7.12 (2019 &#8211; $6.38).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three- and nine-month periods ended November 30, 2020, stock-based compensation expense attributable to stock options amounted to $551,720 and $1,662,155 respectively (2019 - to $549,810 and $1,628,897) and is included in expenses.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Restricted Stock Units</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company applies the fair value method of accounting for awards granted through the issuance of restricted stock units. Fair value is calculated based on the closing share price at grant date multiplied by the number of restricted stock unit awards granted.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three-month period ended November 30, 2020, the Company granted 57,859 restricted stock units (&#8220;RSUs&#8221;) (2019 &#8211; nil) with a weighted average fair value of $12.96 (2019 &#8211; nil), settled 200,000 RSUs (2019 &#8211; 200,000) with a weighted average fair value of $0.80 (2019 &#8211; $0.80) and no RSUs were forfeited (2019 &#8211; nil).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine-month period ended November 30, 2020, the Company granted 180,232 RSUs (2019 &#8211; 4,114,567) with a weighted average fair value of $10.18 (2019 &#8211; $1.06), settled 224,436 RSUs (2019 &#8211; 243,932) with a weighted average fair value of $1.78 (2019 &#8211; 2.52) and 2,989 RSUs were forfeited (2019 &#8211; 53,750) with a weighted average fair value of $8.78 (2019 &#8211; $9.82).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The total number of RSUs outstanding as at November 30, 2020 was 4,171,609 (2019 &#8211; 4,219,753), of which 691,327 were vested (2019 &#8211; 831,684).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three- and nine-month periods ended November 30, 2020, stock-based compensation expense attributable to RSUs amounted to $345,274 and $1,028,152 respectively (2019 - $326,983 and $981,914) and is included in expenses.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three- and nine-month periods ended November 30, 2020 and November 30, 2019, stock-based compensation included in research and development expenses amounted to $350,393 and $1,054,682 respectively (2019 &#8211; $311,353 and $941,142), and in general and administrative expenses amounted to $546,601 and $1,720,067 respectively (2019 - $565,440 and $1,669,669).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 6, 2017, the Company adopted the 2017 Equity Incentive Plan (the &#8220;Plan&#8221;). The Plan permits the granting of warrants, stock options, stock appreciation rights and restricted stock units to employees, directors and consultants of the Company. A total of 3,000,000 shares of common stock were initially reserved for issuance under the Plan at July 6, 2017, with annual automatic share reserve increases, as defined in the Plan, amounting to the lessor of (i) 1,500,000 shares, (ii) 5% of the outstanding shares on the last day of the immediately preceding fiscal year, or (iii) or such number of shares determined by the Administrator of the Plan, effective March 1, 2018. In March 2020, the Board of Directors elected to waive the annual share reserve increase for the fiscal year ending February 28, 2021. The Plan is administered by the Board of Directors who designates eligible participants to be included under the Plan, the number of awards granted, the share price pursuant to the awards and the vesting conditions and period. The awards, when granted, will have an exercise price of no less than the estimated fair value of shares at the date of grant and a life not exceeding 10 years from the grant date. However, where a participant, at the time of the grant, owns stock representing more than 10% of the voting power of the Company, the life of the options shall not exceed 5 years.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes the continuity of the Company&#8217;s Equity Incentive Plan units during the nine-month periods ended November 30, 2020 and 2019:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Number of units</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Number of units</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%; padding-left: 9pt; text-indent: -9pt"><font style="font-size: 8pt">Outstanding, beginning of period</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">1,300,518</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">3,223,516</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"><font style="font-size: 8pt">Share reserve increase</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">2,000,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"><font style="font-size: 8pt">Units granted</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">(183,621</font></td> <td><font style="font-size: 8pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">(4,114,567</font></td> <td><font style="font-size: 8pt">)</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"><font style="font-size: 8pt">Units forfeited</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">2,989</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">93,652</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"><font style="font-size: 8pt">Units expired</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">260,417</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"><font style="font-size: 8pt">Outstanding, end of period</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double">&#160;</td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">1,119,886</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double">&#160;</td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">1,463,018</font></td> <td style="padding-bottom: 3pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three-month period ended November 30, 2020 159,664 warrants were exercised at the price of $8.55 per share and 30,864 warrants were exercised at the price of $9.32 per share. No warrants were granted, were forfeited nor expired in the three-month period ended November 30, 2020.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three-month period ended November 30, 2019, no warrants were granted, were forfeited, were exercised nor expired</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine-month period ended November 30, 2020, the Company issued, in exchange for consulting services, a warrant to purchase 25,000 shares of our common stock at the price of $9.43 per share expiring May 12, 2022 and warrants to issue 200,000 shares of our common stock with an exercise price of $11.00 expired. During the nine-month periods ended November 30, 2020, 159,664 warrants were exercised at the price of $8.55 per share and 30,864 warrants were exercised at the price of $9.32 per share. No warrants were forfeited in the nine-month period ended November 30, 2020.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine-month period ended November 30, 2019, the Company issued a warrant to purchase 159,663 shares of our common stock at the price of $8.55 per share expiring October 5, 2020 as well as a warrant to purchase 4,093,567 shares of our common stock at the price of $11.00 per share expiring June 14, 2022. During the nine-month period ended November 30, 2019, 15,432 shares of our common stock were issued upon the exercise of a warrant with an exercise price of $9.32. No warrants were forfeited, and no warrants expired in the nine-month period ended November 30, 2019.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Interest and other finance costs for the three- and nine-month periods ended November 30, 2020 and 2019 are as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Three Months Ended November 30</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Nine Months Ended November 30</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 50%; padding-left: 9pt"><font style="font-size: 8pt">&#160;&#160;Interest on long-term debt</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">19,185</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">14,778</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">57,917</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">41,840</font></td> <td style="width: 2%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt"><font style="font-size: 8pt">&#160;&#160;Interest on convertible notes</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">98,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">313,433</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt"><font style="font-size: 8pt">&#160;&#160;Accretion expense</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">9,387</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">549,090</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">27,044</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,584,977</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt"><font style="font-size: 8pt">&#160;&#160;Amortization of deferred finance costs</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">19,885</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">86,212</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt"><font style="font-size: 8pt">&#160;&#160;Loss (gain) on revaluation of foreign exchange contracts</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">(70,427</font></td> <td><font style="font-size: 8pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">10,881</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">(58,945</font></td> <td><font style="font-size: 8pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">10,881</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt"><font style="font-size: 8pt">&#160;&#160;Revaluation of warrants</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">8,483</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt"><font style="font-size: 8pt">&#160;&#160;Gain on conversion of November 2018 Notes</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">(232,565</font></td> <td><font style="font-size: 8pt">)</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt"><font style="font-size: 8pt">&#160;&#160;Other</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">393</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">3,830</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">(41,855</font></td> <td style="padding-bottom: 3pt"><font style="font-size: 8pt">)</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">693,027</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">26,016</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">1,817,091</font></td> <td style="padding-bottom: 3pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><i>Commercial commitments</i></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 2, 2020, the Company entered into a know-how and engineering agreement (the &#8220;Chemtex Agreement&#8221;) with Chemtex Global Corporation (&#8220;Chemtex&#8221;) to license the PET plastic and polyester polymer for fiber manufacturing know-how of INVISTA&#8217;s technology and licensing group, INVISTA Performance Technologies (IPT) (&#8220;INVISTA&#8221;). The total value of the Chemtex Agreement is $4,300,000 and covers the know-how and design of two Infinite Loop&#8482; facilities. Payment terms are based on the completion of certain milestones and total $2,150,000 for each facility. During the three and nine months ended November 30, 2020, $500,000 was paid by the Company.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 29, 2020, Coca-Cola Cross Enterprise Procurement Group (&#8220;CEPG&#8221;) advised the Company of its intention to terminate the Master Terms and Conditions Supply Agreement for Loop PET plastic, dated November 14, 2018 (the &#8220;MTC&#8221;) because the Company did not satisfy its first production milestone from the joint venture facility by July 2020 as required by the MTC.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Contingencies</i></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 13, 2020, the Company and certain of its officers were named as defendants in a proposed class action lawsuit filed in the United States District Court for the Southern District of New York, captioned&#160;<i>Olivier Tremblay, Individually and on Behalf of All Other Similarly Situated v. Loop Industries, Inc., Daniel Solomita, and Nelson Gentiletti</i>, Case No. 7:20-cv-0838 (&#8220;Tremblay Class Action&#8221;). The allegations in the complaint claim that the defendants allegedly violated Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 by allegedly making materially false and/or misleading statements, as well as allegedly failing to disclose material adverse facts about the Company&#8217;s business, operations, and prospects, which caused the Company&#8217;s securities to trade at artificially inflated prices. Plaintiff seeks unspecified damages on behalf of a class of purchasers of Loop&#8217;s securities between September 24, 2018 and October 12, 2020.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 13, 2020, the Company, Loop Canada Inc. and certain of their officers and directors were named as defendants in a proposed securities class action filed in the Superior Court of Qu&#233;bec (District of Terrebonne, Province of Qu&#233;bec, Canada), in file no. 700-06-000012-205. The&#160;<i>Application for authorization of a class action and for authorization to bring an action pursuant to section 225.4 of the Qu&#233;bec Securities Act</i>&#160;(&#8220;the Application&#8221;) was filed by an individual shareholder on behalf of himself and a class of buyers who purchased our securities during the &#8220;Class Period&#8221; (not defined). Plaintiff alleges that throughout the Class Period, the defendants allegedly made false and/or misleading statements and allegedly failed to disclose material adverse facts concerning the Company&#8217;s technology, business model, operations and prospects, thus causing the Company&#8217;s stock price to be artificially inflated and thereby causing plaintiff to suffer damages. Plaintiff seeks unspecified damages stemming from losses he claims to have suffered as a result of the foregoing. On December 13, 2020, the Application was amended in order to add allegations regarding specific misrepresentations.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 28, 2020, the Company and certain of its officers were named as defendants in a second proposed class action lawsuit filed in the United States District Court for the Southern District of New York, captioned <i>Michelle Bazzini, Individually and on Behalf of All Other Similarly Situated v. Loop Industries, Inc., Daniel Solomita, and Nelson Gentiletti</i>, Case No. 7:20-cv-09031-UA. The allegations in this complaint are similar in nature to those made in the Tremblay Class Action.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 4, 2021, the United States District Court for the Southern District of New York rendered a stipulation and order granting the consolidation of the two class action lawsuits filed in New York as <i>In re Loop Industries, Inc. Securities Litigation</i>, Master File No. 7:20-cv-08538.&#160;Sakari Johansson and John Jay Cappa have been appointed as Co-Lead Plaintiffs and Glancy Prongay &#38; Murray LLP and Pomerantz LLP have been appointed as Co-Lead Counsel for the class.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management believes that these cases lack merit and intends to defend them vigorously. No amounts have been provided for in the consolidated financial statements with respect to these claims. Management has not yet determined what effect these lawsuits may have on its financial position or results of operations as they are still in the preliminary stages.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for depreciable lives of property, plant and equipment, intangible assets, analysis of impairments of long-lived assets and intangible assets, accruals for potential liabilities and assumptions made in calculating the fair value of stock-based compensation and other equity instruments.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The COVID-19 pandemic has disrupted business operations for us and our customers, suppliers, vendors and other parties with whom we do business, and such disruptions are expected to continue for an indefinite period of time. The uncertain duration of these measures has had and may continue to have an effect on our development and commercialization efforts. In particular, as previously disclosed, the situation in the United States and the continued travel restrictions and quarantine requirements between Canada and the United States have caused disruptions in our timetable of our joint venture with Indorama in the development of our Spartanburg facility and commercialization of our technology.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Although the Company continues to monitor the situation and may adjust the Company&#8217;s current policies as more information and public health guidance become available, the COVID-19 pandemic is ongoing, and its dynamic nature, including uncertainties relating to the ultimate spread of the virus, the severity of the disease, the duration of the outbreak and actions that may be taken by governmental authorities to contain the outbreak or to treat its impact, makes it difficult to assess whether there will be further impact on the development and commercialization of the Company&#8217;s technology which could have a material adverse effect on the Company&#8217;s results of operations and cash flows.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars, the reporting currency of the Company. Assets and liabilities of subsidiaries that have a functional currency other than that of the Company are translated to U.S. dollars at the exchange rate as at the balance sheet date. Income and expenses are translated at the average exchange rate of the period. The resulting translation adjustments are included in other comprehensive income (loss) (&#8220;OCI&#8221;). As a result, foreign currency exchange fluctuations may impact operating expenses. The Company currently has not engaged in any currency hedging activities.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For transactions and balances, monetary assets and liabilities denominated in foreign currencies are translated into the functional currency of the entity at the prevailing exchange rate at the reporting date. Non-monetary assets and liabilities, and revenue and expense items denominated in foreign currencies are translated into the functional currency using the exchange rate prevailing at the dates of the respective transactions. Foreign exchange gains and losses resulting from the settlement of such transactions are recognized in the consolidated statements of operations and comprehensive loss, except for gains or losses arising from the translation of intercompany balances denominated in foreign currencies that forms part in the net investment in the subsidiary which are included in OCI.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company periodically issues stock options, warrants and restricted stock units to employees and non-employees in non-capital raising transactions for services and financing expenses. The Company accounts for stock options granted to employees based on the authoritative guidance provided by the FASB wherein the fair value of the award is measured on the grant date and where there are no performance conditions, recognized as compensation expense on the straight-line basis over the vesting period and where performance conditions exist, recognize compensation expense when it becomes probable that the performance condition will be met. Forfeitures on share-based payments are accounted for by recognizing forfeitures as they occur.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for stock options and warrants granted to non-employees in accordance with the authoritative guidance of the FASB wherein the fair value of the stock compensation is based upon the measurement date determined as the earlier of the date at which either a)&#160;a&#160;commitment is reached with the counterparty for performance or b) the counterparty completes its performance.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company estimates the fair value of restricted stock unit awards to employees and directors based on the closing market price of its common stock on the date of grant.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of the stock options granted are estimated using the Black-Scholes-Merton Option Pricing (&#8220;Black-Scholes&#8221;) model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options, and future dividends. Stock-based compensation expense is recorded based on the value derived from the Black-Scholes model and on actual experience. The assumptions used in the Black-Scholes model could materially affect stock-based compensation expense recorded in the current and future periods.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company calculates its provision for income tax on the basis of the tax laws enacted at the balance sheet date in the countries where the Company and its subsidiaries operate and generate taxable income, in accordance with FASB ASC 740, <i>Income Taxes</i>. The Company uses an asset and liability approach for financial accounting and reporting for income taxes that allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The Company&#8217;s policy is to recognize interest and/or penalties related to income tax matters in income tax expense.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company computes net loss per share in accordance with FASB ASC 260, <i>Earnings Per Share</i>. Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year. The Company includes common stock issuable in its calculation. Diluted earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation if their effect is antidilutive.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the three- and nine-month periods ended November 30, 2020 and 2019, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have an antidilutive effect. As at November 30, 2020, the potentially dilutive securities consisted of 1,590,470 outstanding stock options (November 30, 2019 &#8211; 1,657,081), 4,171,609 outstanding restricted stock units (November 30, 2019 &#8211; 4,219,753) and 4,693,802 outstanding warrants (November 30, 2019 &#8211; 5,040,267).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2018, the FASB issued ASU 2018-15, &#8220;Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that Is a Service Contract,&#8221; which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). This update is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The adoption of the standard had no impact on the consolidated financial statements of the Company.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2018, the FASB issued ASU 2018-02, <i>Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income</i>, which permits entities to reclassify the disproportionate income tax effects of the Tax Reform Act on items within accumulated other comprehensive income (loss) (&#8220;AOCI&#8221;) to retained earnings. These disproportionate income tax effect items are referred to as &#34;stranded tax effects.&#34; Amendments in this update only relate to the reclassification of the income tax effects of the Tax Reform Act. Other accounting guidance that requires the effect of changes in tax laws or rates to be included in net income from continuing operations is not affected by this update. ASU 2018-02 should be applied either in the period of adoption or retrospectively to each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Reform Act is recognized. ASU 2018-02 is applicable beginning March 1, 2020. The adoption of the standard had no impact on the consolidated financial statements of the Company.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the FASB issued ASU 2016-02, &#8220;Leases,&#8221; amended in July by ASU 2018-10, &#8220;Codification Improvements to Topic 842, Leases,&#8221; ASU 2018-11, &#8220;Targeted Improvements,&#8221; and ASU 2018-20, &#8220;Narrow-Scope Improvements for Lessors,&#8221; which requires lessees to recognize leases on the balance sheet while continuing to recognize expenses in the income statement in a manner similar to current accounting standards. For lessors, the new standard modifies the classification criteria and the accounting for sales-type and direct financing leases. Enhanced disclosures will also be required to give financial statement users the ability to assess the amount, timing, and uncertainty of cash flows arising from leases. This ASU may either be adopted on a modified retrospective approach at the beginning of the earliest comparative period, or through a cumulative-effect adjustment at the adoption date. This update is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company adopted these standards effective March 1, 2020. The adoption of the standard had no impact on the consolidated financial statements of the Company. The Company elected to apply the package of practical expedients that allows us not to reassess whether expired or existing contracts contain leases, the classification of these leases and whether previously capitalized initial direct costs would qualify for capitalization under Accounting Standards Codification (or &#8220;<i>ASC</i>&#8221;) 842. Furthermore, we elected to use hindsight in determining the lease term and assessing impairment of the right-of-use assets.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Recently issued accounting pronouncements not yet adopted</u></i></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2019, the FASB issued ASU 2019-12, &#8220;Simplifying the Accounting for Income Taxes,&#8221; which removes specific exceptions to the general principles in ASC 740, &#8220;Income Taxes,&#8221; and clarifies certain aspects of the existing guidance. This update is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years, with early adoption being permitted as of the beginning of an interim or annual reporting period. All amendments to this ASU must be adopted in the same period on a prospective basis, with certain exceptions. We are still evaluating the impact of this accounting guidance on our results of operations and financial position.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2016, the FASB issued ASU 2016-13, &#8220;Financial Instruments&#8212;Credit Losses&#8221;. This ASU added a new impairment model (known as the current expected credit loss (&#8220;CECL&#8221;) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes an allowance for its estimate of expected credit losses and applies to most debt instruments, trade receivables, lease receivables, financial guarantee contracts, and other loan commitments. The CECL model does not have a minimum threshold for recognition of impairment losses and entities will need to measure expected credit losses on assets that have a low risk of loss. This update is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years for smaller reporting companies. We are still evaluating the impact of this accounting guidance on our results of operations and financial position.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>November 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">February 29, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%; padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Sales tax</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">669,966</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">180 971</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Research and development tax credits</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">390,885</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">447,843</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Other receivables</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">121,256</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">35,730</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">1,182,107</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">664,544</font></td> <td style="padding-bottom: 3pt">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>November 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">February 29, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%; text-align: justify"><font style="font-size: 8pt">Deposits on machinery and equipment</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">747,250</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">-</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Insurance</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">427,013</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">61,891</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Other prepaid expenses</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">56,179</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">79,335</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">1,230,442</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">141,226</font></td> <td style="padding-bottom: 3pt">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>November 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">February 29, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%; text-align: justify"><font style="font-size: 8pt">Intangible assets, at cost - beginning of period</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">225,174</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">127,672</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Intangible assets, accumulated depreciation &#8211; beginning of period</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(22,311</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">202,863</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">127,672</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Additions in the period</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">452,758</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">99,972</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Amortization of intangibles</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">(30,165</font></td> <td><font style="font-size: 8pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">(22,631</font></td> <td><font style="font-size: 8pt">)</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Foreign exchange effect &#8211; increase (decrease)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">6,133</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(2,150</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">631,589</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">202,863</font></td> <td style="padding-bottom: 3pt">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Fair Value Measurements as at November 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Carrying Amount</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Fair Value</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Level in the hierarchy</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Instruments measured at fair value on a recurring basis:</font></td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 62%; padding-left: 9pt; text-align: justify"><font style="font-size: 8pt">Foreign exchange contracts</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">(25,797</font></td> <td style="width: 1%"><font style="font-size: 8pt">)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">(25,797</font></td> <td style="width: 1%"><font style="font-size: 8pt">)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">Level 2</font></td> <td style="width: 3%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Instruments measured at amortized cost:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify"><font style="font-size: 8pt">Long-term debt</font></td> <td>&#160;</td> <td><font style="font-size: 8pt">$</font></td> <td style="text-align: right"><font style="font-size: 8pt">2,390,366</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 8pt">$</font></td> <td style="text-align: right"><font style="font-size: 8pt">2,400,897</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">Level 2</font></td> <td>&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Fair Value Measurements at February 29, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Carrying Amount</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Fair Value</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Level in the hierarchy</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Instruments measured at fair value on a recurring basis:</font></td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 62%; padding-left: 9pt; text-align: justify"><font style="font-size: 8pt">Foreign exchange contracts</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">26,840</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">26,840</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">Level 2</font></td> <td style="width: 3%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Instruments measured at amortized cost:</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify"><font style="font-size: 8pt">Long-term debt</font></td> <td>&#160;</td> <td><font style="font-size: 8pt">$</font></td> <td style="text-align: right"><font style="font-size: 8pt">2,290,152</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 8pt">$</font></td> <td style="text-align: right"><font style="font-size: 8pt">2,291,109</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">Level 2</font></td> <td>&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>November 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">February 29, 2020</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Investissement Qu&#233;bec financing facility:</font></td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%; padding-left: 9pt; text-align: justify"><font style="font-size: 8pt">Principal amount</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">1,703,998</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">1,645,122</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify"><font style="font-size: 8pt">Unamortized discount</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">(272,036</font></td> <td><font style="font-size: 8pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">(289,852</font></td> <td><font style="font-size: 8pt">)</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify"><font style="font-size: 8pt">Accrued interest</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">31,549</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">958</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27pt; text-align: justify"><font style="font-size: 8pt">Total Investissement Qu&#233;bec financing facility</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,463,511</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,356,228</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Term loan</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify"><font style="font-size: 8pt">Principal amount</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">926,855</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">933,924</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify"><font style="font-size: 8pt">Less: current portion</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(53,992</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(52,126</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">)</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 27pt"><font style="font-size: 8pt">Total term loan, net of current portion</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">872,863</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">881,798</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt">Long-term debt, net of current portion</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">2,336,374</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">2,238,026</font></td> <td style="padding-bottom: 3pt">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-indent: 9pt"><font style="font-size: 8pt"><b>Years ending</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Amount</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 88%; text-indent: 9pt"><font style="font-size: 8pt">February 28, 2021</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">13,498</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 9pt"><font style="font-size: 8pt">February 28, 2022</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">53,992</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 9pt"><font style="font-size: 8pt">February 28, 2023</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">53,992</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 9pt"><font style="font-size: 8pt">February 29, 2024</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">297,416</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 9pt"><font style="font-size: 8pt">February 28, 2025</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">297,416</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 9pt"><font style="font-size: 8pt">Thereafter</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">1,901,043</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: 9pt"><font style="font-size: 8pt"><b>Total</b></font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">2,617,355</font></td> <td style="padding-bottom: 3pt">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt"><b>For the period ended November 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Number of shares</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Amount</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%; padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Balance, February 29, 2020</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">39,910,774</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">3,992</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Issuance of shares for cash</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">2,087,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">209</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Issuance of shares upon the exercise of warrants</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">190,529</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">19</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Issuance of shares upon settlement of restricted stock units</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">224,436</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">22</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"><font style="font-size: 8pt">Balance, November 30, 2020</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double">&#160;</td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">42,412,739</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">4,242</font></td> <td style="padding-bottom: 3pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt"><b>For the period ended November 30, 2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Number of shares</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Amount</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%; padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Balance, February 28, 2019</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">33,805,706</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">3,381</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Issuance of shares for cash</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">4,693,567</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">469</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Issuance of shares upon vesting of restricted stock units</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">243,932</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">24</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Issuance of shares upon the cashless exercise of stock options</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">4,565</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Issuance of shares upon the exercise of warrants</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">15,432</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Issuance of shares upon settlement of legal matter</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">150,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">15</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Issuance of shares upon conversion of Convertible notes</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">319,326</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">32</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"><font style="font-size: 8pt">Balance, November 30, 2019</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double">&#160;</td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">39,232,528</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">3,923</font></td> <td style="padding-bottom: 3pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%; padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Exercise price</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">8.78</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">-</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Risk-free interest rate</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1.05</font></td> <td><font style="font-size: 8pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Expected dividend yield</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">0.00</font></td> <td><font style="font-size: 8pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Expected volatility</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">75.95</font></td> <td><font style="font-size: 8pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td></tr> <tr> <td style="vertical-align: bottom; padding-left: 9pt; text-align: justify; text-indent: -9pt"><font style="font-size: 8pt">Expected life</font></td> <td style="vertical-align: bottom"> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 6.75pt 0 0; text-align: right"></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td> <td style="vertical-align: bottom">&#160;</td> <td style="text-align: right; vertical-align: bottom">&#160;<font style="font: 8pt Times New Roman, Times, Serif">7.5 years</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 8pt"></font></td> <td style="vertical-align: bottom">&#160;</td> <td>&#160;</td> <td style="text-align: right; vertical-align: bottom">&#160;<font style="font: 8pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2019</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Number of units</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Number of units</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%; padding-left: 9pt; text-indent: -9pt"><font style="font-size: 8pt">Outstanding, beginning of period</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">1,300,518</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">3,223,516</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"><font style="font-size: 8pt">Share reserve increase</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">2,000,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"><font style="font-size: 8pt">Units granted</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">(183,621</font></td> <td><font style="font-size: 8pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">(4,114,567</font></td> <td><font style="font-size: 8pt">)</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"><font style="font-size: 8pt">Units forfeited</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">2,989</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">93,652</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"><font style="font-size: 8pt">Units expired</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">260,417</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt; text-indent: -9pt"><font style="font-size: 8pt">Outstanding, end of period</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double">&#160;</td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">1,119,886</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double">&#160;</td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">1,463,018</font></td> <td style="padding-bottom: 3pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Interest and other finance costs for the three- and nine-month periods ended November 30, 2020 and 2019 are as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Three Months Ended November 30</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>Nine Months Ended November 30</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 50%; padding-left: 9pt"><font style="font-size: 8pt">&#160;&#160;Interest on long-term debt</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">19,185</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">14,778</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">57,917</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">41,840</font></td> <td style="width: 2%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt"><font style="font-size: 8pt">&#160;&#160;Interest on convertible notes</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">98,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">313,433</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt"><font style="font-size: 8pt">&#160;&#160;Accretion expense</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">9,387</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">549,090</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">27,044</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,584,977</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt"><font style="font-size: 8pt">&#160;&#160;Amortization of deferred finance costs</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">19,885</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">86,212</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt"><font style="font-size: 8pt">&#160;&#160;Loss (gain) on revaluation of foreign exchange contracts</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">(70,427</font></td> <td><font style="font-size: 8pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">10,881</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">(58,945</font></td> <td><font style="font-size: 8pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">10,881</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt"><font style="font-size: 8pt">&#160;&#160;Revaluation of warrants</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">8,483</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt"><font style="font-size: 8pt">&#160;&#160;Gain on conversion of November 2018 Notes</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">(232,565</font></td> <td><font style="font-size: 8pt">)</font></td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 9pt"><font style="font-size: 8pt">&#160;&#160;Other</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">393</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">3,830</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">(41,855</font></td> <td style="padding-bottom: 3pt"><font style="font-size: 8pt">)</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">693,027</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">26,016</font></td> <td style="padding-bottom: 3pt">&#160;</td> <td style="padding-bottom: 3pt">&#160;</td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">1,817,091</font></td> <td style="padding-bottom: 3pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> 1590470 1657081 4171609 4219753 4693802 5040267 669966 180971 390885 447843 121256 35730 1182107 664544 747250 0 427013 61891 56179 79335 10525736 9092483 1846070 264868 733884 6085195 162466 1912138 236360 1602766 6514252 260220 7170326 1832229 128911 0 214068 1426465 62785 181308 0 379164 6514252 95602 624189 570165 212968 93006 202863 127672 -22311 0 225174 127672 6133 -2150 30165 15202 22631 6660 11301 452758 99972 2291109 2400897 -25797 26840 4088147 2082698 116605 170211 676153 133038 678925 873242 686061 0 1514881 814081 31549 958 0 0 272036 289852 0 0 2617355 1703998 1645122 926855 933924 1901043 297416 297416 53992 53992 13498 28816 0 10003 0 29102 41840 9172 14778 27045 0 9387 0 8.78 .0105 .0000 .7595 P7Y6M 1662155 1628897 549810 551720 1587081 1657081 6.81 6.55 1132498 1007498 7.12 6.38 180232 4114567 183621 4114567 25000 159663 57859 0 10.18 1.06 9.43 8.55 12.96 0.00 224436 243932 200000 200000 1.78 2.52 .80 0.80 2989 53570 2989 93652 0 0 8.78 9.82 .00 .00 1300518 1119886 4171609 4219753 3223516 1463018 691327 831684 0 2000000 0 260417 159664 15432 8.55 9.32 0 86212 19885 0 27044 1584977 549090 9387 0 313433 98000 0 57917 41840 14778 19185 26016 1817091 693027 -41855 0 -3830 -393 0 0 232565 0 0 0 8483 0 0 <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 8pt Times New Roman, Times, Serif"><b>As at November 30, 2020</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 8pt Times New Roman, Times, Serif"><b>Cost</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 8pt Times New Roman, Times, Serif"><b>Accumulated depreciation, write-down and impairment</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 8pt Times New Roman, Times, Serif"><b>Net book value</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 66%"><font style="font: 8pt Times New Roman, Times, Serif">Building</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">1,912,138</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">(181,308</font></td> <td style="width: 1%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">1,730,830</font></td> <td style="width: 2%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 8pt Times New Roman, Times, Serif">Land</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">236,360</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">236,360</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 8pt Times New Roman, Times, Serif">Building and land improvements</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">1,602,766</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">(379,164</font></td> <td><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">1,223,602</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 8pt Times New Roman, Times, Serif">Machinery and equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">6,514,252</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">(6,514,252</font></td> <td><font style="font: 8pt Times New Roman, Times, Serif">)</font><font style="font: 12pt Times New Roman, Times, Serif">&#160;</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 8pt Times New Roman, Times, Serif">Office equipment and furniture</font></td> <td>&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">260,220</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">(95,602</font></td> <td><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">164,618</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 8pt Times New Roman, Times, Serif">Balances, end of period</font></td> <td>&#160;</td> <td style="border-bottom: black 1pt solid"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">10,525,736</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1pt solid"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">(7,170,326</font></td> <td><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1pt solid"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">3,355,410</font></td> <td>&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 8pt Times New Roman, Times, Serif"><b>As at February 29, 2020</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 8pt Times New Roman, Times, Serif"><b>Cost</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 8pt Times New Roman, Times, Serif"><b>Accumulated depreciation, write-down and impairment</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 8pt Times New Roman, Times, Serif"><b>Net book value</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 66%"><font style="font: 8pt Times New Roman, Times, Serif">Building</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">1,846,070</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">(128,911</font></td> <td style="width: 1%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">1,717,159</font></td> <td style="width: 2%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 8pt Times New Roman, Times, Serif">Land</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">264,868</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">264,868</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 8pt Times New Roman, Times, Serif">Building and land improvements</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">733,884</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">(214,068</font></td> <td><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">519,816</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 8pt Times New Roman, Times, Serif">Machinery and equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">6,085,195</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">(1,426,465</font></td> <td><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">4,658,730</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 8pt Times New Roman, Times, Serif">Office equipment and furniture</font></td> <td>&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">162,466</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">(62,785</font></td> <td><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">99,681</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 8pt Times New Roman, Times, Serif">Balances, end of period</font></td> <td>&#160;</td> <td style="border-bottom: black 1pt solid"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">9,092,483</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1pt solid"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">(1,832,229</font></td> <td><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1pt solid"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">7,260,254</font></td> <td>&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation expense for the three- and nine-month periods ended November 30, 2020 amounted to $93,006 and $624,189, respectively (2019 &#8211; $212,968 and $570,165, respectively), and is recorded as an expense in the consolidated statements of operations and comprehensive loss.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three- and nine-month periods ended November 30, 2020, the Company recorded write-down and impairment expenses of $5,034,606 and $5,043,120, respectively (2019 &#8211; nil and $22,985). In the quarter ended November 30, 2020, the Company&#8217;s management made the decision to convert its pilot plant to exclusively a demonstration and training facility for our future Infinite Loop&#8482; manufacturing facilities, therefore foregoing any alternative future use of its machinery and equipment assets contained within the pilot plant. As such, the carrying value of the machinery and equipment was written off resulting in an expense of $5,034,606 being recognized in the three-month period ended November 30, 2020. With the decision to dedicate the demonstration and training facility to research and development, the accounting for future costs associated with these activities are considered in scope of ASC 730, Research and Development Costs, and will be recognized as a research and development expense in the consolidated statements of operations and comprehensive loss in the period they are incurred. During the three-month period ended November 30, 2020, the Company purchased $2,325,540 of machinery and equipment associated with its ongoing research and development activities, which have no future alternative use and as such, were recognized as research and development expenses in the consolidated statements of operations and comprehensive loss. See Note 13 for components of research and development expenses.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p> 2325540 <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 8pt Times New Roman, Times, Serif"><b>As at November 30, 2020</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 8pt Times New Roman, Times, Serif"><b>Cost</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 8pt Times New Roman, Times, Serif"><b>Accumulated depreciation, write-down and impairment</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 8pt Times New Roman, Times, Serif"><b>Net book value</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 66%"><font style="font: 8pt Times New Roman, Times, Serif">Building</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">1,912,138</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">(181,308</font></td> <td style="width: 1%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">1,730,830</font></td> <td style="width: 2%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 8pt Times New Roman, Times, Serif">Land</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">236,360</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">236,360</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 8pt Times New Roman, Times, Serif">Building and land improvements</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">1,602,766</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">(379,164</font></td> <td><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">1,223,602</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 8pt Times New Roman, Times, Serif">Machinery and equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">6,514,252</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">(6,514,252</font></td> <td><font style="font: 8pt Times New Roman, Times, Serif">)</font><font style="font: 12pt Times New Roman, Times, Serif">&#160;</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 8pt Times New Roman, Times, Serif">Office equipment and furniture</font></td> <td>&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">260,220</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">(95,602</font></td> <td><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">164,618</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 8pt Times New Roman, Times, Serif">Balances, end of period</font></td> <td>&#160;</td> <td style="border-bottom: black 1pt solid"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">10,525,736</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1pt solid"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">(7,170,326</font></td> <td><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1pt solid"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">3,355,410</font></td> <td>&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="10" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 8pt Times New Roman, Times, Serif"><b>As at February 29, 2020</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 8pt Times New Roman, Times, Serif"><b>Cost</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 8pt Times New Roman, Times, Serif"><b>Accumulated depreciation, write-down and impairment</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 8pt Times New Roman, Times, Serif"><b>Net book value</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="width: 66%"><font style="font: 8pt Times New Roman, Times, Serif">Building</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">1,846,070</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">(128,911</font></td> <td style="width: 1%"><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">1,717,159</font></td> <td style="width: 2%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 8pt Times New Roman, Times, Serif">Land</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">264,868</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">264,868</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 8pt Times New Roman, Times, Serif">Building and land improvements</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">733,884</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">(214,068</font></td> <td><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">519,816</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 8pt Times New Roman, Times, Serif">Machinery and equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">6,085,195</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">(1,426,465</font></td> <td><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">4,658,730</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 8pt Times New Roman, Times, Serif">Office equipment and furniture</font></td> <td>&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">162,466</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">(62,785</font></td> <td><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">99,681</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 8pt Times New Roman, Times, Serif">Balances, end of period</font></td> <td>&#160;</td> <td style="border-bottom: black 1pt solid"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">9,092,483</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1pt solid"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">(1,832,229</font></td> <td><font style="font: 8pt Times New Roman, Times, Serif">)</font></td> <td>&#160;</td> <td style="border-bottom: black 1pt solid"><font style="font: 8pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 8pt Times New Roman, Times, Serif">7,260,254</font></td> <td>&#160;</td></tr> </table> <p style="font: 8pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development expenses relate primarily to the development, design, testing of preproduction samples, prototypes and models, compensation, and consulting fees, and are expensed as incurred. Starting in the current quarter, machinery and equipment purchases related to the pilot plant which is now dedicated solely to research and development activities with no alternative use are also expensed as incurred. Total research and development costs recorded during the three- and nine-month periods ended November 30, 2020 amounted to $6,724,283 and $10,504,093 (2019 &#8211; $1,278,172 and $3,246,246), respectively, and are net of government research and development tax credits and government grants from the federal and provincial taxation authorities accrued and recorded based on qualifying expenditures incurred during the fiscal periods.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 8pt">Subsequent to the end of the quarter, the Company entered into an engineering and equipment supply agreement to acquire PET polymerization equipment from Chemtex Global Corporation to manufacture PET resin at the demonstration plant. This agreement represents a total commitment of $4,200,000.</font></p> 42413691 <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt"><b>November 30, 2020</b></font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">February 29, 2020</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="width: 76%; text-align: justify"><font style="font-size: 8pt">Trade accounts payable</font></td> <td style="width: 1%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">1,514,881</font></td> <td style="width: 1%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 8pt">&#160;</font></td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 9%; text-align: right"><font style="font-size: 8pt">814,081</font></td> <td style="width: 1%"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Accrued engineering fees</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">686,061</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">-</font></td> <td><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Accrued employee compensation and payroll taxes</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">678,925</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">873,242</font></td> <td><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Accrued professional fees</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">676,153</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">133,038</font></td> <td><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Accrued cost of machinery and equipment</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">&#160;415,522</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td><font style="font-size: 8pt">&#160;</font></td> <td style="text-align: right"><font style="font-size: 8pt">&#160;92,126</font></td> <td><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><font style="font-size: 8pt">Other accrued liabilities</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">116,605</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">170,211</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 8pt">&#160;</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 3pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">4,088,147</font></td> <td style="padding-bottom: 3pt"><font style="font-size: 8pt">&#160;</font></td> <td style="padding-bottom: 3pt"><font style="font-size: 8pt">&#160;</font></td> <td style="border-bottom: black 1pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 1pt double; text-align: right"><font style="font-size: 8pt">2,082,698</font></td> <td style="padding-bottom: 3pt"><font style="font-size: 8pt">&#160;</font></td></tr> </table> 415522 92126 EX-101.SCH 8 loop-20201130.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statement of Changes in Stockholders Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - The Company, Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Sales Tax, Tax Credits and Other Receivables link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Prepaid Expenses and Deposits link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Property, Plant and Equipment link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Fair Value of Financial Instruments link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Accounts Payable and Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Joint Venture link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Long-Term Debt link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Research and Development Expenses link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Share-Based Payments link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Equity Incentive Plan link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Interest and Other Finance Costs link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Sales Tax, Tax Credits and Other Receivables (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Prepaid Expenses and Deposits (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Property, Plant and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Fair Value of Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Long-Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Research and Development Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Share-Based Payments (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Equity Incentive Plan (Tables) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Interest and Other Financial Costs (Tables) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Sales Tax, Tax Credits and Other Receivables (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Prepaid Expenses and Deposits (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Property, Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Property, Plant and Equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Intangible Assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Fair Value of Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Accounts Payable and Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Long-Term Debt (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Long-Term Debt (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Research and Development Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Share-Based Payments (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Share-Based Payments (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - Equity Incentive Plan (Details) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - Warrants (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - Interest and Other Financial Costs (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 loop-20201130_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 10 loop-20201130_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 11 loop-20201130_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Equity Components [Axis] Common Stock Preferred Stock Additional Paid-in Capital Common Stock Issuable Accumulated Deficit Accumulated Other Comprehensive Income (Loss) Award Type [Axis] Equity Incentive Plan Property, Plant and Equipment, Type [Axis] Building Land Building and Land Improvements Machinery and Equipment Office Equipment and Furniture Restricted Stock Units Additional Paid-in Capital - Warrants Additional Paid-in Capital - Benificial Conversion Feature Warrants Antidilutive Securities [Axis] Stock Options Liability Class [Axis] Long-Term Debt Liability Class [Axis] Level 2 Debt Instrument [Axis] Investissement Québec Financing Facility Term Loan Income Statement Location [Axis] Research and Development Expenses General and Administrative Expenses Foreign Exchange Contracts Research and Development Arrangement, Contract to Perform for Others, Type [Axis] External Engineering Employee Compensation Pilot Plant Operating Expenses Other Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity's Reporting Status Current? Entity Filer Category Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Entity Emerging Growth Company Entity Small Business Entity Shell Company Entity Interactive Data Current? Entity Incorporation State Country Code Entity File Number Statement of Financial Position [Abstract] Assets Current assets Cash and cash equivalents Sales tax, tax credits and other receivables (Note 3) Prepaid expenses and deposits (Note 4) Total current assets Investment in joint venture (Note 9) Property, plant and equipment, net (Note 5) Intangible assets, net (Note 6) Total assets Liabilities and Stockholders' Equity Current liabilities Accounts payable and accrued liabilities (Note 8) Current portion of long-term debt (Note 10) Total current liabilities Long-term debt (Note 10) Total liabilities Stockholders' Equity Series A Preferred stock par value $0.0001; 25,000,000 shares authorized; one share issued and outstanding (Note 12) Common stock par value $0.0001: 250,000,000 shares authorized; 42,412,739 shares issued and outstanding (February 29, 2020 - 39,910,774) (Note 12) Additional paid-in capital Additional paid-in capital - Warrants Accumulated deficit Accumulated other comprehensive loss Total stockholders' equity Total liabilities and stockholders' equity Series A preferred stock, par value Series A preferred stock, share authorized Series A preferred stock, share issued Series A preferred stock, share outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue Expenses Research and development, net (Note 13 and 14) General and administrative (Note 14) Write-down and impairment of property, plant and equipment (Note 5) Depreciation and amortization (Notes 5 and 6) Interest and other financial (income) expense (Note 17) Interest income Foreign exchange loss Total expenses Net loss Other comprehensive income (loss) Foreign currency translation adjustment Comprehensive income (loss) Loss per share Basic and diluted Weighted average common shares outstanding Basic and diluted Statement [Table] Statement [Line Items] Beginning balance, shares Beginning balance, amount Issuance of common shares for cash, net of share issuance costs (Note 12), shares Issuance of common shares for cash, net of share issuance costs (Note 12), amount Issuance of shares for legal settlement, shares Issuance of shares for legal settlement, amount Issuance of shares upon conversion of convertible notes, shares Issuance of shares upon conversion of convertible notes, amount Issuance of shares upon vesting of restricted stock units (Note 12 and 14), shares Issuance of shares upon vesting of restricted stock units (Note 12 and 14), amount Issuance of shares upon the cashless exercise of stock options (Note 13), shares Issuance of shares upon the cashless exercise of stock options (Note 13), amount Issuance of shares upon exercise of warrants (Note 16), shares Issuance of shares upon exercise of warrants (Note 16), amount Warrant issued for services (Note 15) Stock options issued for services (Note 14) Restricted stock units issued for services (Note 13) Foreign currency translation Net loss Ending balance, shares Ending balance, amount Statement of Cash Flows [Abstract] Cash Flows from Operating Activities Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization (Notes 5 and 6) Stock-based compensation expense (Note 14) Accretion and accrued interest (Note 10) Loss on revaluation of warrants Deferred financing costs (Note 16) Gain on conversion of convertible notes Loss on revaluation of foreign exchange contracts Changes in operating assets and liabilities: Sales tax, tax credits and other receivables (Note 3) Prepaid expenses (Note 4) Accounts payable and accrued liabilities (Note 8) Net cash used in operating activities Cash Flows from Investing Activities Investment in a joint venture (Note 9) Additions to property, plant and equipment (Note 5) Additions to intangible assets (Note 6) Net cash used in investing activities Cash Flows from Financing Activities Proceeds from sale of common shares and exercise of warrants, net of share issuance costs (Note 12) Repayment of long-term debt (Note 10) Net cash provided from (used in) financing activities Effect of exchange rate changes Net change in cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Supplemental Disclosure of Cash Flow Information: Income tax paid Interest paid Interest received Organization, Consolidation and Presentation of Financial Statements [Abstract] The Company, Basis of Presentation Accounting Policies [Abstract] Summary of Significant Accounting Policies Receivables [Abstract] Sales Tax, Tax Credits and Other Receivables Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Prepaid Expenses and Deposits Property, Plant and Equipment [Abstract] Property, Plant and Equipment Finite-Lived Intangible Assets, Net [Abstract] Intangible Assets Fair Value Disclosures [Abstract] Fair Value of Financial Instruments Payables and Accruals [Abstract] Accounts Payable and Accrued Liabilities Equity Method Investments and Joint Ventures [Abstract] Joint Venture Long-term Debt, Unclassified [Abstract] Long-Term Debt Related Party Transactions [Abstract] Related Party Transactions Stockholders' Equity Attributable to Parent [Abstract] Stockholders' Equity Research and Development [Abstract] Research and development expenses Share-based Payment Arrangement [Abstract] Share-Based Payments Equity [Abstract] Equity Incentive Plan Warrants Warrants Interest And Other Finance Costs Interest and Other Finance Costs Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Subsequent Events [Abstract] Subsequent Events Use of estimates Foreign currency translations and transactions Stock-based compensation Income taxes Research and development expenses Net earnings (loss) per share Recently adopted accounting pronouncements Sales tax, tax credits and other receivables Prepaid expenses Property, plant and equipment Intangible assets Fair value of financial instruments Accounts payable and accrued liabilities Long-term debt Principal repayments Common stock Key inputs into the valuation model Equity incentive plan Interest And Other Financial Costs Interest and other financial costs Research and development expenses Antidilutive securities Sales tax Research and development tax credits Other receivables Sales tax, research and development tax credits and other receivables Deposits on machinery and equipment Insurance Other prepaid expenses Prepaid expenses Long-Lived Tangible Asset [Axis] Statistical Measurement [Axis] Property, plant and equipment, gross Less: accumulated depreciation, write-down and impairment Property, plant and equipment, net Depreciation expense Write-down and impairment expenses Purchase of machinery and equipment Intangible assets, at cost - beginning of period Intangible assets, accumulated depreciation Total Add: additions in the year Deduct: amortization of intangibles Foreign exchange effect - increase (decrease) Total Amortization expense Fair Value Hierarchy and NAV [Axis] Carrying amount Fair value Trade accounts payable Accrued engineering fees Accrued employee compensation and payroll taxes Accrued professional fees Accrued cost of machinery and equipment Other accrued liabilities Accounts payable and accrued liabilities Principal amount Unamortized discount Accrued interest Less: current portion Long-term debt, net of current portion February 28, 2021 February 28, 2022 February 28, 2023 February 29, 2024 February 28, 2025 Thereafter Total Interest expense Accretion expense Repayment Interest paid Issuance of common shares for cash, net of share issuance expenses (Note 12), shares Issuance of common shares for cash, net of share issuance expenses (Note 12), amount Issuance of shares upon vesting of restricted stock units (Note 13), shares Issuance of shares upon vesting of restricted stock units (Note 13), amount Issuance of shares upon exercise of warrants (Note 15), shares Issuance of shares upon exercise of warrants (Note 15), amount Exercise price Risk-free interest rate Expected dividend yield Expected volatility Expected life Stock options granted Stock options granted, weighted average exercise price Stock options forfeited Stock options forfeited, weighted average exercise price Stock options exercised Stock options exercised, weighted average exercise price Stock options expired Stock options expired, weighted average exercise price Stock options outstanding Stock options outstanding, weighted average exercise price Stock options exercisable Stock options exercisable, weighted average exercise price Stock option expense Restricted stock units granted Restricted stock units granted, weighted average exercise price Restricted stock units settled Restricted stock units settled, weighted average exercise price Restricted stock units forfeited Restricted stock units forfeited, weighted average exercise price Restricted stock units outstanding Restricted stock units vested Restricted stock unit expense Stock-based compensation expense Outstanding, beginning Share reserve increase Units granted Units forfeited Units expired Outstanding, ending Warrants issued Warrants issued, weighted average exercise price Warrants exercised Warrants exercised, weighted average exercise price Interest on long-term debt Interest on convertible notes Accretion expense Amortization of deferred finance costs Loss (gain) on revaluation of foreign exchange contracts Revaluation of warrants Gain on conversion of November 2018 Notes Other Interest and other finance costs Custom Element. Assets, Current Assets [Default Label] Liabilities, Current Stockholders' Equity Attributable to Parent Liabilities and Equity Interest and Dividend Income, Operating Foreign Currency Transaction Gain (Loss), before Tax Operating Expenses Comprehensive Income (Loss), Net of Tax, Attributable to Parent Weighted Average Number of Shares Outstanding, Basic and Diluted Shares, Issued Depreciation, Depletion and Amortization Increase (Decrease) in Accrued Interest Receivable, Net GainLossOnRevaluationOfWarrants Increase (Decrease) in Deferred Charges ConversionGainsAndLossesOnCovertibleNotes GainLossOnRevaluationOfForeignExchangeContracts Sales tax and tax credits receivable Increase (Decrease) in Prepaid Expense Increase (Decrease) in Accounts Payable Net Cash Provided by (Used in) Operating Activities Payments to Acquire Interest in Joint Venture Payments to Acquire Property, Plant, and Equipment Payments to Acquire Intangible Assets Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Long-term Debt [Text Block] Stockholders' Equity Note Disclosure [Text Block] Compensation and Employee Benefit Plans [Text Block] WarrantsDisclosureTextBlock Research, Development, and Computer Software, Policy [Policy Text Block] SalesTaxResearchAndDevelopmentTaxCreditsAndOtherReceivables Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accounts Payable and Accrued Liabilities [Default Label] Debt Instrument, Unamortized Discount Interest Paid, Including Capitalized Interest, Operating and Investing Activities NumberOfOptionsExercised Accretion Expense GainOnConversionOfNovember2018Notes Other Nonoperating Income (Expense) InterestAndOtherFinanceCosts EX-101.PRE 12 loop-20201130_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 13 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Document and Entity Information - shares
9 Months Ended
Nov. 30, 2020
Jan. 14, 2021
Cover [Abstract]    
Entity Registrant Name Loop Industries, Inc.  
Entity Central Index Key 0001504678  
Document Type 10-Q  
Document Period End Date Nov. 30, 2020  
Amendment Flag false  
Current Fiscal Year End Date --02-28  
Is Entity's Reporting Status Current? Yes  
Entity Filer Category Non-accelerated Filer  
Entity Common Stock, Shares Outstanding   42,413,691
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2021  
Entity Emerging Growth Company false  
Entity Small Business true  
Entity Shell Company false  
Entity Interactive Data Current? Yes  
Entity Incorporation State Country Code NV  
Entity File Number 000-54768  
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Consolidated Balance Sheets - USD ($)
Nov. 30, 2020
Feb. 29, 2020
Current assets    
Cash and cash equivalents $ 43,613,815 $ 33,717,671
Sales tax, tax credits and other receivables (Note 3) 1,182,107 664,544
Prepaid expenses and deposits (Note 4) 1,230,442 141,226
Total current assets 46,026,364 34,523,441
Investment in joint venture (Note 9) 1,500,000 850,000
Property, plant and equipment, net (Note 5) 3,355,410 7,260,254
Intangible assets, net (Note 6) 631,590 202,863
Total assets 51,513,364 42,836,558
Current liabilities    
Accounts payable and accrued liabilities (Note 8) 4,088,147 2,082,698
Current portion of long-term debt (Note 10) 53,992 52,126
Total current liabilities 4,142,139 2,134,824
Long-term debt (Note 10) 2,336,374 2,238,026
Total liabilities 6,478,513 4,372,850
Stockholders' Equity    
Series A Preferred stock par value $0.0001; 25,000,000 shares authorized; one share issued and outstanding (Note 12) 0 0
Common stock par value $0.0001: 250,000,000 shares authorized; 42,412,739 shares issued and outstanding (February 29, 2020 - 39,910,774) (Note 12) 4,242 3,992
Additional paid-in capital 112,112,970 82,379,413
Additional paid-in capital - Warrants 9,475,996 9,785,799
Accumulated deficit (76,468,478) (53,317,047)
Accumulated other comprehensive loss (89,879) (388,449)
Total stockholders' equity 45,034,851 38,463,708
Total liabilities and stockholders' equity $ 51,513,364 $ 42,836,558
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Nov. 30, 2020
Feb. 29, 2020
Stockholders' Equity    
Series A preferred stock, par value $ .0001 $ 0.0001
Series A preferred stock, share authorized 25,000,000 25,000,000
Series A preferred stock, share issued 1 1
Series A preferred stock, share outstanding 1 1
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 250,000,000 250,000,000
Common stock, shares issued 42,412,739 39,910,774
Common stock, shares outstanding 42,412,739 39,910,774
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Nov. 30, 2020
Nov. 30, 2019
Nov. 30, 2020
Nov. 30, 2019
Income Statement [Abstract]        
Revenue $ 0 $ 0 $ 0 $ 0
Expenses        
Research and development, net (Note 13 and 14) 6,274,283 1,278,172 10,504,093 3,246,246
General and administrative (Note 14) 2,724,016 1,825,813 6,726,339 5,447,056
Write-down and impairment of property, plant and equipment (Note 5) 5,034,606 0 5,043,120 22,985
Depreciation and amortization (Notes 5 and 6) 104,307 219,628 654,354 562,382
Interest and other financial (income) expense (Note 17) (41,855) 693,027 26,016 1,817,091
Interest income (20,008) (171,274) (78,394) (363,565)
Foreign exchange loss 95,644 5,533 275,903 15,297
Total expenses 14,170,993 3,850,899 23,151,431 10,747,492
Net loss (14,170,993) (3,850,899) (23,151,431) (10,747,492)
Other comprehensive income (loss)        
Foreign currency translation adjustment 66,170 7,552 298,570 (30,133)
Comprehensive income (loss) $ (14,104,823) $ (3,843,347) $ (22,852,861) $ (10,777,625)
Loss per share        
Basic and diluted $ (0.34) $ (0.10) $ (0.57) $ (0.29)
Weighted average common shares outstanding        
Basic and diluted 41,715,806 39,133,627 40,515,885 37,404,165
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Consolidated Statement of Changes in Stockholders Equity (Unaudited) - USD ($)
Common Stock
Preferred Stock
Additional Paid-in Capital
Additional Paid-in Capital - Warrants
Additional Paid-in Capital - Benificial Conversion Feature
Common Stock Issuable
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Total
Beginning balance, shares at Feb. 28, 2019 33,805,706 1              
Beginning balance, amount at Feb. 28, 2019 $ 3,381 $ 0 $ 38,966,208 $ 757,704 $ 1,200,915 $ 800,000 $ (38,811,592) $ (290,224) $ 2,626,392
Issuance of common shares for cash, net of share issuance costs (Note 12), shares 4,693,567                
Issuance of common shares for cash, net of share issuance costs (Note 12), amount $ 469   30,359,394 8,663,769         39,023,632
Issuance of shares for legal settlement, shares 150,000                
Issuance of shares for legal settlement, amount $ 15   (15)           0
Issuance of shares upon conversion of convertible notes, shares 319,326                
Issuance of shares upon conversion of convertible notes, amount $ 32   2,372,549 316,929         2,689,510
Issuance of shares upon vesting of restricted stock units (Note 12 and 14), shares 243,932                
Issuance of shares upon vesting of restricted stock units (Note 12 and 14), amount $ 24   799,976     (800,000)     0
Issuance of shares upon the cashless exercise of stock options (Note 13), shares 4,565                
Issuance of shares upon the cashless exercise of stock options (Note 13), amount $ 1   (1)           0
Issuance of shares upon exercise of warrants (Note 16), shares 15,432                
Issuance of shares upon exercise of warrants (Note 16), amount $ 1   182,048 (38,300)         143,749
Stock options issued for services (Note 14)     1,628,897           1,628,897
Restricted stock units issued for services (Note 13)     981,914           981,914
Foreign currency translation               (30,133) (30,133)
Net loss             (10,747,492)   (10,747,492)
Ending balance, shares at Nov. 30, 2019 39,232,528 1              
Ending balance, amount at Nov. 30, 2019 $ 3,923 $ 0 75,290,970 9,700,102 1,200,915 0 (49,559,084) (320,357) 36,316,469
Beginning balance, shares at Aug. 31, 2019 39,032,528 1              
Beginning balance, amount at Aug. 31, 2019 $ 3,903 $ 0 74,414,197 9,700,102 1,200,915 0 (45,708,185) (327,909) 39,283,023
Issuance of shares upon vesting of restricted stock units (Note 12 and 14), shares 200,000                
Issuance of shares upon vesting of restricted stock units (Note 12 and 14), amount $ 20   (20)           0
Stock options issued for services (Note 14)     549,810           549,810
Restricted stock units issued for services (Note 13)     326,983           326,983
Foreign currency translation               7,552 7,552
Net loss             (3,850,899)   (3,850,899)
Ending balance, shares at Nov. 30, 2019 39,232,528 1              
Ending balance, amount at Nov. 30, 2019 $ 3,923 $ 0 75,290,970 9,700,102 1,200,915 0 (49,559,084) (320,357) 36,316,469
Beginning balance, shares at Feb. 29, 2020 39,910,774 1              
Beginning balance, amount at Feb. 29, 2020 $ 3,992 $ 0 82,379,413 9,785,799 0 0 (53,317,047) (388,449) 38,463,708
Issuance of common shares for cash, net of share issuance costs (Note 12), shares 2,087,000                
Issuance of common shares for cash, net of share issuance costs (Note 12), amount $ 209   24,996,419           24,996,628
Issuance of shares for legal settlement, shares                
Issuance of shares for legal settlement, amount                
Issuance of shares upon conversion of convertible notes, shares                
Issuance of shares upon conversion of convertible notes, amount                
Issuance of shares upon vesting of restricted stock units (Note 12 and 14), shares 224,436                
Issuance of shares upon vesting of restricted stock units (Note 12 and 14), amount $ 22   (22)           0
Issuance of shares upon the cashless exercise of stock options (Note 13), shares                
Issuance of shares upon the cashless exercise of stock options (Note 13), amount                
Issuance of shares upon exercise of warrants (Note 16), shares 190,529                
Issuance of shares upon exercise of warrants (Note 16), amount $ 19   2,046,853 (394,245)         1,652,627
Warrant issued for services (Note 15)       84,442         84,442
Stock options issued for services (Note 14)     1,662,155           1,662,155
Restricted stock units issued for services (Note 13)     1,028,152           1,028,152
Foreign currency translation               298,570 298,570
Net loss             (23,151,431)   (23,151,431)
Ending balance, shares at Nov. 30, 2020 42,412,739 1              
Ending balance, amount at Nov. 30, 2020 $ 4,242 $ 0 112,112,970 9,475,996 0 0 (76,468,478) (89,879) 45,034,851
Beginning balance, shares at Aug. 31, 2020 39,935,210 1              
Beginning balance, amount at Aug. 31, 2020 $ 3,994 $ 0 84,172,723 9,870,241 0 0 (62,297,485) (156,049) 31,593,424
Issuance of common shares for cash, net of share issuance costs (Note 12), shares 2,087,000                
Issuance of common shares for cash, net of share issuance costs (Note 12), amount $ 209   24,996,419           24,996,628
Issuance of shares upon vesting of restricted stock units (Note 12 and 14), shares 200,000                
Issuance of shares upon vesting of restricted stock units (Note 12 and 14), amount $ 20   (20)           0
Issuance of shares upon exercise of warrants (Note 16), shares 190,529                
Issuance of shares upon exercise of warrants (Note 16), amount $ 19   2,046,854 (394,245)         1,652,628
Stock options issued for services (Note 14)     551,720           551,720
Restricted stock units issued for services (Note 13)     345,274           345,274
Foreign currency translation               66,170 66,170
Net loss             (14,170,993)   (14,170,993)
Ending balance, shares at Nov. 30, 2020 42,412,739 1              
Ending balance, amount at Nov. 30, 2020 $ 4,242 $ 0 $ 112,112,970 $ 9,475,996 $ 0 $ 0 $ (76,468,478) $ (89,879) $ 45,034,851
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Nov. 30, 2020
Nov. 30, 2019
Cash Flows from Operating Activities    
Net loss $ (23,151,431) $ (10,747,492)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization (Notes 5 and 6) 654,354 562,382
Stock-based compensation expense (Note 14) 2,774,749 2,610,811
Write-down and impairment of property, plant and equipment (Note 5) 5,043,120 22,985
Accretion and accrued interest (Note 10) 56,259 1,898,409
Loss on revaluation of warrants 0 8,483
Deferred financing costs (Note 16) 0 86,212
Gain on conversion of convertible notes 0 (232,565)
Loss on revaluation of foreign exchange contracts (58,945) 10,881
Changes in operating assets and liabilities:    
Sales tax, tax credits and other receivables (Note 3) (477,855) (37,536)
Prepaid expenses (Note 4) (1,075,291) 52,649
Accounts payable and accrued liabilities (Note 8) 1,690,789 (1,054,967)
Net cash used in operating activities (14,544,251) (6,819,748)
Cash Flows from Investing Activities    
Investment in a joint venture (Note 9) (650,000) (850,000)
Additions to property, plant and equipment (Note 5) (1,580,795) (1,647,433)
Additions to intangible assets (Note 6) (155,798) (95,488)
Net cash used in investing activities (2,386,593) (2,592,921)
Cash Flows from Financing Activities    
Proceeds from sale of common shares and exercise of warrants, net of share issuance costs (Note 12) 26,649,253 39,167,381
Repayment of long-term debt (Note 10) (32,781) (39,506)
Net cash provided from (used in) financing activities 26,616,472 39,127,875
Effect of exchange rate changes 210,516 (57,105)
Net change in cash and cash equivalents 9,896,144 29,658,101
Cash and cash equivalents, beginning of period 33,717,671 5,833,390
Cash and cash equivalents, end of period 43,613,815 35,491,491
Supplemental Disclosure of Cash Flow Information:    
Income tax paid 0 0
Interest paid 28,613 45,668
Interest received $ 78,394 $ 363,565
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.20.4
The Company, Basis of Presentation
9 Months Ended
Nov. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
The Company, Basis of Presentation

The Company

 

Loop Industries, Inc. (the “Company,” “Loop Industries,” “we,” or “our”) is a technology company that owns patented and proprietary technology that depolymerizes no and low-value waste PET plastic and polyester fiber to its base building blocks (monomers).  The monomers are filtered, purified and polymerized to create virgin-quality Loop™ branded PET resin suitable for use in food-grade packaging and polyester fiber.

 

On November 20, 2017, Loop Industries commenced trading on the NASDAQ Global Market under its new trading symbol, “LOOP.” From April 10, 2017 to November 19, 2017, our common stock was quoted on the OTCQX tier of the OTC Markets Group Inc. under the symbol “LLPP.”

 

Basis of presentation

 

The accompanying unaudited interim condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“US GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures included in these unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended February 29, 2020, filed with the SEC on May 5, 2020. The unaudited interim condensed consolidated financial statements comprise the consolidated financial position and results of operations of Loop Industries, Inc. and its subsidiaries, Loop Innovations, LLC and Loop Canada Inc. All subsidiaries are, either directly or indirectly, wholly owned subsidiaries of Loop Industries, Inc. (collectively, the “Company”). The Company also owns, through Loop Innovations, LLC, a 50% interest in a joint venture, Indorama Loop Technologies, LLC, which is accounted for under the equity method.

 

Intercompany balances and transactions are eliminated on consolidation. The condensed consolidated balance sheet as of February 29, 2020, included herein, was derived from the audited financial statements as of that date, but does not include all disclosures including certain notes required by GAAP on an annual reporting basis. In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements present fairly the financial position, results of operations, comprehensive loss and cash flows for the interim periods. The results for the three- and nine-month periods ended November 30, 2020 are not necessarily indicative of the results to be expected for any subsequent quarter, the fiscal year ending February 28, 2021, or any other period.

 

XML 20 R8.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies
9 Months Ended
Nov. 30, 2020
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Use of estimates

 

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for depreciable lives of property, plant and equipment, intangible assets, analysis of impairments of long-lived assets and intangible assets, accruals for potential liabilities and assumptions made in calculating the fair value of stock-based compensation and other equity instruments.

 

The COVID-19 pandemic has disrupted business operations for us and our customers, suppliers, vendors and other parties with whom we do business, and such disruptions are expected to continue for an indefinite period of time. The uncertain duration of these measures has had and may continue to have an effect on our development and commercialization efforts. In particular, as previously disclosed, the situation in the United States and the continued travel restrictions and quarantine requirements between Canada and the United States have caused disruptions in our timetable of our joint venture with Indorama in the development of our Spartanburg facility and commercialization of our technology.

 

Although the Company continues to monitor the situation and may adjust the Company’s current policies as more information and public health guidance become available, the COVID-19 pandemic is ongoing, and its dynamic nature, including uncertainties relating to the ultimate spread of the virus, the severity of the disease, the duration of the outbreak and actions that may be taken by governmental authorities to contain the outbreak or to treat its impact, makes it difficult to assess whether there will be further impact on the development and commercialization of the Company’s technology which could have a material adverse effect on the Company’s results of operations and cash flows.

 

Foreign currency translations and transactions

 

The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars, the reporting currency of the Company. Assets and liabilities of subsidiaries that have a functional currency other than that of the Company are translated to U.S. dollars at the exchange rate as at the balance sheet date. Income and expenses are translated at the average exchange rate of the period. The resulting translation adjustments are included in other comprehensive income (loss) (“OCI”). As a result, foreign currency exchange fluctuations may impact operating expenses. The Company currently has not engaged in any currency hedging activities.

 

For transactions and balances, monetary assets and liabilities denominated in foreign currencies are translated into the functional currency of the entity at the prevailing exchange rate at the reporting date. Non-monetary assets and liabilities, and revenue and expense items denominated in foreign currencies are translated into the functional currency using the exchange rate prevailing at the dates of the respective transactions. Foreign exchange gains and losses resulting from the settlement of such transactions are recognized in the consolidated statements of operations and comprehensive loss, except for gains or losses arising from the translation of intercompany balances denominated in foreign currencies that forms part in the net investment in the subsidiary which are included in OCI.

 

Stock-based compensation

 

The Company periodically issues stock options, warrants and restricted stock units to employees and non-employees in non-capital raising transactions for services and financing expenses. The Company accounts for stock options granted to employees based on the authoritative guidance provided by the FASB wherein the fair value of the award is measured on the grant date and where there are no performance conditions, recognized as compensation expense on the straight-line basis over the vesting period and where performance conditions exist, recognize compensation expense when it becomes probable that the performance condition will be met. Forfeitures on share-based payments are accounted for by recognizing forfeitures as they occur.

 

The Company accounts for stock options and warrants granted to non-employees in accordance with the authoritative guidance of the FASB wherein the fair value of the stock compensation is based upon the measurement date determined as the earlier of the date at which either a) a commitment is reached with the counterparty for performance or b) the counterparty completes its performance.

 

The Company estimates the fair value of restricted stock unit awards to employees and directors based on the closing market price of its common stock on the date of grant.

 

The fair value of the stock options granted are estimated using the Black-Scholes-Merton Option Pricing (“Black-Scholes”) model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options, and future dividends. Stock-based compensation expense is recorded based on the value derived from the Black-Scholes model and on actual experience. The assumptions used in the Black-Scholes model could materially affect stock-based compensation expense recorded in the current and future periods.

 

Income taxes

 

The Company calculates its provision for income tax on the basis of the tax laws enacted at the balance sheet date in the countries where the Company and its subsidiaries operate and generate taxable income, in accordance with FASB ASC 740, Income Taxes. The Company uses an asset and liability approach for financial accounting and reporting for income taxes that allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The Company’s policy is to recognize interest and/or penalties related to income tax matters in income tax expense.

 

Research and development expenses

 

Research and development expenses relate primarily to the development, design, testing of preproduction samples, prototypes and models, compensation, and consulting fees, and are expensed as incurred. Starting in the current quarter, machinery and equipment purchases related to the pilot plant which is now dedicated solely to research and development activities with no alternative use are also expensed as incurred. Total research and development costs recorded during the three- and nine-month periods ended November 30, 2020 amounted to $6,724,283 and $10,504,093 (2019 – $1,278,172 and $3,246,246), respectively, and are net of government research and development tax credits and government grants from the federal and provincial taxation authorities accrued and recorded based on qualifying expenditures incurred during the fiscal periods.

 

 Net earnings (loss) per share

 

The Company computes net loss per share in accordance with FASB ASC 260, Earnings Per Share. Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year. The Company includes common stock issuable in its calculation. Diluted earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation if their effect is antidilutive.

 

For the three- and nine-month periods ended November 30, 2020 and 2019, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have an antidilutive effect. As at November 30, 2020, the potentially dilutive securities consisted of 1,590,470 outstanding stock options (November 30, 2019 – 1,657,081), 4,171,609 outstanding restricted stock units (November 30, 2019 – 4,219,753) and 4,693,802 outstanding warrants (November 30, 2019 – 5,040,267).

 

Recently adopted accounting pronouncements

 

In August 2018, the FASB issued ASU 2018-15, “Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that Is a Service Contract,” which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). This update is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The adoption of the standard had no impact on the consolidated financial statements of the Company.

 

In February 2018, the FASB issued ASU 2018-02, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which permits entities to reclassify the disproportionate income tax effects of the Tax Reform Act on items within accumulated other comprehensive income (loss) (“AOCI”) to retained earnings. These disproportionate income tax effect items are referred to as "stranded tax effects." Amendments in this update only relate to the reclassification of the income tax effects of the Tax Reform Act. Other accounting guidance that requires the effect of changes in tax laws or rates to be included in net income from continuing operations is not affected by this update. ASU 2018-02 should be applied either in the period of adoption or retrospectively to each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Reform Act is recognized. ASU 2018-02 is applicable beginning March 1, 2020. The adoption of the standard had no impact on the consolidated financial statements of the Company.

 

In February 2016, the FASB issued ASU 2016-02, “Leases,” amended in July by ASU 2018-10, “Codification Improvements to Topic 842, Leases,” ASU 2018-11, “Targeted Improvements,” and ASU 2018-20, “Narrow-Scope Improvements for Lessors,” which requires lessees to recognize leases on the balance sheet while continuing to recognize expenses in the income statement in a manner similar to current accounting standards. For lessors, the new standard modifies the classification criteria and the accounting for sales-type and direct financing leases. Enhanced disclosures will also be required to give financial statement users the ability to assess the amount, timing, and uncertainty of cash flows arising from leases. This ASU may either be adopted on a modified retrospective approach at the beginning of the earliest comparative period, or through a cumulative-effect adjustment at the adoption date. This update is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company adopted these standards effective March 1, 2020. The adoption of the standard had no impact on the consolidated financial statements of the Company. The Company elected to apply the package of practical expedients that allows us not to reassess whether expired or existing contracts contain leases, the classification of these leases and whether previously capitalized initial direct costs would qualify for capitalization under Accounting Standards Codification (or “ASC”) 842. Furthermore, we elected to use hindsight in determining the lease term and assessing impairment of the right-of-use assets.

 

Recently issued accounting pronouncements not yet adopted

 

In December 2019, the FASB issued ASU 2019-12, “Simplifying the Accounting for Income Taxes,” which removes specific exceptions to the general principles in ASC 740, “Income Taxes,” and clarifies certain aspects of the existing guidance. This update is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years, with early adoption being permitted as of the beginning of an interim or annual reporting period. All amendments to this ASU must be adopted in the same period on a prospective basis, with certain exceptions. We are still evaluating the impact of this accounting guidance on our results of operations and financial position.

 

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments—Credit Losses”. This ASU added a new impairment model (known as the current expected credit loss (“CECL”) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes an allowance for its estimate of expected credit losses and applies to most debt instruments, trade receivables, lease receivables, financial guarantee contracts, and other loan commitments. The CECL model does not have a minimum threshold for recognition of impairment losses and entities will need to measure expected credit losses on assets that have a low risk of loss. This update is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years for smaller reporting companies. We are still evaluating the impact of this accounting guidance on our results of operations and financial position.

 

XML 21 R9.htm IDEA: XBRL DOCUMENT v3.20.4
Sales Tax, Tax Credits and Other Receivables
9 Months Ended
Nov. 30, 2020
Receivables [Abstract]  
Sales Tax, Tax Credits and Other Receivables

Sales tax, research and development tax credits and other receivables as at November 30, 2020 and February 29, 2020 were as follows:

 

    November 30, 2020     February 29, 2020  
Sales tax   $ 669,966     $ 180 971  
Research and development tax credits     390,885       447,843  
Other receivables     121,256       35,730  
    $ 1,182,107     $ 664,544  

 

XML 22 R10.htm IDEA: XBRL DOCUMENT v3.20.4
Prepaid Expenses and Deposits
9 Months Ended
Nov. 30, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Prepaid Expenses and Deposits

Prepaid expenses and deposits as at November 30, 2020 and February 29, 2020 were as follows:

 

    November 30, 2020     February 29, 2020  
Deposits on machinery and equipment   $ 747,250     $ -  
Insurance     427,013       61,891  
Other prepaid expenses     56,179       79,335  
    $ 1,230,442     $ 141,226  

 

Non-refundable cash deposits on machinery and equipment that will be used in research and development activities will be expensed, and classified as research and development expenses, in the period the equipment is received and placed into use.

 

XML 23 R11.htm IDEA: XBRL DOCUMENT v3.20.4
Property, Plant and Equipment
9 Months Ended
Nov. 30, 2020
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment
    As at November 30, 2020  
    Cost     Accumulated depreciation, write-down and impairment     Net book value  
Building   $ 1,912,138     $ (181,308 )   $ 1,730,830  
Land     236,360       -       236,360  
Building and land improvements     1,602,766       (379,164 )     1,223,602  
Machinery and equipment     6,514,252       (6,514,252 )      -  
Office equipment and furniture     260,220       (95,602 )     164,618  
Balances, end of period   $ 10,525,736     $ (7,170,326 )   $ 3,355,410  

 

    As at February 29, 2020  
    Cost     Accumulated depreciation, write-down and impairment     Net book value  
Building   $ 1,846,070     $ (128,911 )   $ 1,717,159  
Land     264,868       -       264,868  
Building and land improvements     733,884       (214,068 )     519,816  
Machinery and equipment     6,085,195       (1,426,465 )     4,658,730  
Office equipment and furniture     162,466       (62,785 )     99,681  
Balances, end of period   $ 9,092,483     $ (1,832,229 )   $ 7,260,254  

 

Depreciation expense for the three- and nine-month periods ended November 30, 2020 amounted to $93,006 and $624,189, respectively (2019 – $212,968 and $570,165, respectively), and is recorded as an expense in the consolidated statements of operations and comprehensive loss.

 

During the three- and nine-month periods ended November 30, 2020, the Company recorded write-down and impairment expenses of $5,034,606 and $5,043,120, respectively (2019 – nil and $22,985). In the quarter ended November 30, 2020, the Company’s management made the decision to convert its pilot plant to exclusively a demonstration and training facility for our future Infinite Loop™ manufacturing facilities, therefore foregoing any alternative future use of its machinery and equipment assets contained within the pilot plant. As such, the carrying value of the machinery and equipment was written off resulting in an expense of $5,034,606 being recognized in the three-month period ended November 30, 2020. With the decision to dedicate the demonstration and training facility to research and development, the accounting for future costs associated with these activities are considered in scope of ASC 730, Research and Development Costs, and will be recognized as a research and development expense in the consolidated statements of operations and comprehensive loss in the period they are incurred. During the three-month period ended November 30, 2020, the Company purchased $2,325,540 of machinery and equipment associated with its ongoing research and development activities, which have no future alternative use and as such, were recognized as research and development expenses in the consolidated statements of operations and comprehensive loss. See Note 13 for components of research and development expenses.

 

XML 24 R12.htm IDEA: XBRL DOCUMENT v3.20.4
Intangible Assets
9 Months Ended
Nov. 30, 2020
Finite-Lived Intangible Assets, Net [Abstract]  
Intangible Assets
    November 30, 2020     February 29, 2020  
             
Intangible assets, at cost - beginning of period   $ 225,174     $ 127,672  
Intangible assets, accumulated depreciation – beginning of period     (22,311 )     -  
      202,863       127,672  
                 
Additions in the period     452,758       99,972  
Amortization of intangibles     (30,165 )     (22,631 )
Foreign exchange effect – increase (decrease)     6,133       (2,150 )
    $ 631,589     $ 202,863  

 

Amortization expense for the three- and nine-month periods ended November 30, 2020 amounted to $11,301 and $30,165, respectively (2019 - $6,660 and $15,202, respectively), and is recorded as an expense in the unaudited condensed consolidated statements of operations and comprehensive loss.

 

XML 25 R13.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value of Financial Instruments
9 Months Ended
Nov. 30, 2020
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments

The following tables present the fair value of the Company’s financial (assets) liabilities as at November 30, 2020 and February 29, 2020:

 

    Fair Value Measurements as at November 30, 2020  
    Carrying Amount     Fair Value     Level in the hierarchy  
Instruments measured at fair value on a recurring basis:                  
Foreign exchange contracts   $ (25,797 )   $ (25,797 )     Level 2  
                         
Instruments measured at amortized cost:                        
Long-term debt   $ 2,390,366     $ 2,400,897       Level 2  

 

    Fair Value Measurements at February 29, 2020  
    Carrying Amount     Fair Value     Level in the hierarchy  
Instruments measured at fair value on a recurring basis:                  
Foreign exchange contracts   $ 26,840     $ 26,840       Level 2  
                         
Instruments measured at amortized cost:                        
Long-term debt   $ 2,290,152     $ 2,291,109       Level 2  

 

XML 26 R14.htm IDEA: XBRL DOCUMENT v3.20.4
Accounts Payable and Accrued Liabilities
9 Months Ended
Nov. 30, 2020
Payables and Accruals [Abstract]  
Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities as at November 30, 2020 and February 29, 2020 were as follows:

 

    November 30, 2020     February 29, 2020  
Trade accounts payable   $ 1,514,881     $ 814,081  
Accrued engineering fees     686,061       -  
Accrued employee compensation and payroll taxes     678,925       873,242  
Accrued professional fees     676,153       133,038  
Accrued cost of machinery and equipment      415,522        92,126  
Other accrued liabilities     116,605       170,211  
    $ 4,088,147     $ 2,082,698  

 

XML 27 R15.htm IDEA: XBRL DOCUMENT v3.20.4
Joint Venture
9 Months Ended
Nov. 30, 2020
Equity Method Investments and Joint Ventures [Abstract]  
Joint Venture

On September 15, 2018, the Company, through its wholly-owned subsidiary Loop Innovations, LLC, a Delaware limited liability company, entered into a Joint Venture Agreement (the “Joint Venture Agreement”) with Indorama Ventures Holdings LP, USA, an indirect subsidiary of Indorama Ventures Public Company Limited, to manufacture and commercialize sustainable polyester resin. Each company has a 50/50 equity interest in Indorama Loop Technologies, LLC (“ILT”), which was specifically formed to operate and execute the joint venture.

 

Under the Joint Venture Agreement, Indorama Ventures is contributing manufacturing knowledge and Loop Industries is required to contribute its proprietary science and technology. Specifically, the Company is contributing an exclusive world-wide royalty-free license to ILT to use its proprietary technology to produce 100% sustainably produced PET resin and polyester fiber.

 

ILT meets the accounting definition of a joint venture where neither party has control of the joint venture entity and both parties have joint control over the decision-making process in ILT. As such, the Company uses the equity method of accounting to account for its share of the investment in ILT. There were no operations in ILT from the date of inception of September 24, 2018 to November 30, 2020 and, as at November 30, 2020, the carrying value of the equity investment was $1,500,000, which is the total of the cash contributions we have made to ILT. During the three- and nine-month periods ended November 30, 2020, we made contributions to ILT of nil and $650,000 respectively (2019 – $350,000 and $850,000). These contributions to ILT, which have been matched by Indorama Ventures, were used to fund engineering design costs which have been capitalized in ILT.

 

The joint venture made a decision in July that due to the COVID-19 situation it would delay work on the project. Since then, no expenditures have been incurred by the joint venture.

 

 

XML 28 R16.htm IDEA: XBRL DOCUMENT v3.20.4
Long-Term Debt
9 Months Ended
Nov. 30, 2020
Long-term Debt, Unclassified [Abstract]  
Long-Term Debt
    November 30, 2020     February 29, 2020  
Investissement Québec financing facility:            
Principal amount   $ 1,703,998     $ 1,645,122  
Unamortized discount     (272,036 )     (289,852 )
Accrued interest     31,549       958  
Total Investissement Québec financing facility     1,463,511       1,356,228  
Term loan                
Principal amount     926,855       933,924  
Less: current portion     (53,992 )     (52,126 )
Total term loan, net of current portion     872,863       881,798  
Long-term debt, net of current portion   $ 2,336,374     $ 2,238,026  

 

Investissement Québec financing facility

 

On February 21, 2020, the Company received $1,703,998 (CDN$2,209,234) from Investissement Québec as the first disbursement of our financing facility, out of a maximum of $3,548,014 (CDN$4,600,000) (the “Financing Facility”). The loan bears interest at 2.36% and there is a 36-month moratorium on both capital and interest repayments starting on the date of the first disbursement, after which capital and interest is repayable in 84 monthly installments. The Company established the fair value of the loan for the first disbursement at $1,354,408 based on a discount rate of 5.45%, which reflected a debt discount of $290,714. The discount rate used was based on the external financing from a Canadian bank. The Company, under the loan agreement, was required to pay fees representing 1% of the loan amount, $35,480 (CDN$46,000) to Investissment Québec which we deferred and recorded as a reduction of the Financing Facility. Debt discount and deferred financing expenses are amortized to “Interest and other financial expenses” in our Consolidated Statements of Operations and Comprehensive Loss. The Company recorded interest expense on the Investissement Québec loan for the three- and nine-month periods ended November 30, 2020 in the amount of $10,003 and $28,816 respectively (2019 – nil and nil) and an accretion expense of $9,387 and $27,045 respectively (2019 – nil and nil).

 

The Company has also agreed to issue to Investissement Québec warrants to purchase shares of common stock of the Company in an amount equal to 10% of each disbursement up to a maximum aggregate amount of $354,801 (CDN$460,000). The exercise price of the warrants is equal to the higher of (i) $11.00 per share and (ii) the ten-day weighted average closing price of Loop Industries shares of common stock on the Nasdaq stock market for the 10 days prior to the issue of the warrants. The warrants can be exercised immediately upon grant and will have a term of three years from the date of issuance. The loan can be repaid at any time by the Company without penalty. In connection the first disbursement of the Financing Facility, the Company issued a warrant (“First Disbursement Warrant”) to acquire 15,153 shares of common stock at a strike price of $11.00 per share to Investissement Québec. The Company determined the fair value of the warrants using the Black-Scholes pricing formula. The fair value of the First Disbursement Warrant was determined to be $77,954 and is included in “Additional paid-in capital – Warrants” in our Condensed Consolidated Balance Sheets. The First Disbursement Warrant remains outstanding as at November 30, 2020.

 

The remaining amount available under the financing facility is $1,844,015 (CDN$2,390,766) to be received in a maximum of two additional disbursements.

 

Term loan

 

On January 24, 2018, the Company obtained a $1,079,830 (CDN$1,400,000) 20-year term instalment loan (the “Loan”), from a Canadian bank. The Loan bears interest at the bank’s Canadian prime rate plus 1.5%. By agreement, the Loan is repayable in monthly payments of $4,499 (CDN$5,833) plus interest, until January 2021, at which time the monthly repayment amount and interest rate will be subject to renewal. It includes an option allowing for the prepayment of the Loan without penalty. In January 2021, the Company and the Canadian bank agreed to maintain the same repayment amount and interest rate until January 2022. During the three- and nine-month periods ended November 30, 2020, we repaid $13,497 and $32,781 respectively (2019 – $13,168 and $39,506) on the principal balance of the Loan and interest paid amounted to $9,172 and $29,102 and (2019 - $14,778 and $41,840). The terms of the credit facility require the Company to comply with certain financial covenants. As at November 30, 2020 and 2019, the Company was in compliance with its financial covenants.

  

Principal repayments due on the Company’s long-term debt over the next five years are as follows:

 

Years ending   Amount  
February 28, 2021   $ 13,498  
February 28, 2022     53,992  
February 28, 2023     53,992  
February 29, 2024     297,416  
February 28, 2025     297,416  
Thereafter     1,901,043  
Total   $ 2,617,355  

 

XML 29 R17.htm IDEA: XBRL DOCUMENT v3.20.4
Related Party Transactions
9 Months Ended
Nov. 30, 2020
Related Party Transactions [Abstract]  
Related Party Transactions

Employment Agreement

 

On June 29, 2015, the Company entered into an employment agreement with Mr. Daniel Solomita, the Company’s President and Chief Executive Officer (“CEO”). The employment agreement is for an indefinite term.

 

On July 13, 2018, the Company and Mr. Solomita entered into an amendment and restatement of the employment agreement which provided for a long-term incentive grant of 4,000,000 shares of the Company’s common stock, in tranches of one million shares each, upon the achievement of four performance milestones. This was modified to provide a grant of 4,000,000 restricted stock units (“RSUs”) covering 4,000,000 shares of the Company’s common stock while the performance milestones remained the same. The grant of the restricted stock units became effective upon approval by the Company’s shareholders at the Company’s 2019 annual meeting, of an increase in the number of shares available for grant under the Plan.  Such approval was granted by the Company’s shareholders at the Company’s 2019 annual meeting.

 

On April 30, 2020, the Company and Mr. Solomita entered into an amendment of Mr. Solomita’s employment agreement.  The amendment clarified the milestones consistent with the shift in the Company’s business from the production of terephthalate to the production of dimethyl terephthalate, another proven monomer of PET plastic.

 

As at November 30, 2020, 3,600,000 (2019 – 3,800,000) of Mr. Solomita’s RSUs were outstanding of which 600,000 were vested (2019 – 800,000). The vested units are settled annually in tranches of 200,000 units. During the three- and nine-month periods ended November 30, 2020 and November 30, 2019, no outstanding milestones were probable of being met based on the authoritative guidance provided by the FASB and, accordingly, the Company did not record any additional compensation expense. When a milestone becomes probable, the corresponding expense will be valued based on the grant date fair value on April 30, 2020, the date of the last modification of Mr. Solomita’s employment agreement. The closing price of the Company’s common stock on the Nasdaq on April 30, 2020 was $7.74 per share.

 

XML 30 R18.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders' Equity
9 Months Ended
Nov. 30, 2020
Stockholders' Equity  
Stockholders' Equity

Common Stock

 

For the period ended November 30, 2020   Number of shares     Amount  
Balance, February 29, 2020     39,910,774     $ 3,992  
Issuance of shares for cash     2,087,000       209  
Issuance of shares upon the exercise of warrants     190,529       19  
Issuance of shares upon settlement of restricted stock units     224,436       22  
Balance, November 30, 2020     42,412,739     $ 4,242  

 

For the period ended November 30, 2019   Number of shares     Amount  
Balance, February 28, 2019     33,805,706     $ 3,381  
Issuance of shares for cash     4,693,567       469  
Issuance of shares upon vesting of restricted stock units     243,932       24  
Issuance of shares upon the cashless exercise of stock options     4,565       1  
Issuance of shares upon the exercise of warrants     15,432       1  
Issuance of shares upon settlement of legal matter     150,000       15  
Issuance of shares upon conversion of Convertible notes     319,326       32  
Balance, November 30, 2019     39,232,528     $ 3,923  

 

 

During the nine months ended November 30, 2020, the Company recorded the following common stock transaction:

 

(i) On September 23, 2020 and October 1, 2020, the Company sold 1,880,000 and 207,000 shares, respectively of its common stock at an offering price of $12.75 per share in a registered direct offering, for total gross proceeds of $26,609,250.

 

(ii) The company issued 192,529 shares of its common stock upon the exercise of warrants.

 

(iii) On October 15, 2020, the Company issued 200,000 shares of common stock to settle restricted stock units related to the President and Chief Executive Officer.

 

(iv) The Company issued 24,436 shares of its common stock to settle restricted stock units that vested in the period.

 

 

During the nine months ended November 30, 2019, the Company recorded the following common stock transactions:

 

(i) On March 1, 2019, the Company sold 600,000 shares of its common stock at an offering price of $8.55 per share in a registered direct offering, for gross proceeds of $5,130,000.

 

(ii) On March 8, 2019 and March 11, 2019, the Company issued 150,000 shares of its common stock in settlement of a legal matter.

 

(iii) On April 9, 2019, the Company converted Convertible notes with a face value of $2,650,000 plus accrued interest of $80,241 at a conversion price of $8.55, into 319,326 common shares.

 

(iv) On June 14, 2019, the Company sold 4,093,567 shares of its common stock at an offering price of $8.55 per share in a registered direct offering, for gross proceeds of $35,000,000.

 

(v) On June 21, 2019, the Company issued 7,043 shares of common stock upon the vesting of restricted stock units related to an employee.

 

(vi) On July 2, 2019 and July 3, 2019, the Company issued 23,547 shares of common stock upon the vesting of restricted stock units related to current and former Directors.

 

(vii) On July 12, 2019, the Company issued 4,565 shares of common stock upon the cashless exercise of stock options related to an employee.

 

(viii) On July 15, 2019, the Company issued 13,342 shares of common stock upon the vesting of restricted stock units related to a former Director.

 

(ix) On July 17, 2019, the Company issued 15,432 shares of common stock upon the exercise of warrants.

 

(x) On October 15, 2019, the Company issued 200,000 shares of common stock to settle restricted stock units related to the President and Chief Executive Officer.

 

XML 31 R19.htm IDEA: XBRL DOCUMENT v3.20.4
Research and Development Expenses
9 Months Ended
Nov. 30, 2020
Research and Development [Abstract]  
Research and development expenses

Research and development expenses for the three months ended November 30, 2020 and 2019 were as follows:

 

    November 30, 2020     November 30, 2019  
External engineering   $ 2,224,910     $ 33,131  
Machinery and equipment expenditures     2,325,540       -  
Employee compensation     1,214,434       973,679  
Pilot plant operating expenses     399,031       166,753  
Other     110,368       104,610  
    $ 6,274,283     $ 1,278,173  

 

Research and development expenses for the nine months ended November 30, 2020 and 2019 were as follows:

 

    November 30, 2020      November 30, 2019  
External engineering   $ 3,241,959     $ 83,462  
Employee compensation     3,094,151       2,453,743  
Machinery and equipment expenditures     2,325,540       -  
Pilot plant operating expenses     1,537,271       456,942  
Other     305,172       252,099  
    $ 10,504,093     $ 3,246,246  

 

XML 32 R20.htm IDEA: XBRL DOCUMENT v3.20.4
Share-Based Payments
9 Months Ended
Nov. 30, 2020
Share-based Payment Arrangement [Abstract]  
Share-Based Payments

Stock Options

 

During the three- and nine-month period ended November 30, 2020, the Company granted 3,389 stock options (2019 – nil) with a weighted average exercise price of $8.78 (2019 – nil), no stock options were forfeited (2019 – 39,902; weighted average exercise price: $9.67) or exercised (2019 – 5,000; weighted average exercise price: $0.80) and no stock options expired (2019 – 260,417; weighted average exercise price: $13.59).

 

The Company applies the fair value method of accounting for stock-based compensation awards granted. Fair value is calculated based on a Black-Scholes option pricing model. The principal components of the pricing model were as follows:

 

    2020     2019  
Exercise price   $ 8.78     $ -  
Risk-free interest rate     1.05 %     -  
Expected dividend yield     0.00 %     -  
Expected volatility     75.95 %     -  
Expected life

 

 

   7.5 years      -  

 

The total number of stock options outstanding as at November 30, 2020 was 1,587,081 (2019 – 1,657,081) with a weighted average exercise price of $6.81 (2019 - $6.55), of which 1,132,498 were exercisable (2019 – 1,007,498) with a weighted average exercise price of $7.12 (2019 – $6.38).

 

During the three- and nine-month periods ended November 30, 2020, stock-based compensation expense attributable to stock options amounted to $551,720 and $1,662,155 respectively (2019 - to $549,810 and $1,628,897) and is included in expenses.

 

Restricted Stock Units

 

The Company applies the fair value method of accounting for awards granted through the issuance of restricted stock units. Fair value is calculated based on the closing share price at grant date multiplied by the number of restricted stock unit awards granted.

 

During the three-month period ended November 30, 2020, the Company granted 57,859 restricted stock units (“RSUs”) (2019 – nil) with a weighted average fair value of $12.96 (2019 – nil), settled 200,000 RSUs (2019 – 200,000) with a weighted average fair value of $0.80 (2019 – $0.80) and no RSUs were forfeited (2019 – nil).

 

During the nine-month period ended November 30, 2020, the Company granted 180,232 RSUs (2019 – 4,114,567) with a weighted average fair value of $10.18 (2019 – $1.06), settled 224,436 RSUs (2019 – 243,932) with a weighted average fair value of $1.78 (2019 – 2.52) and 2,989 RSUs were forfeited (2019 – 53,750) with a weighted average fair value of $8.78 (2019 – $9.82).

 

The total number of RSUs outstanding as at November 30, 2020 was 4,171,609 (2019 – 4,219,753), of which 691,327 were vested (2019 – 831,684).

 

During the three- and nine-month periods ended November 30, 2020, stock-based compensation expense attributable to RSUs amounted to $345,274 and $1,028,152 respectively (2019 - $326,983 and $981,914) and is included in expenses.

 

During the three- and nine-month periods ended November 30, 2020 and November 30, 2019, stock-based compensation included in research and development expenses amounted to $350,393 and $1,054,682 respectively (2019 – $311,353 and $941,142), and in general and administrative expenses amounted to $546,601 and $1,720,067 respectively (2019 - $565,440 and $1,669,669).

 

XML 33 R21.htm IDEA: XBRL DOCUMENT v3.20.4
Equity Incentive Plan
9 Months Ended
Nov. 30, 2020
Equity [Abstract]  
Equity Incentive Plan

On July 6, 2017, the Company adopted the 2017 Equity Incentive Plan (the “Plan”). The Plan permits the granting of warrants, stock options, stock appreciation rights and restricted stock units to employees, directors and consultants of the Company. A total of 3,000,000 shares of common stock were initially reserved for issuance under the Plan at July 6, 2017, with annual automatic share reserve increases, as defined in the Plan, amounting to the lessor of (i) 1,500,000 shares, (ii) 5% of the outstanding shares on the last day of the immediately preceding fiscal year, or (iii) or such number of shares determined by the Administrator of the Plan, effective March 1, 2018. In March 2020, the Board of Directors elected to waive the annual share reserve increase for the fiscal year ending February 28, 2021. The Plan is administered by the Board of Directors who designates eligible participants to be included under the Plan, the number of awards granted, the share price pursuant to the awards and the vesting conditions and period. The awards, when granted, will have an exercise price of no less than the estimated fair value of shares at the date of grant and a life not exceeding 10 years from the grant date. However, where a participant, at the time of the grant, owns stock representing more than 10% of the voting power of the Company, the life of the options shall not exceed 5 years.

 

The following table summarizes the continuity of the Company’s Equity Incentive Plan units during the nine-month periods ended November 30, 2020 and 2019:

 

    2020     2019  
    Number of units     Number of units  
Outstanding, beginning of period     1,300,518       3,223,516  
Share reserve increase     -       2,000,000  
Units granted     (183,621 )     (4,114,567 )
Units forfeited     2,989       93,652  
Units expired     -       260,417  
Outstanding, end of period     1,119,886       1,463,018  

 

XML 34 R22.htm IDEA: XBRL DOCUMENT v3.20.4
Warrants
9 Months Ended
Nov. 30, 2020
Warrants Abstract  
Warrants

During the three-month period ended November 30, 2020 159,664 warrants were exercised at the price of $8.55 per share and 30,864 warrants were exercised at the price of $9.32 per share. No warrants were granted, were forfeited nor expired in the three-month period ended November 30, 2020.

 

During the three-month period ended November 30, 2019, no warrants were granted, were forfeited, were exercised nor expired

 

During the nine-month period ended November 30, 2020, the Company issued, in exchange for consulting services, a warrant to purchase 25,000 shares of our common stock at the price of $9.43 per share expiring May 12, 2022 and warrants to issue 200,000 shares of our common stock with an exercise price of $11.00 expired. During the nine-month periods ended November 30, 2020, 159,664 warrants were exercised at the price of $8.55 per share and 30,864 warrants were exercised at the price of $9.32 per share. No warrants were forfeited in the nine-month period ended November 30, 2020.

 

During the nine-month period ended November 30, 2019, the Company issued a warrant to purchase 159,663 shares of our common stock at the price of $8.55 per share expiring October 5, 2020 as well as a warrant to purchase 4,093,567 shares of our common stock at the price of $11.00 per share expiring June 14, 2022. During the nine-month period ended November 30, 2019, 15,432 shares of our common stock were issued upon the exercise of a warrant with an exercise price of $9.32. No warrants were forfeited, and no warrants expired in the nine-month period ended November 30, 2019.

 

XML 35 R23.htm IDEA: XBRL DOCUMENT v3.20.4
Interest and Other Finance Costs
9 Months Ended
Nov. 30, 2020
Interest And Other Finance Costs  
Interest and Other Finance Costs

Interest and other finance costs for the three- and nine-month periods ended November 30, 2020 and 2019 are as follows:

 

    Three Months Ended November 30     Nine Months Ended November 30  
    2020     2019     2020     2019  
  Interest on long-term debt   $ 19,185     $ 14,778     $ 57,917     $ 41,840  
  Interest on convertible notes     -       98,000       -       313,433  
  Accretion expense     9,387       549,090       27,044       1,584,977  
  Amortization of deferred finance costs     -       19,885       -       86,212  
  Loss (gain) on revaluation of foreign exchange contracts     (70,427 )     10,881       (58,945 )     10,881  
  Revaluation of warrants     -       -       -       8,483  
  Gain on conversion of November 2018 Notes     -       -       -       (232,565 )
  Other     -       393       -       3,830  
    $ (41,855 )   $ 693,027     $ 26,016     $ 1,817,091  

 

XML 36 R24.htm IDEA: XBRL DOCUMENT v3.20.4
Commitments and Contingencies
9 Months Ended
Nov. 30, 2020
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Commercial commitments

 

On September 2, 2020, the Company entered into a know-how and engineering agreement (the “Chemtex Agreement”) with Chemtex Global Corporation (“Chemtex”) to license the PET plastic and polyester polymer for fiber manufacturing know-how of INVISTA’s technology and licensing group, INVISTA Performance Technologies (IPT) (“INVISTA”). The total value of the Chemtex Agreement is $4,300,000 and covers the know-how and design of two Infinite Loop™ facilities. Payment terms are based on the completion of certain milestones and total $2,150,000 for each facility. During the three and nine months ended November 30, 2020, $500,000 was paid by the Company.

 

On October 29, 2020, Coca-Cola Cross Enterprise Procurement Group (“CEPG”) advised the Company of its intention to terminate the Master Terms and Conditions Supply Agreement for Loop PET plastic, dated November 14, 2018 (the “MTC”) because the Company did not satisfy its first production milestone from the joint venture facility by July 2020 as required by the MTC.

 

Contingencies

 

On October 13, 2020, the Company and certain of its officers were named as defendants in a proposed class action lawsuit filed in the United States District Court for the Southern District of New York, captioned Olivier Tremblay, Individually and on Behalf of All Other Similarly Situated v. Loop Industries, Inc., Daniel Solomita, and Nelson Gentiletti, Case No. 7:20-cv-0838 (“Tremblay Class Action”). The allegations in the complaint claim that the defendants allegedly violated Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 by allegedly making materially false and/or misleading statements, as well as allegedly failing to disclose material adverse facts about the Company’s business, operations, and prospects, which caused the Company’s securities to trade at artificially inflated prices. Plaintiff seeks unspecified damages on behalf of a class of purchasers of Loop’s securities between September 24, 2018 and October 12, 2020.

 

On October 13, 2020, the Company, Loop Canada Inc. and certain of their officers and directors were named as defendants in a proposed securities class action filed in the Superior Court of Québec (District of Terrebonne, Province of Québec, Canada), in file no. 700-06-000012-205. The Application for authorization of a class action and for authorization to bring an action pursuant to section 225.4 of the Québec Securities Act (“the Application”) was filed by an individual shareholder on behalf of himself and a class of buyers who purchased our securities during the “Class Period” (not defined). Plaintiff alleges that throughout the Class Period, the defendants allegedly made false and/or misleading statements and allegedly failed to disclose material adverse facts concerning the Company’s technology, business model, operations and prospects, thus causing the Company’s stock price to be artificially inflated and thereby causing plaintiff to suffer damages. Plaintiff seeks unspecified damages stemming from losses he claims to have suffered as a result of the foregoing. On December 13, 2020, the Application was amended in order to add allegations regarding specific misrepresentations.

 

On October 28, 2020, the Company and certain of its officers were named as defendants in a second proposed class action lawsuit filed in the United States District Court for the Southern District of New York, captioned Michelle Bazzini, Individually and on Behalf of All Other Similarly Situated v. Loop Industries, Inc., Daniel Solomita, and Nelson Gentiletti, Case No. 7:20-cv-09031-UA. The allegations in this complaint are similar in nature to those made in the Tremblay Class Action.

 

On January 4, 2021, the United States District Court for the Southern District of New York rendered a stipulation and order granting the consolidation of the two class action lawsuits filed in New York as In re Loop Industries, Inc. Securities Litigation, Master File No. 7:20-cv-08538. Sakari Johansson and John Jay Cappa have been appointed as Co-Lead Plaintiffs and Glancy Prongay & Murray LLP and Pomerantz LLP have been appointed as Co-Lead Counsel for the class.

 

Management believes that these cases lack merit and intends to defend them vigorously. No amounts have been provided for in the consolidated financial statements with respect to these claims. Management has not yet determined what effect these lawsuits may have on its financial position or results of operations as they are still in the preliminary stages.

 

XML 37 R25.htm IDEA: XBRL DOCUMENT v3.20.4
Subsequent Events
9 Months Ended
Nov. 30, 2020
Subsequent Events [Abstract]  
Subsequent Events

Subsequent to the end of the quarter, the Company entered into an engineering and equipment supply agreement to acquire PET polymerization equipment from Chemtex Global Corporation to manufacture PET resin at the demonstration plant. This agreement represents a total commitment of $4,200,000.

XML 38 R26.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies (Policies)
9 Months Ended
Nov. 30, 2020
Accounting Policies [Abstract]  
Use of estimates

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for depreciable lives of property, plant and equipment, intangible assets, analysis of impairments of long-lived assets and intangible assets, accruals for potential liabilities and assumptions made in calculating the fair value of stock-based compensation and other equity instruments.

 

The COVID-19 pandemic has disrupted business operations for us and our customers, suppliers, vendors and other parties with whom we do business, and such disruptions are expected to continue for an indefinite period of time. The uncertain duration of these measures has had and may continue to have an effect on our development and commercialization efforts. In particular, as previously disclosed, the situation in the United States and the continued travel restrictions and quarantine requirements between Canada and the United States have caused disruptions in our timetable of our joint venture with Indorama in the development of our Spartanburg facility and commercialization of our technology.

 

Although the Company continues to monitor the situation and may adjust the Company’s current policies as more information and public health guidance become available, the COVID-19 pandemic is ongoing, and its dynamic nature, including uncertainties relating to the ultimate spread of the virus, the severity of the disease, the duration of the outbreak and actions that may be taken by governmental authorities to contain the outbreak or to treat its impact, makes it difficult to assess whether there will be further impact on the development and commercialization of the Company’s technology which could have a material adverse effect on the Company’s results of operations and cash flows.

 

Foreign currency translations and transactions

The accompanying unaudited condensed consolidated financial statements are presented in U.S. dollars, the reporting currency of the Company. Assets and liabilities of subsidiaries that have a functional currency other than that of the Company are translated to U.S. dollars at the exchange rate as at the balance sheet date. Income and expenses are translated at the average exchange rate of the period. The resulting translation adjustments are included in other comprehensive income (loss) (“OCI”). As a result, foreign currency exchange fluctuations may impact operating expenses. The Company currently has not engaged in any currency hedging activities.

 

For transactions and balances, monetary assets and liabilities denominated in foreign currencies are translated into the functional currency of the entity at the prevailing exchange rate at the reporting date. Non-monetary assets and liabilities, and revenue and expense items denominated in foreign currencies are translated into the functional currency using the exchange rate prevailing at the dates of the respective transactions. Foreign exchange gains and losses resulting from the settlement of such transactions are recognized in the consolidated statements of operations and comprehensive loss, except for gains or losses arising from the translation of intercompany balances denominated in foreign currencies that forms part in the net investment in the subsidiary which are included in OCI.

 

Stock-based compensation

The Company periodically issues stock options, warrants and restricted stock units to employees and non-employees in non-capital raising transactions for services and financing expenses. The Company accounts for stock options granted to employees based on the authoritative guidance provided by the FASB wherein the fair value of the award is measured on the grant date and where there are no performance conditions, recognized as compensation expense on the straight-line basis over the vesting period and where performance conditions exist, recognize compensation expense when it becomes probable that the performance condition will be met. Forfeitures on share-based payments are accounted for by recognizing forfeitures as they occur.

 

The Company accounts for stock options and warrants granted to non-employees in accordance with the authoritative guidance of the FASB wherein the fair value of the stock compensation is based upon the measurement date determined as the earlier of the date at which either a) a commitment is reached with the counterparty for performance or b) the counterparty completes its performance.

 

The Company estimates the fair value of restricted stock unit awards to employees and directors based on the closing market price of its common stock on the date of grant.

 

The fair value of the stock options granted are estimated using the Black-Scholes-Merton Option Pricing (“Black-Scholes”) model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options, and future dividends. Stock-based compensation expense is recorded based on the value derived from the Black-Scholes model and on actual experience. The assumptions used in the Black-Scholes model could materially affect stock-based compensation expense recorded in the current and future periods.

 

Income taxes

The Company calculates its provision for income tax on the basis of the tax laws enacted at the balance sheet date in the countries where the Company and its subsidiaries operate and generate taxable income, in accordance with FASB ASC 740, Income Taxes. The Company uses an asset and liability approach for financial accounting and reporting for income taxes that allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The Company’s policy is to recognize interest and/or penalties related to income tax matters in income tax expense.

 

Research and development expenses

Research and development expenses relate primarily to the development, design, testing of preproduction samples, prototypes and models, compensation, and consulting fees, and are expensed as incurred. Starting in the current quarter, machinery and equipment purchases related to the pilot plant which is now dedicated solely to research and development activities with no alternative use are also expensed as incurred. Total research and development costs recorded during the three- and nine-month periods ended November 30, 2020 amounted to $6,724,283 and $10,504,093 (2019 – $1,278,172 and $3,246,246), respectively, and are net of government research and development tax credits and government grants from the federal and provincial taxation authorities accrued and recorded based on qualifying expenditures incurred during the fiscal periods.

 

Net earnings (loss) per share

The Company computes net loss per share in accordance with FASB ASC 260, Earnings Per Share. Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year. The Company includes common stock issuable in its calculation. Diluted earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation if their effect is antidilutive.

 

For the three- and nine-month periods ended November 30, 2020 and 2019, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have an antidilutive effect. As at November 30, 2020, the potentially dilutive securities consisted of 1,590,470 outstanding stock options (November 30, 2019 – 1,657,081), 4,171,609 outstanding restricted stock units (November 30, 2019 – 4,219,753) and 4,693,802 outstanding warrants (November 30, 2019 – 5,040,267).

 

Recently adopted accounting pronouncements

In August 2018, the FASB issued ASU 2018-15, “Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that Is a Service Contract,” which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). This update is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The adoption of the standard had no impact on the consolidated financial statements of the Company.

 

In February 2018, the FASB issued ASU 2018-02, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which permits entities to reclassify the disproportionate income tax effects of the Tax Reform Act on items within accumulated other comprehensive income (loss) (“AOCI”) to retained earnings. These disproportionate income tax effect items are referred to as "stranded tax effects." Amendments in this update only relate to the reclassification of the income tax effects of the Tax Reform Act. Other accounting guidance that requires the effect of changes in tax laws or rates to be included in net income from continuing operations is not affected by this update. ASU 2018-02 should be applied either in the period of adoption or retrospectively to each period in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Reform Act is recognized. ASU 2018-02 is applicable beginning March 1, 2020. The adoption of the standard had no impact on the consolidated financial statements of the Company.

 

In February 2016, the FASB issued ASU 2016-02, “Leases,” amended in July by ASU 2018-10, “Codification Improvements to Topic 842, Leases,” ASU 2018-11, “Targeted Improvements,” and ASU 2018-20, “Narrow-Scope Improvements for Lessors,” which requires lessees to recognize leases on the balance sheet while continuing to recognize expenses in the income statement in a manner similar to current accounting standards. For lessors, the new standard modifies the classification criteria and the accounting for sales-type and direct financing leases. Enhanced disclosures will also be required to give financial statement users the ability to assess the amount, timing, and uncertainty of cash flows arising from leases. This ASU may either be adopted on a modified retrospective approach at the beginning of the earliest comparative period, or through a cumulative-effect adjustment at the adoption date. This update is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company adopted these standards effective March 1, 2020. The adoption of the standard had no impact on the consolidated financial statements of the Company. The Company elected to apply the package of practical expedients that allows us not to reassess whether expired or existing contracts contain leases, the classification of these leases and whether previously capitalized initial direct costs would qualify for capitalization under Accounting Standards Codification (or “ASC”) 842. Furthermore, we elected to use hindsight in determining the lease term and assessing impairment of the right-of-use assets.

 

Recently issued accounting pronouncements not yet adopted

 

In December 2019, the FASB issued ASU 2019-12, “Simplifying the Accounting for Income Taxes,” which removes specific exceptions to the general principles in ASC 740, “Income Taxes,” and clarifies certain aspects of the existing guidance. This update is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years, with early adoption being permitted as of the beginning of an interim or annual reporting period. All amendments to this ASU must be adopted in the same period on a prospective basis, with certain exceptions. We are still evaluating the impact of this accounting guidance on our results of operations and financial position.

 

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments—Credit Losses”. This ASU added a new impairment model (known as the current expected credit loss (“CECL”) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes an allowance for its estimate of expected credit losses and applies to most debt instruments, trade receivables, lease receivables, financial guarantee contracts, and other loan commitments. The CECL model does not have a minimum threshold for recognition of impairment losses and entities will need to measure expected credit losses on assets that have a low risk of loss. This update is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years for smaller reporting companies. We are still evaluating the impact of this accounting guidance on our results of operations and financial position.

 

XML 39 R27.htm IDEA: XBRL DOCUMENT v3.20.4
Sales Tax, Tax Credits and Other Receivables (Tables)
9 Months Ended
Nov. 30, 2020
Receivables [Abstract]  
Sales tax, tax credits and other receivables
    November 30, 2020     February 29, 2020  
Sales tax   $ 669,966     $ 180 971  
Research and development tax credits     390,885       447,843  
Other receivables     121,256       35,730  
    $ 1,182,107     $ 664,544  
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.20.4
Prepaid Expenses and Deposits (Tables)
9 Months Ended
Nov. 30, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Prepaid expenses
    November 30, 2020     February 29, 2020  
Deposits on machinery and equipment   $ 747,250     $ -  
Insurance     427,013       61,891  
Other prepaid expenses     56,179       79,335  
    $ 1,230,442     $ 141,226  
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.20.4
Property, Plant and Equipment (Tables)
9 Months Ended
Nov. 30, 2020
Property, Plant and Equipment [Abstract]  
Property, plant and equipment
    As at November 30, 2020  
    Cost     Accumulated depreciation, write-down and impairment     Net book value  
Building   $ 1,912,138     $ (181,308 )   $ 1,730,830  
Land     236,360       -       236,360  
Building and land improvements     1,602,766       (379,164 )     1,223,602  
Machinery and equipment     6,514,252       (6,514,252 )      -  
Office equipment and furniture     260,220       (95,602 )     164,618  
Balances, end of period   $ 10,525,736     $ (7,170,326 )   $ 3,355,410  

 

    As at February 29, 2020  
    Cost     Accumulated depreciation, write-down and impairment     Net book value  
Building   $ 1,846,070     $ (128,911 )   $ 1,717,159  
Land     264,868       -       264,868  
Building and land improvements     733,884       (214,068 )     519,816  
Machinery and equipment     6,085,195       (1,426,465 )     4,658,730  
Office equipment and furniture     162,466       (62,785 )     99,681  
Balances, end of period   $ 9,092,483     $ (1,832,229 )   $ 7,260,254  

 

XML 42 R30.htm IDEA: XBRL DOCUMENT v3.20.4
Intangible Assets (Tables)
9 Months Ended
Nov. 30, 2020
Finite-Lived Intangible Assets, Net [Abstract]  
Intangible assets
    November 30, 2020     February 29, 2020  
             
Intangible assets, at cost - beginning of period   $ 225,174     $ 127,672  
Intangible assets, accumulated depreciation – beginning of period     (22,311 )     -  
      202,863       127,672  
                 
Additions in the period     452,758       99,972  
Amortization of intangibles     (30,165 )     (22,631 )
Foreign exchange effect – increase (decrease)     6,133       (2,150 )
    $ 631,589     $ 202,863  
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value of Financial Instruments (Tables)
9 Months Ended
Nov. 30, 2020
Fair Value Disclosures [Abstract]  
Fair value of financial instruments
    Fair Value Measurements as at November 30, 2020  
    Carrying Amount     Fair Value     Level in the hierarchy  
Instruments measured at fair value on a recurring basis:                  
Foreign exchange contracts   $ (25,797 )   $ (25,797 )     Level 2  
                         
Instruments measured at amortized cost:                        
Long-term debt   $ 2,390,366     $ 2,400,897       Level 2  

 

    Fair Value Measurements at February 29, 2020  
    Carrying Amount     Fair Value     Level in the hierarchy  
Instruments measured at fair value on a recurring basis:                  
Foreign exchange contracts   $ 26,840     $ 26,840       Level 2  
                         
Instruments measured at amortized cost:                        
Long-term debt   $ 2,290,152     $ 2,291,109       Level 2  

 

XML 44 R32.htm IDEA: XBRL DOCUMENT v3.20.4
Accounts Payable and Accrued Liabilities (Tables)
9 Months Ended
Nov. 30, 2020
Payables and Accruals [Abstract]  
Accounts payable and accrued liabilities
    November 30, 2020     February 29, 2020  
Trade accounts payable   $ 1,514,881     $ 814,081  
Accrued engineering fees     686,061       -  
Accrued employee compensation and payroll taxes     678,925       873,242  
Accrued professional fees     676,153       133,038  
Accrued cost of machinery and equipment      415,522        92,126  
Other accrued liabilities     116,605       170,211  
    $ 4,088,147     $ 2,082,698  
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.20.4
Long-Term Debt (Tables)
9 Months Ended
Nov. 30, 2020
Long-term Debt, Unclassified [Abstract]  
Long-term debt
    November 30, 2020     February 29, 2020  
Investissement Québec financing facility:            
Principal amount   $ 1,703,998     $ 1,645,122  
Unamortized discount     (272,036 )     (289,852 )
Accrued interest     31,549       958  
Total Investissement Québec financing facility     1,463,511       1,356,228  
Term loan                
Principal amount     926,855       933,924  
Less: current portion     (53,992 )     (52,126 )
Total term loan, net of current portion     872,863       881,798  
Long-term debt, net of current portion   $ 2,336,374     $ 2,238,026  
Principal repayments
Years ending   Amount  
February 28, 2021   $ 13,498  
February 28, 2022     53,992  
February 28, 2023     53,992  
February 29, 2024     297,416  
February 28, 2025     297,416  
Thereafter     1,901,043  
Total   $ 2,617,355  
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders' Equity (Tables)
9 Months Ended
Nov. 30, 2020
Stockholders' Equity  
Common stock
For the period ended November 30, 2020   Number of shares     Amount  
Balance, February 29, 2020     39,910,774     $ 3,992  
Issuance of shares for cash     2,087,000       209  
Issuance of shares upon the exercise of warrants     190,529       19  
Issuance of shares upon settlement of restricted stock units     224,436       22  
Balance, November 30, 2020     42,412,739     $ 4,242  

 

For the period ended November 30, 2019   Number of shares     Amount  
Balance, February 28, 2019     33,805,706     $ 3,381  
Issuance of shares for cash     4,693,567       469  
Issuance of shares upon vesting of restricted stock units     243,932       24  
Issuance of shares upon the cashless exercise of stock options     4,565       1  
Issuance of shares upon the exercise of warrants     15,432       1  
Issuance of shares upon settlement of legal matter     150,000       15  
Issuance of shares upon conversion of Convertible notes     319,326       32  
Balance, November 30, 2019     39,232,528     $ 3,923  

 

XML 47 R35.htm IDEA: XBRL DOCUMENT v3.20.4
Research and Development Expenses (Tables)
9 Months Ended
Nov. 30, 2020
Research and Development [Abstract]  
Research and development expenses

Research and development expenses for the three months ended November 30, 2020 and 2019 were as follows:

 

    November 30, 2020     November 30, 2019  
External engineering   $ 2,224,910     $ 33,131  
Machinery and equipment expenditures     2,325,540       -  
Employee compensation     1,214,434       973,679  
Pilot plant operating expenses     399,031       166,753  
Other     110,368       104,610  
    $ 6,274,283     $ 1,278,173  

 

Research and development expenses for the nine months ended November 30, 2020 and 2019 were as follows:

 

    November 30, 2020      November 30, 2019  
External engineering   $ 3,241,959     $ 83,462  
Employee compensation     3,094,151       2,453,743  
Machinery and equipment expenditures     2,325,540       -  
Pilot plant operating expenses     1,537,271       456,942  
Other     305,172       252,099  
    $ 10,504,093     $ 3,246,246  

 

XML 48 R36.htm IDEA: XBRL DOCUMENT v3.20.4
Share-Based Payments (Tables)
9 Months Ended
Nov. 30, 2020
Share-based Payment Arrangement [Abstract]  
Key inputs into the valuation model
    2020     2019  
Exercise price   $ 8.78     $ -  
Risk-free interest rate     1.05 %     -  
Expected dividend yield     0.00 %     -  
Expected volatility     75.95 %     -  
Expected life

 

 

   7.5 years      -  
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.20.4
Equity Incentive Plan (Tables)
9 Months Ended
Nov. 30, 2020
Equity [Abstract]  
Equity incentive plan
    2020     2019  
    Number of units     Number of units  
Outstanding, beginning of period     1,300,518       3,223,516  
Share reserve increase     -       2,000,000  
Units granted     (183,621 )     (4,114,567 )
Units forfeited     2,989       93,652  
Units expired     -       260,417  
Outstanding, end of period     1,119,886       1,463,018  
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.20.4
Interest and Other Financial Costs (Tables)
9 Months Ended
Nov. 30, 2020
Interest And Other Finance Costs  
Interest and other financial costs

Interest and other finance costs for the three- and nine-month periods ended November 30, 2020 and 2019 are as follows:

 

    Three Months Ended November 30     Nine Months Ended November 30  
    2020     2019     2020     2019  
  Interest on long-term debt   $ 19,185     $ 14,778     $ 57,917     $ 41,840  
  Interest on convertible notes     -       98,000       -       313,433  
  Accretion expense     9,387       549,090       27,044       1,584,977  
  Amortization of deferred finance costs     -       19,885       -       86,212  
  Loss (gain) on revaluation of foreign exchange contracts     (70,427 )     10,881       (58,945 )     10,881  
  Revaluation of warrants     -       -       -       8,483  
  Gain on conversion of November 2018 Notes     -       -       -       (232,565 )
  Other     -       393       -       3,830  
    $ (41,855 )   $ 693,027     $ 26,016     $ 1,817,091  

 

XML 51 R39.htm IDEA: XBRL DOCUMENT v3.20.4
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Nov. 30, 2020
Nov. 30, 2019
Nov. 30, 2020
Nov. 30, 2019
Research and development expenses $ 6,274,283 $ 1,278,172 $ 10,504,093 $ 3,246,246
Stock Options        
Antidilutive securities     1,590,470 1,657,081
Restricted Stock Units        
Antidilutive securities     4,171,609 4,219,753
Warrants        
Antidilutive securities     4,693,802 5,040,267
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.20.4
Sales Tax, Tax Credits and Other Receivables (Details) - USD ($)
Nov. 30, 2020
Feb. 29, 2020
Receivables [Abstract]    
Sales tax $ 669,966 $ 180,971
Research and development tax credits 390,885 447,843
Other receivables 121,256 35,730
Sales tax, research and development tax credits and other receivables $ 1,182,107 $ 664,544
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.20.4
Prepaid Expenses and Deposits (Details) - USD ($)
Nov. 30, 2020
Feb. 29, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Deposits on machinery and equipment $ 747,250 $ 0
Insurance 427,013 61,891
Other prepaid expenses 56,179 79,335
Prepaid expenses $ 1,230,442 $ 141,226
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.20.4
Property, Plant and Equipment (Details) - USD ($)
Nov. 30, 2020
Feb. 29, 2020
Property, plant and equipment, gross $ 10,525,736 $ 9,092,483
Less: accumulated depreciation, write-down and impairment (7,170,326) (1,832,229)
Property, plant and equipment, net 3,355,410 7,260,254
Building    
Property, plant and equipment, gross 1,912,138 1,846,070
Less: accumulated depreciation, write-down and impairment (181,308) (128,911)
Property, plant and equipment, net 1,730,830 1,717,159
Land    
Property, plant and equipment, gross 236,360 264,868
Less: accumulated depreciation, write-down and impairment 0 0
Property, plant and equipment, net 236,360 264,868
Building and Land Improvements    
Property, plant and equipment, gross 1,602,766 733,884
Less: accumulated depreciation, write-down and impairment (379,164) (214,068)
Property, plant and equipment, net 1,223,602 519,816
Machinery and Equipment    
Property, plant and equipment, gross 6,514,252 6,085,195
Less: accumulated depreciation, write-down and impairment (6,514,252) (1,426,465)
Property, plant and equipment, net 0 4,658,730
Office Equipment and Furniture    
Property, plant and equipment, gross 260,220 162,466
Less: accumulated depreciation, write-down and impairment (95,602) (62,785)
Property, plant and equipment, net $ 164,618 $ 99,681
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.20.4
Property, Plant and Equipment (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Nov. 30, 2020
Nov. 30, 2019
Nov. 30, 2020
Nov. 30, 2019
Property, Plant and Equipment [Abstract]        
Depreciation expense $ 93,006 $ 212,968 $ 624,189 $ 570,165
Write-down and impairment expenses 5,034,606 0 5,043,120 22,985
Purchase of machinery and equipment $ 2,325,540
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.20.4
Intangible Assets (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Nov. 30, 2020
Nov. 30, 2019
Nov. 30, 2020
Nov. 30, 2019
Feb. 29, 2020
Finite-Lived Intangible Assets, Net [Abstract]          
Intangible assets, at cost - beginning of period $ 225,174   $ 225,174   $ 127,672
Intangible assets, accumulated depreciation (22,311)   (22,311)   0
Total 202,863   202,863   127,672
Add: additions in the year     452,758   99,972
Deduct: amortization of intangibles (11,301) $ (6,660) (30,165) $ (15,202) (22,631)
Foreign exchange effect - increase (decrease)     6,133   (2,150)
Total $ 631,590   $ 631,590   $ 202,863
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.20.4
Intangible Assets (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Nov. 30, 2020
Nov. 30, 2019
Nov. 30, 2020
Nov. 30, 2019
Feb. 29, 2020
Finite-Lived Intangible Assets, Net [Abstract]          
Amortization expense $ 11,301 $ 6,660 $ 30,165 $ 15,202 $ 22,631
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value of Financial Instruments (Details) - USD ($)
Nov. 30, 2020
Feb. 29, 2020
Carrying amount $ 6,478,513 $ 4,372,850
Foreign Exchange Contracts | Level 2    
Carrying amount (25,797) 26,840
Fair value (25,797) 26,840
Long-Term Debt | Level 2    
Carrying amount 2,390,366 2,290,152
Fair value $ 2,400,897 $ 2,291,109
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.20.4
Accounts Payable and Accrued Liabilities (Details) - USD ($)
Nov. 30, 2020
Feb. 29, 2020
Payables and Accruals [Abstract]    
Trade accounts payable $ 1,514,881 $ 814,081
Accrued engineering fees 686,061 0
Accrued employee compensation and payroll taxes 678,925 873,242
Accrued professional fees 676,153 133,038
Accrued cost of machinery and equipment 415,522 92,126
Other accrued liabilities 116,605 170,211
Accounts payable and accrued liabilities $ 4,088,147 $ 2,082,698
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.20.4
Long-Term Debt (Details) - USD ($)
Nov. 30, 2020
Feb. 29, 2020
Principal amount $ 2,617,355  
Less: current portion (53,992) $ (52,126)
Long-term debt, net of current portion 2,336,374 2,238,026
Investissement Québec Financing Facility    
Principal amount 1,703,998 1,645,122
Unamortized discount (272,036) (289,852)
Accrued interest 31,549 958
Less: current portion 0 0
Long-term debt, net of current portion 1,463,511 1,356,228
Term Loan    
Principal amount 926,855 933,924
Unamortized discount 0 0
Accrued interest 0 0
Less: current portion (53,992) (52,126)
Long-term debt, net of current portion $ 872,863 $ 881,798
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.20.4
Long-Term Debt (Details 1)
Nov. 30, 2020
USD ($)
Long-term Debt, Unclassified [Abstract]  
February 28, 2021 $ 13,498
February 28, 2022 53,992
February 28, 2023 53,992
February 29, 2024 297,416
February 28, 2025 297,416
Thereafter 1,901,043
Total $ 2,617,355
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.20.4
Long-Term Debt (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Nov. 30, 2020
Nov. 30, 2019
Nov. 30, 2020
Nov. 30, 2019
Repayment     $ 32,781 $ 39,506
Investissement Québec Financing Facility        
Interest expense $ 10,003 $ 0 28,816 0
Accretion expense 9,387 0 27,045 0
Term Loan        
Repayment 13,497 13,168 32,781 39,506
Interest paid $ 9,172 $ 14,778 $ 29,102 $ 41,840
XML 63 R51.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders' Equity (Details) - USD ($)
3 Months Ended 9 Months Ended
Nov. 30, 2020
Nov. 30, 2019
Nov. 30, 2020
Nov. 30, 2019
Beginning balance, amount $ 31,593,424 $ 39,283,023 $ 38,463,708 $ 2,626,392
Issuance of common shares for cash, net of share issuance expenses (Note 12), amount 24,996,628   24,996,628 39,023,632
Issuance of shares upon vesting of restricted stock units (Note 13), amount 0 0 0 0
Issuance of shares upon the cashless exercise of stock options (Note 13), amount       0
Issuance of shares upon exercise of warrants (Note 15), amount 1,652,628   1,652,627 143,749
Issuance of shares for legal settlement, amount       0
Issuance of shares upon conversion of convertible notes, amount       2,689,510
Ending balance, amount $ 45,034,851 $ 36,316,469 $ 45,034,851 $ 36,316,469
Common Stock        
Beginning balance, shares 39,935,210 39,032,528 39,910,774 33,805,706
Beginning balance, amount $ 3,994 $ 3,903 $ 3,992 $ 3,381
Issuance of common shares for cash, net of share issuance expenses (Note 12), shares 2,087,000   2,087,000 4,693,567
Issuance of common shares for cash, net of share issuance expenses (Note 12), amount $ 209   $ 209 $ 469
Issuance of shares upon vesting of restricted stock units (Note 13), shares 200,000 200,000 224,436 243,932
Issuance of shares upon vesting of restricted stock units (Note 13), amount $ 20 $ 20 $ 22 $ 24
Issuance of shares upon the cashless exercise of stock options (Note 13), shares     4,565
Issuance of shares upon the cashless exercise of stock options (Note 13), amount     $ 1
Issuance of shares upon exercise of warrants (Note 15), shares 190,529   190,529 15,432
Issuance of shares upon exercise of warrants (Note 15), amount $ 19   $ 19 $ 1
Issuance of shares for legal settlement, shares     150,000
Issuance of shares for legal settlement, amount     $ 15
Issuance of shares upon conversion of convertible notes, shares     319,326
Issuance of shares upon conversion of convertible notes, amount     $ 32
Ending balance, shares 42,412,739 39,232,528 42,412,739 39,232,528
Ending balance, amount $ 4,242 $ 3,923 $ 4,242 $ 3,923
XML 64 R52.htm IDEA: XBRL DOCUMENT v3.20.4
Research and Development Expenses (Details) - USD ($)
3 Months Ended 9 Months Ended
Nov. 30, 2020
Nov. 30, 2019
Nov. 30, 2020
Nov. 30, 2019
Research and development expenses $ 6,274,283 $ 1,278,172 $ 10,504,093 $ 3,246,246
External Engineering        
Research and development expenses 2,224,910 33,131 3,241,959 83,462
Machinery and Equipment        
Research and development expenses 2,325,540 0 2,325,540 0
Employee Compensation        
Research and development expenses 1,214,434 973,679 3,094,151 2,453,743
Pilot Plant Operating Expenses        
Research and development expenses 399,031 166,753 1,537,271 456,942
Other        
Research and development expenses $ 110,368 $ 104,610 $ 305,172 $ 252,099
XML 65 R53.htm IDEA: XBRL DOCUMENT v3.20.4
Share-Based Payments (Details) - $ / shares
9 Months Ended
Nov. 30, 2020
Nov. 30, 2019
Share-based Payment Arrangement [Abstract]    
Exercise price $ 8.78
Risk-free interest rate 1.05%
Expected dividend yield 0.00%
Expected volatility 75.95%
Expected life 7 years 6 months  
XML 66 R54.htm IDEA: XBRL DOCUMENT v3.20.4
Share-Based Payments (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Nov. 30, 2020
Nov. 30, 2019
Nov. 30, 2020
Nov. 30, 2019
Stock options outstanding 1,587,081 1,657,081 1,587,081 1,657,081
Stock options outstanding, weighted average exercise price $ 6.81 $ 6.55 $ 6.81 $ 6.55
Stock options exercisable 1,132,498 1,007,498 1,132,498 1,007,498
Stock options exercisable, weighted average exercise price $ 7.12 $ 6.38 $ 7.12 $ 6.38
Stock option expense $ 551,720 $ 549,810 $ 1,662,155 $ 1,628,897
Stock-based compensation expense     2,774,749 2,610,811
Research and Development Expenses        
Stock-based compensation expense 350,393 311,353 1,054,682 941,142
General and Administrative Expenses        
Stock-based compensation expense $ 546,601 $ 565,440 $ 1,720,067 $ 1,669,669
Restricted Stock Units        
Restricted stock units granted 57,859 0 180,232 4,114,567
Restricted stock units granted, weighted average exercise price $ 12.96 $ 0.00 $ 10.18 $ 1.06
Restricted stock units settled 200,000 200,000 224,436 243,932
Restricted stock units settled, weighted average exercise price $ .80 $ 0.80 $ 1.78 $ 2.52
Restricted stock units forfeited 0 0 2,989 53,570
Restricted stock units forfeited, weighted average exercise price $ .00 $ .00 $ 8.78 $ 9.82
Restricted stock units outstanding 4,171,609 4,219,753 4,171,609 4,219,753
Restricted stock units vested     691,327 831,684
Stock-based compensation expense $ 345,274 $ 326,983 $ 1,028,152 $ 981,914
XML 67 R55.htm IDEA: XBRL DOCUMENT v3.20.4
Equity Incentive Plan (Details) - Equity Incentive Plan - shares
9 Months Ended
Nov. 30, 2020
Nov. 30, 2019
Outstanding, beginning 1,300,518 3,223,516
Share reserve increase 0 2,000,000
Units granted (183,621) (4,114,567)
Units forfeited 2,989 93,652
Units expired 0 260,417
Outstanding, ending 1,119,886 1,463,018
XML 68 R56.htm IDEA: XBRL DOCUMENT v3.20.4
Warrants (Details Narrative) - Warrants - $ / shares
9 Months Ended
Nov. 30, 2020
Nov. 30, 2019
Warrants issued 25,000 159,663
Warrants issued, weighted average exercise price $ 9.43 $ 8.55
Warrants exercised 159,664 15,432
Warrants exercised, weighted average exercise price $ 8.55 $ 9.32
XML 69 R57.htm IDEA: XBRL DOCUMENT v3.20.4
Interest and Other Financial Costs (Details) - USD ($)
3 Months Ended 9 Months Ended
Nov. 30, 2020
Nov. 30, 2019
Nov. 30, 2020
Nov. 30, 2019
Interest And Other Finance Costs        
Interest on long-term debt $ 19,185 $ 14,778 $ 57,917 $ 41,840
Interest on convertible notes 0 98,000 0 313,433
Accretion expense 9,387 549,090 27,044 1,584,977
Amortization of deferred finance costs 0 19,885 0 86,212
Loss (gain) on revaluation of foreign exchange contracts (70,427) 10,881 (58,945) 10,881
Revaluation of warrants 0 0 0 8,483
Gain on conversion of November 2018 Notes 0 0 0 (232,565)
Other 0 393 0 3,830
Interest and other finance costs $ (41,855) $ 693,027 $ 26,016 $ 1,817,091
EXCEL 70 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 72 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 73 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 154 288 1 false 31 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://loopindustries.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://loopindustries.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://loopindustries.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://loopindustries.com/role/StatementsOfOperationsAndComprehensiveLoss Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statement of Changes in Stockholders Equity (Unaudited) Sheet http://loopindustries.com/role/StatementOfChangesInStockholdersEquity Condensed Consolidated Statement of Changes in Stockholders Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://loopindustries.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - The Company, Basis of Presentation Sheet http://loopindustries.com/role/CompanyBasisOfPresentation The Company, Basis of Presentation Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://loopindustries.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Sales Tax, Tax Credits and Other Receivables Sheet http://loopindustries.com/role/SalesTaxTaxCreditsAndOtherReceivables Sales Tax, Tax Credits and Other Receivables Notes 9 false false R10.htm 00000010 - Disclosure - Prepaid Expenses and Deposits Sheet http://loopindustries.com/role/PrepaidExpensesAndDeposits Prepaid Expenses and Deposits Notes 10 false false R11.htm 00000011 - Disclosure - Property, Plant and Equipment Sheet http://loopindustries.com/role/PropertyPlantAndEquipment Property, Plant and Equipment Notes 11 false false R12.htm 00000012 - Disclosure - Intangible Assets Sheet http://loopindustries.com/role/IntangibleAssets Intangible Assets Notes 12 false false R13.htm 00000013 - Disclosure - Fair Value of Financial Instruments Sheet http://loopindustries.com/role/FairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 13 false false R14.htm 00000014 - Disclosure - Accounts Payable and Accrued Liabilities Sheet http://loopindustries.com/role/AccountsPayableAndAccruedLiabilities Accounts Payable and Accrued Liabilities Notes 14 false false R15.htm 00000015 - Disclosure - Joint Venture Sheet http://loopindustries.com/role/JointVenture Joint Venture Notes 15 false false R16.htm 00000016 - Disclosure - Long-Term Debt Sheet http://loopindustries.com/role/Long-termDebt Long-Term Debt Notes 16 false false R17.htm 00000017 - Disclosure - Related Party Transactions Sheet http://loopindustries.com/role/RelatedPartyTransactions Related Party Transactions Notes 17 false false R18.htm 00000018 - Disclosure - Stockholders' Equity Sheet http://loopindustries.com/role/StockholdersEquity Stockholders' Equity Notes 18 false false R19.htm 00000019 - Disclosure - Research and Development Expenses Sheet http://loopindustries.com/role/ResearchAndDevelopmentExpenses Research and Development Expenses Notes 19 false false R20.htm 00000020 - Disclosure - Share-Based Payments Sheet http://loopindustries.com/role/Share-basedPayments Share-Based Payments Notes 20 false false R21.htm 00000021 - Disclosure - Equity Incentive Plan Sheet http://loopindustries.com/role/EquityIncentivePlan Equity Incentive Plan Notes 21 false false R22.htm 00000022 - Disclosure - Warrants Sheet http://loopindustries.com/role/Warrants Warrants Notes 22 false false R23.htm 00000023 - Disclosure - Interest and Other Finance Costs Sheet http://loopindustries.com/role/InterestAndOtherFinanceCosts Interest and Other Finance Costs Notes 23 false false R24.htm 00000024 - Disclosure - Commitments and Contingencies Sheet http://loopindustries.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 24 false false R25.htm 00000025 - Disclosure - Subsequent Events Sheet http://loopindustries.com/role/SubsequentEvents Subsequent Events Notes 25 false false R26.htm 00000026 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://loopindustries.com/role/SummaryOfSignificantAccountingPolicies 26 false false R27.htm 00000027 - Disclosure - Sales Tax, Tax Credits and Other Receivables (Tables) Sheet http://loopindustries.com/role/SalesTaxTaxCreditsAndOtherReceivablesTables Sales Tax, Tax Credits and Other Receivables (Tables) Tables http://loopindustries.com/role/SalesTaxTaxCreditsAndOtherReceivables 27 false false R28.htm 00000028 - Disclosure - Prepaid Expenses and Deposits (Tables) Sheet http://loopindustries.com/role/PrepaidExpensesAndDepositsTables Prepaid Expenses and Deposits (Tables) Tables http://loopindustries.com/role/PrepaidExpensesAndDeposits 28 false false R29.htm 00000029 - Disclosure - Property, Plant and Equipment (Tables) Sheet http://loopindustries.com/role/PropertyPlantAndEquipmentTables Property, Plant and Equipment (Tables) Tables http://loopindustries.com/role/PropertyPlantAndEquipment 29 false false R30.htm 00000030 - Disclosure - Intangible Assets (Tables) Sheet http://loopindustries.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://loopindustries.com/role/IntangibleAssets 30 false false R31.htm 00000031 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://loopindustries.com/role/FairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://loopindustries.com/role/FairValueOfFinancialInstruments 31 false false R32.htm 00000032 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) Sheet http://loopindustries.com/role/AccountsPayableAndAccruedLiabilitiesTables Accounts Payable and Accrued Liabilities (Tables) Tables http://loopindustries.com/role/AccountsPayableAndAccruedLiabilities 32 false false R33.htm 00000033 - Disclosure - Long-Term Debt (Tables) Sheet http://loopindustries.com/role/Long-termDebtTables Long-Term Debt (Tables) Tables http://loopindustries.com/role/Long-termDebt 33 false false R34.htm 00000034 - Disclosure - Stockholders' Equity (Tables) Sheet http://loopindustries.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://loopindustries.com/role/StockholdersEquity 34 false false R35.htm 00000035 - Disclosure - Research and Development Expenses (Tables) Sheet http://loopindustries.com/role/ResearchAndDevelopmentExpensesTables Research and Development Expenses (Tables) Tables http://loopindustries.com/role/ResearchAndDevelopmentExpenses 35 false false R36.htm 00000036 - Disclosure - Share-Based Payments (Tables) Sheet http://loopindustries.com/role/Share-basedPaymentsTables Share-Based Payments (Tables) Tables http://loopindustries.com/role/Share-basedPayments 36 false false R37.htm 00000037 - Disclosure - Equity Incentive Plan (Tables) Sheet http://loopindustries.com/role/EquityIncentivePlanTables Equity Incentive Plan (Tables) Tables http://loopindustries.com/role/EquityIncentivePlan 37 false false R38.htm 00000038 - Disclosure - Interest and Other Financial Costs (Tables) Sheet http://loopindustries.com/role/InterestAndOtherFinancialCostsTables Interest and Other Financial Costs (Tables) Tables 38 false false R39.htm 00000039 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://loopindustries.com/role/SummaryOfSignificantAccountingPoliciesPolicies 39 false false R40.htm 00000040 - Disclosure - Sales Tax, Tax Credits and Other Receivables (Details) Sheet http://loopindustries.com/role/SalesTaxTaxCreditsAndOtherReceivablesDetails Sales Tax, Tax Credits and Other Receivables (Details) Details http://loopindustries.com/role/SalesTaxTaxCreditsAndOtherReceivablesTables 40 false false R41.htm 00000041 - Disclosure - Prepaid Expenses and Deposits (Details) Sheet http://loopindustries.com/role/PrepaidExpensesAndDepositsDetails Prepaid Expenses and Deposits (Details) Details http://loopindustries.com/role/PrepaidExpensesAndDepositsTables 41 false false R42.htm 00000042 - Disclosure - Property, Plant and Equipment (Details) Sheet http://loopindustries.com/role/PropertyPlantAndEquipmentDetails Property, Plant and Equipment (Details) Details http://loopindustries.com/role/PropertyPlantAndEquipmentTables 42 false false R43.htm 00000043 - Disclosure - Property, Plant and Equipment (Details Narrative) Sheet http://loopindustries.com/role/PropertyPlantAndEquipmentDetailsNarrative Property, Plant and Equipment (Details Narrative) Details http://loopindustries.com/role/PropertyPlantAndEquipmentTables 43 false false R44.htm 00000044 - Disclosure - Intangible Assets (Details) Sheet http://loopindustries.com/role/IntangibleAssetsDetails Intangible Assets (Details) Details http://loopindustries.com/role/IntangibleAssetsTables 44 false false R45.htm 00000045 - Disclosure - Intangible Assets (Details Narrative) Sheet http://loopindustries.com/role/IntangibleAssetsDetailsNarrative Intangible Assets (Details Narrative) Details http://loopindustries.com/role/IntangibleAssetsTables 45 false false R46.htm 00000046 - Disclosure - Fair Value of Financial Instruments (Details) Sheet http://loopindustries.com/role/FairValueOfFinancialInstrumentsDetails Fair Value of Financial Instruments (Details) Details http://loopindustries.com/role/FairValueOfFinancialInstrumentsTables 46 false false R47.htm 00000047 - Disclosure - Accounts Payable and Accrued Liabilities (Details) Sheet http://loopindustries.com/role/AccountsPayableAndAccruedLiabilitiesDetails Accounts Payable and Accrued Liabilities (Details) Details http://loopindustries.com/role/AccountsPayableAndAccruedLiabilitiesTables 47 false false R48.htm 00000048 - Disclosure - Long-Term Debt (Details) Sheet http://loopindustries.com/role/Long-termDebtDetails Long-Term Debt (Details) Details http://loopindustries.com/role/Long-termDebtTables 48 false false R49.htm 00000049 - Disclosure - Long-Term Debt (Details 1) Sheet http://loopindustries.com/role/Long-termDebtDetails1 Long-Term Debt (Details 1) Details http://loopindustries.com/role/Long-termDebtTables 49 false false R50.htm 00000050 - Disclosure - Long-Term Debt (Details Narrative) Sheet http://loopindustries.com/role/Long-termDebtDetailsNarrative Long-Term Debt (Details Narrative) Details http://loopindustries.com/role/Long-termDebtTables 50 false false R51.htm 00000051 - Disclosure - Stockholders' Equity (Details) Sheet http://loopindustries.com/role/StockholdersEquityDetails Stockholders' Equity (Details) Details http://loopindustries.com/role/StockholdersEquityTables 51 false false R52.htm 00000052 - Disclosure - Research and Development Expenses (Details) Sheet http://loopindustries.com/role/ResearchAndDevelopmentExpensesDetails Research and Development Expenses (Details) Details http://loopindustries.com/role/ResearchAndDevelopmentExpensesTables 52 false false R53.htm 00000053 - Disclosure - Share-Based Payments (Details) Sheet http://loopindustries.com/role/Share-basedPaymentsDetails Share-Based Payments (Details) Details http://loopindustries.com/role/Share-basedPaymentsTables 53 false false R54.htm 00000054 - Disclosure - Share-Based Payments (Details Narrative) Sheet http://loopindustries.com/role/Share-basedPaymentsDetailsNarrative Share-Based Payments (Details Narrative) Details http://loopindustries.com/role/Share-basedPaymentsTables 54 false false R55.htm 00000055 - Disclosure - Equity Incentive Plan (Details) Sheet http://loopindustries.com/role/EquityIncentivePlanDetails Equity Incentive Plan (Details) Details http://loopindustries.com/role/EquityIncentivePlanTables 55 false false R56.htm 00000056 - Disclosure - Warrants (Details Narrative) Sheet http://loopindustries.com/role/WarrantsDetailsNarrative Warrants (Details Narrative) Details http://loopindustries.com/role/Warrants 56 false false R57.htm 00000057 - Disclosure - Interest and Other Financial Costs (Details) Sheet http://loopindustries.com/role/InterestAndOtherFinancialCostsDetails Interest and Other Financial Costs (Details) Details http://loopindustries.com/role/InterestAndOtherFinancialCostsTables 57 false false All Reports Book All Reports loop-20201130.xml loop-20201130.xsd loop-20201130_cal.xml loop-20201130_def.xml loop-20201130_lab.xml loop-20201130_pre.xml http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/us-gaap/2020-01-31 true true ZIP 76 0001654954-21-000482-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001654954-21-000482-xbrl.zip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

G,XX:?-&8A[A%7)*D_ M/0;T^=R0O2I7R 0*0E>D";1.T*3 &5S" \V"5[C+1C^57#VDA%W**\H%XYQY M&A00^"H(+*]P.$67[5.&]6%-@,$GX07P2$G?'*BI?$,735J>NE/U/ 4?H4N5 M_T,;PLA\)83]\RIKY<]U;EMJ54_OM^7PV\(OU^^?QGNB M;=%&0]E0:UUB[,:^<'8Y519YOR]+Z:*8!D '\L/0.:$M MH8K4^J9LXL:,[SY'#@6(/%"'LE[Y'LU9Y,AEY:-*BT M5XKZQCP\[[G%*H/? M0]N/;#HG;&=16QPX#>#/\<-':AQ&D<^L/BSB8I[NS8N*^,]])NPQK/F;#^45 MZ_#R""'+L)<&SGF$[[?P4OI@^R[SI+O "Z9N;,MK(UVW6.K382+X>_WHLHGT MD'(Q!D];D(MJ M8H4_GW:8LAV2% *#*E]B7<@L.V,=X>2/^67*>8*1QH_\I0!(>>IZ'IYZB*$P MO47F&1:\JBJ0VE.ZD GFA]'I$ OQ0)[BU3 "+!?&HC-LH"0,:4\#QYVX(@V/ MKP^6QI,V"DM 5(4N)1CR7(2YC['O/"E_N_L]?ZS^6N0O//%^H[MB Y'O\4A_ M^6K$R;)(7\#C&'Z 4-B+F$Z@2Y=PS\9XA,,F$WY$PK%JSQ =>.RQ6 LF+>0Q M\$!I1\EI7=ES:=%0V_7QSLC/S6\_V9WBC6EMQW.5)Q*2]%_%S-0MTM/)W'<)D0RFUQ,5\S&W+LV:'@YL<"AX"Y$KE1G)Q/DEXC9GET M)W%"=F5;?8_I/EC[.$W,XH6MTPQ96-SL,7ZTT71*$L>*CS@NED)>>,5G9<$/ M/-\5:971<70PY92/9;-GG@W('[\(VEIS&"E+>I*27W)NJ\M6DJ[/J:F@^PH; MB;*95Q'.YR3!6URU)7/0$Y@ZQIR2^9+9N'P5CW$ABL=V$8MCC[*J431X7-@L MJ3)-3$1OU3W\I@'+#VR7OL736RR5G5MKCAUHE4!S]R13 :I[1D^P.-O]0C:\ M/8\?@Q!PRI7\W'50!XG\"V$4"#WQZ>KNO2BE/<;\:1AXN4*]X\(2@U@D6%/Z M8BX_J=#W5Z0E7TK_>&24UI0L K46\$J4P$!+X=/ H'C>'_!E)XG-27X%9>,Y MQ61_KE$HY3*?L59"3Q!2% MER(?7@Z-+$?R]#(E;;1Z O!7G: M(^.[=,Y?K4;'TE'PQ2Z!N4\B99P+Y74)28U%[CJ1*O!ER5@_U>J[C,.S2+>H M48AX#UX4R>BRM&]![Q.6X]TK\T(?R2-5D8>U[]_W]8?7872'"D.MK3V\!VO= MB*M&N< +AENP/4U%[%0EC[IDM%=SQ"'Z6R=:P/$6JE0M&7O6])K&@]-[BNCA M)S>>.DK$ZDB136W__6W],GL*%A3, TE)E+0\;'\2Z[HKF2.:9LA&Y6+TK?) M.H?I;CDKZWAZ+U^D/ 30PI2=YL;;IT6Y)ANJ)@_U?:O<]Q7$&FL:KQG[\G&G M,J/Z8&4[X.=:X.= MNG6(NXQGX'IW/=AIR(.1+IN#X8D6<+R%#OI041(JHC)7/)-IKSA1ZS99,W1Y MI)_JWNT1E]F30":#NKV3.A8;'@0_01N(>QC7] M%;L8Z_6#F/4GJ)O;$(]DOH*R>HM0.<+^L$5<=^*9IL5N[Q MVY^@'GI'Y%'E8E1G>()Z3M/FKN3A/3Q>PW=]]5D"9JG9$6\;0O6\@Z1(;^'6 M5IQ=<^I A4_]L(?A&UAD63O%P2P=2A_,?E1ESU=NW:ZN>W3Y_>K#HF"D:KV<[;HA%IY,W9=X=@[J:/H1!A.T-@C%C#J^0 MK0WD ?;L,D7U_C*T[B2OJE!2L1SOBR7HRA1=<42Z@EKLZZ&.T,88Y>I5K!#< MQEA7!XAC_RE>&-4U378@+%.I:):)14&+VDKM%$Z'-*M0JH&(6JTK=!+RB\9) MF89*M8HZ0,-G2FI/1U39WTL(CC+(-\F^K?06/X(^%E4B1(T1GDS7,%%UVMSN M@)6OCO:V\KM0R/\FO&BH#:V(F)9:\.?-7D@R(N:96%CV7F^=2Z)-$76#)4W<=L\!BUEBL73$XJ+7_^^O7V;?;[-Q8QC#1> M^NNTYYLSO1*^V+S\NE] MC^9,^-1/)BY9R2%3PD]4+:0ME:$[B,2F$\)/5B:DZH(__@#L8/\#YH,(8!26 MK+GF,R]=HX&$C%9?R&S;]\%O(.1 RLFIRF=]QX M'E:^ZU5UF^N2PQXTKVNF;!IG?VWQ8N\%'I?H/HI@6*%=35>I3)4U%=/=3M6W M^V@+'0UU>3!L3?68BE#?NEX08S

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end